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Su m m a r y
The attenuated cell-lines of Leishmania mexicana Wild Type (Z. mexicana WT) and 
Leishmania major Wild Type (Z. major WT) known as Z. mexicana Hamid's line (H- 
line) and Z. major H-line, respectively have been established under the pressure of 
gentamicin which was routinely added to the medium to prevent bacterial 
contamination of promastigote culture. The mechanism by which gentamicin, an 
aminoglycoside, attenuates Z. mexicana WT is unknown.
Following culture of promastigotes of Z. mexicana WT (20 passages) and Z. major 
WT (11 passages) in HOMEM medium supplemented with 10% (v/v) FCS and 
gentamicin at 20 pg/ml, promastigotes of the two strains formed attenuated lines. Z. 
mexicana H-line was developed on four separate occasions with the same procedure 
and was stable in gentamicin-free medium for 23 weeks. There was no significant 
difference between the growth rate of promastigotes of Z. mexicana H-line and Z. 
mexicana WT in vitro. 12% of stationary phase promastigotes of Z. mexicana H-line 
were longer than that of promastigotes of Z. mexicana WT.
Total lysate protein of stationary or log phase promastigotes of Z. mexicana H-line and 
WT, on 10-20% SDS-PAGE gradient gel, showed some differences between protein 
expression o f the attenuated cell line and Z. mexicana WT. Two bands were detected 
around 66 kDa with stationary or log phase promastigotes o f Z. mexicana WT, 
whereas one (possibly two) line is absent with stationary and log phase promastigotes 
of Z. mexicana H-line. The optical density o f proteins in lysates of stationary phase 
promastigotes of two lines of Z. mexicana separated using SDS-PAGE was displayed 
with a Lane profile graph using Lab Works Image Acquisition and Analysis Software 
(UVP Laboratory products). The optical density o f protein of lysate o f L. mexicana H- 
line showed just one peak of protein with high concentration, whereas three peaks of 
protein are found in the same position o f graph o f Z. mexicana WT.
The comparative proteome analysis of the two lines of Z. mexicana using high- 
resolution techniques has been done using 2-dimentional electrophoresis (2-DE). Both 
lines o f Leishmania comprise patterns with a high density of spots in the gel with pH 
range pH 4-7. The results of proteome analysis of promastigotes of the two lines of Z. 
mexicana suggest that adaptation o f Z. mexicana H-line to grow in the presence of 
gentamicin has involved change in protein expression. The proteome analysis of
XIX
patterns of two lines of L. mexicana reveals high similarity and significant differences 
between attenuated line of Z. mexicana and Z. mexicana WT pattern have been found. 
One spot of pattern of Z. mexicana WT was shifted to less acidic position in the 
pattern of Z. mexicana H-line and one spot was absent from the pattern of Z. mexicana 
H-line. Two spots were found in the Z. mexicana WT gel, whereas the expression of 
these proteins by promastigotes o f Z. mexicana H-line decreased.
The ability of promastigotes o f Z. mexicana H-line to infect BMMs was similar to that 
of promastigotes of Z. mexicana WT. In contrast, however, to the continued 
intracellular growth of Z. mexicana WT, only a small population of amastigotes of Z. 
mexicana H-line survived within the infected macrophages at 72-96 h post infection. 
Macrophages infected with stationary phase promastigotes of either Z. mexicana WT 
or Z. mexicana H-line, however, led no significant difference in nitric oxide 
production.
Z. mexicana WT disseminated rapidly to the draining lymph node (LN) and visceral 
organs of BALB/c mice, whereas Z. mexicana H-line remained localized in the skin, at 
the site where the promastigotes were injected, and in the draining LN of BALB/c 
mice. The mice did not normally develop any lesions.
Following injection stationary phase promastigotes of Z. mexicana H-line at week 12, 
the epidermal cells from the site where the promastigoted were injected were 
transferred in to HOMEM medium. Amastigotes derived promastigote, were 
designated Z. mexicana HAD-line, grew very poorly in medium, with or vdthout 
gentamicin and morphology of 83% cells were amastigote forms in which some of 
them had a small size flagellum.
The levels of IFN-y, IL-2, IL-4, and IL-10 in the supernatant o f cultured splenocytes 
from the mice infected v\4th Z. mexicana H-line or Z. mexicana WT were measured at 
12 weeks post infection. It was found that the levels of IFN-y and IL-2 in the 
supernatant of cultured Ag-stimulated-splenocytes of mice infected with Z. mexicana 
H-line were significantly higher than those of mice infected with Z. mexicana WT. In 
contrast to the mice infected with Z. mexicana WT, IL-4 and IL-10 production by Ag- 
stimulated-splenocytes from mice infected with Z. mexicana H-line was significantly 
decreased.
All non-vaccinated mice infected with Z. mexicana WT developed large size, non­
healing lesions, whereas the vaccinated mice challenged with Z. mexicana WT
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developed small and some cases healing lesions over 22 weeks post infection. There 
was no protection against L. major in the mice vaccinated with L. mexicana H-line. 
The levels of IFN-y and IL-4 in the supernatant of cultured splenocytes from the mice 
immunized with L. mexicana H-line and challenged and infected mice with L. 
mexicana WT were measured. The level o f IFN-y in the supernatant of cultured Ag- 
stimulated-splenocytes of challenged mice was significantly greater than that of non- 
vaccinated mice infected with L. mexicana WT (P<0.005). In contrast to vaccinated 
mice, the amount o f IL-4 production by non-vaccinated mice infected with L. 
mexicana WT was higher than that of vaccinated mice challenged with L. mexicana 
WT at the same time.
In this study it has been demonstrated that in the presence of the attenuated cell line, 
L. mexicana WT were eliminated from the draining LN, skin and visceral organs. In 
contrast, L. mexicana WT disseminated and survived in the visceral organs of 
challenged mice in the absence of the attenuated cell line.
The preliminary results of interaction between stationary phase promastigotes of L. 
major H-line and macrophages showed the percentage of macrophages infected with 
promastigotes o f L. major H-line was 41% at 8 h and decreased to 10.5% at 96 h post 
infection. In contrast to L. major H-line, the percentage of infected macrophages with 
L. major WT was 46.5% and increased to 65% at 96 h post infection. The number of 
amastigotes of Z. major H-line within infected macrophages after 9 h incubation was 
94 amastigotes /ICO macrophages which rapidly decreased to 14 amastigotes / 100 
macrophages at 96 h post infection.
It was found BALB/c mice infected with Z. major H-line failed to develop cutaneous 
lesions during 12 weeks post infection. In contrast to Z. major H-line, all mice infected 
with Z. major WT went to grow non-healing lesions are the same period.
The dissemination of Z. major H-line and Z, major WT from the skin where the 
promastigotes were injected to visceral organs of BALB/c mice was investigated at 12 
weeks post infection. It was found that Z. major WT spread to BM, spleen, lung, 
popliteal LN, and skin. In contrast, Z. major H-line remained localized in the ECs and 
draining LN of (two up tree) mice.
The preliminary initially result showed that Z. major H-line induced protection in mice 
against infection with Z. major WT, All non-vaccinated mice developed progressive 
non-healing lesions that peaked in size at about 12 weeks post infection. In contrast to 
non-vaccinated mice the lesions developed slowly in vaccinated mice.
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C h a p t e r  O n e
G e n e r a l  I n t r o d u c t io n
1.1. Introduction
Leishmania spp. are obligatory intracellular protozoan parasites, which are 
responsible for a wide spectrum of diseases ranging from local, self-healing skin 
ulcers [cutaneous leishmaniasis (CL)] to a severe and life threatening systemic disease 
[visceral leishmanisis (VL)] (Pearson and Sousa, 1996).
The World Health Organisation (WHO) has identified leishmaniasis as a major target 
for eradication (Ivens and Smith, 1997). This disease affects approximately 12 million 
people, mostly children and young adults, with two million new cases occurring 
annually, and 350 million people at risk of infection in 88 countries, 82% of which are 
developing countries (WHO report, http://www.who.int/ctd/htmi/leish.html. 2000). 
Leishmania I Human immunodeficiency virus (HIV) co-infection is regarded as an 
emerging problem in 33 countries worldwide, especially in southern European 
countries, where up to 9% of all HIV cases suffer from either newly acquired or 
reactivated leishmaniasis (Desjeux, 1998; http://www.who.int/inf-fs/en/factll6.html.. 
2000). This combination of diseases produces a cumulative deficiency of the immune 
response since Leishmania parasites and HIV destroy the same cells, exponentially 
increasing disease severity and its consequences. It is expected that the number of 
Leishmania / HIV co-infections will continue to rise in the coming years and there are 
indications that cases are no longer restricted to endemic areas (Wolday et a l, 1999). 
There has been much recent interest in attempts to vaccinate against Leishmania 
infection because leishmanicidal drugs frequently have unpleasant side effects, are 
relatively ineffective against cutaneous leishmaniasis, and drug resistance exists in 
various endemic regions of the world (Jackson et al, 1990). In addition, many 
countries, where the. disease is endemic, are economically poor. As a result, major 
pharmaceutical companies have historically had little interest in anti-leishmanial drug 
development.
Vaccination with live Leishmania to produce self-healing lesion at an inconspicuous 
site has been practised for a long time in the Middle East (Liew and Donnell, 1993). 
This method induced resistance in at least 70% of the individuals treated, but serious 
clinical complications associated with the live vaccine emphasises the need for an 
attenuated or a defined vaccine against cutaneous leishmaniasis (Liew and Donnell, 
1993).
Some detailed knowledge of the parasite, the relationship of the parasite with its 
mammalian host cells and the mechanism by which this relationship determines the 
development of the ensuing immune response, are important for vaccination strategies 
against leishmaniasis.
1.2. Parasite
1.2.1. Classification
The genus Leishmania belongs to the Family Trypanosomatidea in the Class 
Kinetoplastidea (Cox, 1998). The parasite occurs as zoonotic infections of stray and 
domestic dogs, rodents, hyraxes, or sloths with variable penetration to man. At least 
30 species of Leishmania have been recognised (Lainson and Shaw, 1987), of which 
15 species of Leishmania with different geographical distributions and clinical 
features are pathogenic for humans (Bryceson, 1996). L. major is a distinct species 
but the L. mexicana complex includes five species (Cox, 1998):
i) L. amazonensis
ii) L. mexicana
iii) L. pifanoi
iv) L, gamhami
v) L. venezuelensis
1.2.2. Clinical manifestation
The two most important species in the L. mexicana complex and L, amazonensis 
which cause New World CL and New World diffuse CL (Cox, 1998).
L. mexicana causes cutaneous leishmaniasis in Central and South America. The 
disease is known as Chiclero’s ulcer and has been characterised by two forms: 
localised and disseminated lesions. Local cutaneous leishmaniasis is similar to 
lepromatous leprosy and is typically confined to a single, indolent, ulcerative lesion 
that remains for about 1 year, leaving a characteristic depressed circular scar. If the 
lesion involves the rim of the pinna it destroys the underlying cartilage. The pinna is
swollen, ulcerated or crested usually with a cartilage-attacking infection without 
ulceration and with few parasites (Walton, 1987).
L. major causes Old World CL. The lesions are described as ‘rural wet sores’ (Cox, 
1998).
1.2.3. Morphology
The parasite exists in two principal morphological forms:
Promastigote, a motile form with an anterior flagellum (1.5-3 x 10-20 pm) which 
resides in the midgut of the sandfly and can be grown in culture (Bryceson, 1996). 
Amastigote, a non-motile, oval form with only a very short flagellum with a 
maximum diameter of 2.5 x 6.8 pm which multiplies intracellularly in mononuclear 
phagocytes of the mammalian host (Bryceson, 1996).
Multiplication of each form is by binary fission (Bryceson, 1996).
1.2.4. Diagnosis
Infection is diagnosed by direct demonstration of the parasites (microscopy, culture, 
DNA or RNA analysis). Cutaneous leishmaniasis is diagnosed from lesion, while 
visceral leishmaniasis from biopsies of spleen, bone marrow, and other suspected sites 
of infection (Bryceson, 1996). Examination for cellular immune response to 
Leishmania can be made using leshmanin (a suspension of killed promastigotes 
derived from culture) inoculated into the dermis (ID) of the forearm. The area of 
inflammation is measured 48-72 hours later. Leishmaniasis can be diagnosed 
serologically by ELISA, immunofluorescence or agglutination assays (Berman,
1997).
1.2.5. Treatment
Local CL ulcers usually heal spontaneously and do not require treatment, but if 
visceral organs are involved chemotherapy is required, and drugs include pentavalent 
antimonials, pentamidine, liposomal amphotericin B, paromomycin, inteiferon-y 
(IFN-y), and others (reviewed by Berman, 1997).
1.2.6. Life Cycle
Leishmania species cycle between sandfly vectors and several mammalian hosts 
including humans. They are transmitted between long-lived mammalian hosts by 
short-lived sandflies.
1.2.6.1, In the sandfly
Development of Leishmania spp. in the digestive tract of sandflies involves several 
morphological transformations from the intracellular amastigote form via a succession 
of free and gut wall-attached promastigote stages to the infective promastigote forms 
(Stierhof et a l, 1999). The parasite multiplies in the midgut of female phlebotomine 
sandflies {Phlebotomus spp. and Lutzomyia spp.). In the Old Word, sandflies of the 
genus Phlebotomus transmit the disease, while in the Americas it is transmitted 
primarily by Lutzomyia species. Leishmania exist in three distinct forms in the 
digestive tract of the sandfly during their life cycle:
i) Amastigote forms, following ingestion of infected macrophages.
ii) Free and gut wall-attached promastigote forms.
iii) Infective promastigote forms, which occur in the mouthpart of the sandfly.
The life cycle in the sandfly can be divided into four stages: ingestion, transformation, 
colonisation, and transmission (Molyneux and Killick Kendrick, 1987).
I.2.6.I.I. Ingestion stage
Following ingestion of a blood meal from an infected host amastigotes are released 
from the parasitised macrophages and enveloped in the peritrophic membrane, which 
is secreted by the midgut cells (Molyneux and Killick Kendrick, 1987).
1.2.6.1.2. Transformation
Following differentiation o f the amastigotes, which were enclosed in the peritrophic 
membrane, into the promastigotes, an increasingly dense coat of a glycocalyx is 
formed on the surface of the promastigotes. The glycocalyx is composed o f a variety 
o f glycoconjugates that are bound to the surface of the promastigote by a 
glycophosphatidylinositol (GPI) anchor (Turco and Descoteaux, 1992; McConville 
and Ralton, 1997) and is thought to have barrier functions (Solbach and Laskay, 
2000).
It has been reported that glycoconjugates play crucial roles in the survival, 
development, and virulence in both developmental stages of the parasite (Ilg et al.,
1998). The major cell surface glycoconjugate is lipophosphoglycan (LPG) which is 
found over the entire surface of the parasite, including the flagellum (Mosser and 
Brittingham, 1997), LPG serves as a ligand for the attachment of non-infectious 
procyclic promastigotes to the midgut wall lining and may protect the parasites 
against the hydrolytic environment of the insect's digestive tract (Ilg et ah, 1998). 
Following rupture of the peritrophic membrane, after about 3 days, free-swimming 
promastigotes are released into the midgut (Stierhof et aL, 1999).
1.2 6.1.3. Colonization
The free promastigotes establish a colony o f parasites in the sand fly gut. They 
attach to a gel-like plug, which is formed mainly by parasite-derived mucin-like 
filamentous proteophosphoglycan (fPPG) (Stierhof et al,, 1999). Promastigotes 
differentiate into non-dividing metacyclic promastigotes, which have a structurally 
altered LPG (Sacks et al, 1995).
This modification is necessary to allow the infective form of the promastigotes to be 
released from the midgut and move toward the foregut (Pimenta et a l,  1992).
Three other important alterations occur as promastigotes progress from the procyclic 
to the metacyclic form. Metacyclic promastigotes have been shown to increase in the 
expression of:
I) The major surface glycoprotein 63 (gp63) (Kweider et aL, 1989).
n) Surface-associated acid phosphate activity (Gottlieb and Dwyer, 1981).
ni) Cysteine proteinases (Robertson and Coombs, 1992).
It has been reported that the metacyclic promastigote has individual distinct 
biochemical properties that separate it from the non-infective promastigote (Mottram 
et al., 1997). Metacyclic promastigotes are generally more elongated and thinner than 
procyclic forms (Mosser and Brittingham, 1997) showing increased motility in culture 
(Sacks et al., 1985).
1.2.6.1.4. Transmission
Metacyclic promastigotes migrate to the foregut and oesophagus of the sandfly, are 
suspended in the sandfly’s saliva and are ready to be inoculated during the blood 
meal. In the sandfly’s gut, the saliva probably promotes survival and development of 
the promastigotes, since feeding of Phlebotomus argentipes with L. donovani 
suspended in serum containing anti-saliva antibodies led to the death of a significant 
number of promastigotes and inhibited the promastigotes development in the foregut 
(Ghosh and Mukhopadhyay, 1998).
The life cycle of Leishmania in the sandfly
Ingestion stage 
(ingestion of infected host macrophages during blood meal)
Transmission stage 
(Metacyclic promastigotes migrate to the foregut and oesophagus)
Transformation stage 
(Differentiation of amastigotes into the promastigotes)
Colonization stage 
(The free promastigotes generate a colony of promastigotes in the 
midgut and then differentiate into metacyclic promastigotes)
1.2.6.2. In the mammalian host
I.2.6.2.I. Inoculation
Metacyclic promastigotes are inoculated into the skin of the vertebrate by an infected 
female sandfly’s bite. It was shown that about 75% of P. papatasi sandflies infected 
with L. major are able to transfer disease with less than 100 promastigotes (Warburg 
and Schlein, 1986). In the presence of saliva, promastigotes establish a successful 
infection. It was found that injection of both saliva and promastigotes of L. major or 
L. braziliensis into various strains of mice resulted in exacerbation of both the size of 
the lesion and the number of recoverable parasites even when a low inoculation (10^- 
10"^  promastigotes) was used for infection (Lima and Titus, 1996; Belkaid et aL,
1998). Under natural conditions, sandflies transmit very low numbers of 
promastigotes. Under experimental conditions, when promastigotes are usually
suspended in saline and inoculated by syringe into the skin of inbred mouse strains, 
the same low number of parasites will rarely cause disease, even in mouse strains, like 
BALB/c, which are extremely susceptible to L. major infection.
I.2.6.2.2. Binding of promastigotes to mononuclear phagocytes
Following transmission but before entry into their host cells, the surviving 
promastigotes are exposed to serum components, including factors of the complement 
system, for a relatively short time. The majority of non-metacyclic promastigotes are 
rapidly destroyed by complement factors (Mosser and Brittingham, 1997). The 
surviving promastigotes, which are relatively resistant to complement-mediated lysis, 
rapidly bind to resident or recruited cells of the monocyte / macrophage lineage 
including dendritic cells and Langerhans cells (Blank et al., 1993; Moll et al., 1995). 
Phagocytosis of promastigotes by macrophages requires the preliminary attachment of 
the promastigotes to a macrophage through either serum-dependent adhesions or 
serum-independent adhesions (Antoine et al., 1998).
i) Serum-dependent adhesion
The two most abundant surface structures on metacyclic promastigotes, gp63 and 
LPG, have both been identified as C3 (Russell, 1987), C3b (Puentes at al., 1988), and 
iC3b (Mosser et al., 1985) acceptor sites. Other receptors may promote binding of 
promastigotes to the macrophage, including receptors CRl, CD35, the receptor for 
C3b and C4b, and CR3, GDI lb  / CD18 the receptor for iC3b (Sutterwala et al.,
1996). It has been reported that iC3b functions as an opsonin for Leishmania via 
binding to CR3, the predominant receptor for the uptake of metacyclic promastigotes 
(Rosenthal et al, 1996).
ii) Serum-independent adhesion
Several receptors that may take part in the interaction between parasite and 
macrophage include the mannose-fucose receptor, the fibronectin receptor, and C- 
reactive protein receptor (Bogdan and Rollingoff, 1998). In addition, macrophage
CR3 is able to bind directly to promastigotes (Mosser et al., 1985). These receptors 
link directly to the parasite through LPG and gp63 (Bogdan and Rollingoff, 1998).
1.2.6.2.3, Invasion
Following binding of metacyclic promastigotes to the surface of a macrophage, the 
parasite is surrounded by “coiling phagocytosis” (i.e., by wrapping with multiple 
layers of unilateral pseudopods of the phagocytic cells) (Rittig et al., 1998b) or by 
conventional “zipperlike” interactions (Rittig et al., 1998a).
Initially the parasite is located in a phagosomal compartment that is limited by a 
membrane originating from the host cell plasmalemma. This phagosome then 
undergoes remodelling via maturation and fusion with an endocytic organelle and 
forms a parasitophorous vacuole (PV) containing lysosomal hydrolases, and 
cathepsins (Russell and Talamas-Rohana, 1989; Lang et al., 1994). PVs in the 
infected macrophages are formed 1 to 14 days after ingestion of promastigotes or 
amastigotes (Antoine et al., 1998). Much less is known about early events before PV 
formation. However, PVs containing amastigotes are rapidly acidified and reach pH 5 
in < 30 min (Sturgill-Koszycki et al., 1994).
1.2.6 2.4. Transformation
Promastigotes require 2-5 days to transform into the amastigotes, depending on the 
Leishmania species (Antoine et al., 1998). Although all Leishmania PV have many 
common features, they are not identical morphologically. For example, macrophages 
that contain L. donovani or L. major have many individual small PV with only one or 
two amastigotes inside each, whereas macrophages that are infected with L. 
amazonensis or L. mexicana harbour numerous parasites within one large vacuole 
(Antoine et al., 1998). Ilg and colleagues (1995) suggested that amastigotes of L. 
mexicana WT secret PPG which is one of the factors involved in the formation of 
large PVs in the infected macrophage. The PVs that harbour amastigotes of L. 
amazonensis or L. mexicana are rapidly acidified and reach pH 5 in less than 30 min
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(Sturgill-Koszycki et a l, 1994). Several groups have proposed that surface gp63 and 
LPG expression are down-regulated in the amastigote stage (McConville and 
Blackwell, 1991).
Following division of amastigotes within the PV, the latter ruptures and the cell 
releases the amastigotes, which are then taken up by neighbouring macrophages. 
Alternatively, it is possible that amastigotes can be released by fusion of the PV with 
the plasma membrane, thus leaving the host cell intact. Evidence for the latter 
mechanism is that infection with L. donovani inhibits apoptosis of macrophages 
(Moore and Matlashewski, 1994).
The life cycle of Leishmania in the mammalian host
Binding of promastigotes to the mononuclear phagocyte 
(Attachment of the promastigotes to the macrophages requires two mechanisms: 
serum-dependent and serum-independent adhesion)
Transformation stage 
(Promastigote transforms into amastigote)
Inoculation stage 
(Metacyciic promastigotes are inoculated into the skin of mammal)
Invasion stage
(promastigotes located in the PV containing lysosomal hydrolases, cathepsins and
beta-glyconidase)
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1.3. The host immune response to leishmaniasis
The pathogenicity of Leishmania depends to a large extent on their degree of 
susceptibility or resistance to various innate and adaptive immune mechanisms of the 
mammalian host (Reiner and Locksley, 1995).
1.3.1. The hosts’ innate response
When the infective promastigotes enter the host’s body they initially encounter 
elements of the innate response which consists of a variety of molecules and cells, 
distributed throughout the body (Roitt et al., 1996).
The innate immunity has several effects but the three most important are:
i) Killing the non-infective promastigote by the complement system.
ii) Initiation of inflammation
iii) Avoiding dissemination of amastigotes to the visceral organs of host, by the 
natural killer cells (NK cells).
1.3.1.1. Complement system
The complement system can be activated by all Leishmania spp. via the alternative 
pathway, a process that proceeds in the absence of antibody (Mosser and Brittingham,
1997). Fixation of C3 on the surface membrane of promastigotes is a crucial step in 
the interaction of the promastigote with the innate inunune system (Mosser and 
Brittingham, 1997). As mentioned previously, the majority of non-infective 
promastigotes are rapidly destroyed before entry into host magrophages. Immediately 
following injection, promastigotes are exposed for a short while to potentially toxic 
serum components, including elements of the complement system (Mosser and 
Brittingham, 1997), even in the absence of mii-Leishmania antibodies. Promastigotes 
can shed C5b-C9 complexes from the parasite surface (Puentes et al., 1990), which 
might be causally linked to the phosphoglycan chain of the surface LPG (Puentes et 
al., 1988; Sacks et al., 1995). A correlation between gp63 expression and resistance to 
complement-mediated lysis has been demonstrated (Brittingham et al., 1999) and this
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mechanism is dependent on the proteolytic activity of gp63 (Brittingham et aL, 1997). 
Gp63 is a surface acid proteinase and not only binds to considerable amounts of the 
terminal complement components but also rapidly converts C3b to iC3b, thus 
facilitating the uptake of the parasites by cells expressing the iC3b-receptor CR3 (CD 
11b / CD 18) (Brittingham et al., 1995; Mosser and Brittingham, 1997). In addition, 
leishmanial protein kinases (LPKs) (Puentes et al., 1990) and serine threonine protein 
kinase (Li et al., 1996), which are increasingly expressed on the surface of infective 
stage promastigotes, have been shown to inactivate C3, C5, and C9 by 
phosphorylation, thus avoiding complement mediated lysis.
In addition to opsonization and lysis, activation of complement also leads to the 
generation of the chemotactic peptides C3a and C5a. These peptides have been shown 
not only to be potent inducers of leukocyte migration, but they also up-regulate the 
expression of complement receptors on mononuclear phagocytes (Yancey et al., 
1985). Macrophages were found not to move toward promastigotes themselves, but 
following the activation of complement by Leishmania, macrophages showed a 
directional migration toward the products of complement activation (Bray, 1983).
1.3,1.2. Initiation of inflammation
Inflammation is the body’s reaction to the invasion by an infectious agent (Roitt, 
1996) such as Leishmania. Immediately after the inoculation of promastigotes by a 
sandfly, a local inflammatory process is started, which involves local accumulation of 
cells to clear damaged tissue and to initiate wound healing, and this may limit 
dissemination of Leishmania. Moore and Matlashewski (1994) reported that 
macrophages are a major source of inflammatory and growth cytokines in the 
leishmaniasis. Initially, leukocytes, particularly neutrophils and eosinophils, followed 
by a wave of inflammatory macrophages, migrate out of the capillaries into the site 
sun'ounding the promastigotes inoculated by infective sandfly. Lymphocytes are 
hardy detected at this early stage of infection (Sunderkotter et al, 1993) but there is 
an accumulation of NK cells (Solbach and Laskay, 2000). By the time invading 
macrophages appear, extracellular promastigotes are mostly dead while others have 
invaded resident cells which they may use as a “safe haven” (Greil et a l, 1988).
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The migration of inflammatory cells towards the site of infection is orchestrated by 
the chemotactic peptides C3a and C5a. Frankenberg and colleagues (1990) reported 
that LPG down-regulated chemotaxis of macrophages and IL-1 production.
I.3.I.3. Avoiding dissemination of amastigotes into the visceral organs of host
The prevention of dissemination of amastigotes is not fully understood. After 
transformation of promastigote to amastigote within infected macrophage, 
amastigotes start to divide and continue until the PV ruptures. Irrespective of the way 
in which amastigotes infect neighbouring competent host cells, there is a striking 
difference between the kinetics of parasite dissemination into the visceral organs of 
susceptible and resistant mice. Interestingly, microscopical analysis of thoracic duct 
lymph obtained from BALB/c mice 3 hours after infection showed that most of the 
parasites disseminated as intracellular forms (largely amastigote-like), but 
occasionally extracellular promastigotes were also observed (lonac et al., 1997).
When BALB/c mice, which are susceptible to L. major were subcutaneously infected 
with L. major promastigotes, after 2-5 hours the parasites were found in the draining 
lymph node and within 10-24 hours could be detected in other organs such as the 
para-aortic lymph nodes, the spleen, the liver, the bone marrow, and occasionally the 
kidney (Laskay et al., 1995). In other mouse strains which are resistant to Leishmania, 
like C57BL/6, CBA/J, and C3H/Hej, the parasites remained localised in the site where 
the parasite was injected and in the draining popliteal lymph node for 5 days or more 
without evidence of dissemination into other organs (Laskay et al., 1995).
It was thought that local restriction of parasites in the pre-T cell phase of the infection 
is mediated by the innate immune system and this plays an important role in the 
development of a protective T cell response (Laskay et al., 1995), and is dependent on 
several factors including the size of the infectious dose and species of Leishmania. 
Menon and Bretscher (1998) reported that low numbers (2 x 10^) of L. major 
promastigotes were localized in the skin and draining lymph nodes of BALB/c mice, 
whereas high numbers (5 xlO^) of the parasite disseminated into skin and visceral 
organs of this strain of mice and led to overt disease.
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Laskay et a l  (1993) showed that NK cells participated in the non-specific phase of 
anti-leishmania activity in the control of early multiplication of parasite in the course 
of leishmaniasis in resistant C57BL/6 mice. Indeed, depletion of NK cells by antibody 
led to rapid parasite dissemination. NK cells play a crucial role in infection processes 
since, unlike naive T cells, they respond very rapidly to stimuli and do not require 
priming (Scott and Trinchieri, 1995; Lanier, 1997). NK cells can produce a wide 
range of cytokines such as IFN-y and tumour necrosis factor-a (TNF-a), which 
inhibit the growth of microorganisms during the initial stage of infection, thus 
allowing the host to develop an efficient adaptive immune response (Louis et a l,
1998). NK cells can also play a crucial role in shaping the adaptive immune response, 
particularly by influencing the pathway of differentiation of CD4'*’ T cells. The 
effector function of NK cells and their role in the generation of a CD4'*' Thl response 
during infection with L. major has shown that depletion of NK cells in resistant mice 
led to an increase in the number of parasites and enhanced the lesions (Sharton and 
Scott, 1993). Moreover, this treatment also decreased the IFN-y production and 
increased the IL-4 derived response. It was found that administration of IL-12 with 
Leishmania antigens induces CD4^ Thl cell development and resistance (Afonso and 
Scott, 1994). Scott and Trinchieri (1995) reported that NK cells appear to function as 
a source of IFN-y that was critical for CD4^ Thl cell development. It was also shown 
that NK cells rapidly produced IFN-y after activation by both parasite antigens and 
IL-12, which in turn led to parasite containment (Laskay et a l, 1995). Scharton- 
Kersten and Scott (1995) reported that NK cells are not required for the development 
of CD4^ Thl cells following infection of C3H mice with L. major.
Associated with the healing process, the cured mice showed a strong, long-lasting 
cellular immunity to the parasites. In spite of the clinical healing, however, L. major 
persists in various organs, possibly life-long. Parasites could be detected by both PCR 
and culture in the draining LN, spleen, and bone marrow as long as 1 year after 
healing (Aebischer et a l, 1993).
In addition to the role of IL-12, NK cells, and IFN-y in regulating parasite 
dissemination and containment, more recent data pointed to a critical role for IFN-0(/p 
and inducible nitric oxide synthase (iNOS) (Diefenbach et a l, 1998). Mice genetically 
deficient for the iNOS gene were shown to control the activity of NK cells and the 
early cytokine response [IFN-y, IL-12 and transforming growth factor (TGF)] during
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the first 24 hours of infection with L. major, thereby playing a critical regulatory role 
in the innate response to this parasite (Diefenbach et al., 1998). NOS2 gene knockout 
(NOS2' '^) mice or C57BL/6 mice treated with anti-fFN-y antibody or mice with a 
disrupted IFN-y gene, permitted rapid spreading of the parasites and developed 
disease, even with a low inoculation of 500-2000 parasites (Diefenbach et al., 1998; 
Laskay et al., 1995). As the early production of IFN-y in L. mq/or-infected mice is 
predominantly due to NK cells (Laskay et al., 1993; Reiner et al., 1994b; Scharton 
and Scott, 1993), Diefenbach and colleagues (1998) suggested that the early 
containment is orchestrated by the co-ordinated action of IFN-ot/p, IFN-y, IL-12, 
NOS2, and NK cells, which are activated at the site of infection and the draining 
lymph node. In vivo depletion of NK cells using the NK cell-specific anti-NKl.l 
monoclonal antibody further underlined the importance of NK cells in the early 
defence against L. major. The enhanced disease, as measured by parasite number and 
lesion development, was observed in NK cell-depleted mice (Laskay et at., 1993).
In the L. major infection model a delicate balance between stimulatory and inhibitory 
lymphokines appears to regulate the early activation of NK cells. Rapid Thl cell 
development and resistance to infection in mice that develop an early NK cell 
response after infection was reported (Scharton-Kersten and Scott, 1995). IL-12 is 
likely to play a key role in NK cell activation, since in vivo neutralisation of IL-12 
eliminated the early NK cell response in L. major infected resistant C3H/HeN mice 
(Scharton-Kersten et al., 1995). In susceptible BALB/c mice the simultaneous early 
production of IL-12 and cytokines that inhibit IL-12 function, such as TGF-P, EL-4 
and IL-10, was observed. Even though NK cells play a major role in the early control 
of parasites, NK cells alone could not sustain control of L. major in the absence of 
CD4+ T cell-derived EFN-y, and Thl development was unaffected by the presence or 
absence of EFN-y from non-T-cells (Wakil et al., 1998). The role of NK cell-derived 
EFN-y remains to be clarified. However, several groups of researchers reported that 
the contribution from NK cells in the early stage of infection is independent EFN-y.
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1.3.2. The host’s adaptive immune response
1.3.2.1. Antigen presentation
Several microorganisms including Leishmania are able to replicate within resting 
macrophages of the mammalian host. Upon activation, infected cells mobilize potent 
microbicidal mechanisms that eliminate the intracellular pathogen. This transition 
from a resting to an activated state is mediated by the interaction with specific T cells 
that recognize pathogen-derived peptides complexed with major histocompatibility 
complex (MHC) molecules at the surface of host cells (Lang et al., 1994). Antigen 
presentation by macrophages, dendritic cells and B cells to primed T lymphocytes and 
their cytokine productions following exposure to immunostimulating complexes are 
important for generation of a CD4’*' Thl response (Villacres-Eriksson, 1995).
The establishment of a protective mti-Leishmania immune response requires the 
presentation of appropriate antigens by antigen presenting cells (APCs), the induction 
and expansion of CD4^ Thl and the activation of macrophages for efficient killing of 
the parasites. There are different kind of APCs in the body, the best studied are 
macrophages and dendritic cells (DCs) (Roitt et al., 1996).
1.3.2.1.1. Macrophage
In leishmaniasis, for induction of the primary immune response, the macrophage is 
inefficient in the presentation of parasite to the naive T cell (Moll and Flohe, 1997). In 
addition, in contrast to other macrophages resident in the other organs, the quality of 
the respiratory burst of dermal macrophages following ingestion of promastigotes is 
poor (Locksley et al., 1988). Three states of infected mouse macrophages in vitro 
have been reported:
1) Resting macrophages, which were deficient in the synthesis of MHC class II 
molecules and unable to present any parasite peptides (Overath and Aebischer,
1999).
2) Macrophages primed with IFN-y, which were able to synthesise MHC molecules 
but the viability of the amastigotes was not affected (Antoine et al., 1991; 
Wolfram et al., 1995). Primed macrophages were able to present leishmanial 
antigens but were restricted to those proteins that were accessible to host cell
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proteases, ie. proteins secreted into the parasitophorous vacuole or located at the 
parasite surface. Intracellular proteins o f the parasites were not available to the 
antigen-processing machinery as long as the parasites remained intact (Overath 
and Aebischer, 1999).
3) Activated macrophages [which in the presence of IFN-y and a second signal, 
TNF-a, produce nitric oxide (NO)] kill the parasite (Bogdan et ah, 1990; Liew et 
a l,  1990).
Interaction of primed macrophages from resistant mice, which express a highly 
selective group o f peptides, with T cells leads to the production o f IFN-y and TNF-a. 
The infected macrophages will in turn also start to produce TNF-a, thus establishing 
an autocrine / paracrine TNF-a loop that drives the macrophage to full activation. It is 
important to point out that macrophages harbouring live parasites in lesion-derived 
tissue express a low level o f MHC class II molecules (Overath and Aebischer, 1999). 
It has been reported that after in vitro infection with L  major, macrophages had a 
greatly reduced capacity to present both L. major-dQnved and unrelated antigens such 
as OVA or p-galactosidase (Fruth et al, 1993). Therefore, Leishmania infection 
interferes with the intracellular loading of MHC-II molecules with antigenic peptides. 
Similar conclusions can be drawn from experiments with murine macrophages 
infected with L. amazonensis amastigotes (Prina et al., 1993).
Several groups of researchers have suggested that amastigotes of several Leishmania 
species within PV lead to internalization and degradation of MHC class II molecules 
(De Souza et a l, 1995), suppression o f MHC class II synthesis (Reiner et a l, 1987), 
down-regulation o f CD80 expression (Kaye et al., 1994), and /or partial inhibition of 
antigen processing / peptide loading in the host cell (Fruth et a l,  1993; Prina et a l, 
1993). In contrast, macrophages infected with promastigotes present endogenous 
parasite molecules to CD4^ T cells, although only for a limited time, with maximal 
presentation occurring within 24 h and decreasing to minimal antigen presentation at 
72 h post infection (Kima et a l, 1996). Thereby, Leishmania interferes with antigen 
presentation, and thus might impair recognition of infected macrophages by T cells.
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13.2.1.2. Dendritic cells
Dendritic cells (DCs) belong to a family of bone marrow derived APCs and have an 
exquisite capacity to interact with T cells and modulate their responses. DCs are 
found in most non-lymphoid organs, including the epidermis and mucosa, where they 
are called Langerhans cells (LCs) and are present in the T cell areas of all lymphoid 
organs, where they are called interdigitating DCs (Roitt et al., 1996). The relationship 
between DC populations was partly unravelled by the observation that LCs from skin 
can migrate to secondary lymphoid organs, via the blood or lymph, bringing antigens 
to naive T cells from peripheral sites from which the latter are excluded (Moll et al., 
1995).
Following inoculation of metacyclic promastigotes by an infectious sandfly bite, the 
local inflammatory response leads to migration of LCs through the epidermal-dermal 
layer and to phagocytosis of the parasite in the dermis (Blank et al., 1993). The 
parasite will be captured by the attachment of LPG on the surface of the parasite to 
the LCs’ complement receptor (CR3). It has been reported that mannose receptors of 
DCs may be involved in the antigen capturing (Sallusto et al., 1995) but this receptor 
appears not contribute to uptake of parasites by LCs (Moll and Flohe, 1997).
Infected LCs transport parasites from the skin to the draining LNs, which can be 
detected as early as 24-48 hours after infection (Moll et al., 1993). They acquire a 
heightened ability to present antigenic peptides to T-cells (Xu et al., 1995). This is 
accompanied by drastic changes in cell morphology, motility, and expression of high 
levels of MHC class II molecules and rapid up-regulation of the expression of co­
stimulatory molecules (B7-1 and B7-2) (Inaba et al., 1994; Larsen et al., 1994), which 
results in a marked increase in the ability of DCs to activate T cells. This process is 
variously termed maturation or activation.
LCs play a crucial role in the induction of the immune response in early L. major 
infection because only infected LCs are able to carry parasites from the infected skin 
to the draining LN for primary antigen presentation to T cells (Moll et al., 1993). 
After healing of the lesion, DCs of the lymph node have the capacity to present very 
low amounts of Leishmania antigen to specific T cells (Moll et al., 1995). LCs take up 
small numbers of promastigotes which do not differentiate into amastigotes but be 
degraded whereas macrophages internalize large numbers of promastigotes into the 
PV where they differentiate into amastigotes (Konecny et al., 1999). In contrast to 
macrophages, the Leishmania infected LC is unable to release NO, an important
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molecule for killing the parasite and cannot be induced to express the cytokine-iNOS 
(Blank et al., 1996).
LCs infected with promastigotes up-regulate production of EL-12 p40 in both resistant 
and susceptible mice whereas infected macrophages are unable to produce EL-12 
(Konecny et al., 1999). Thereby, LCs play a crucial role in the regulation of the 
immune response of mice infected with L. major in both early and later phase of 
infection and after cure of skin lesion in genetically resistant mice (Moll and Flohe, 
1997; Flohe et a l, 1998). Dendritic cells produce IL-12 and direct the development of 
Thl immune responses in resistant mice (Macatonia et a l, 1995; Konecny et a l,
1999).
I.3.2.2. Co-stimulatory molecules
The role of co-stimulatory signals in the nature and the amplitude of an antigen- 
specific T cell response is essential (Saha et a l, 1998). Analysis of macrophages from 
BALB/c mice infected with L. donovani revealed that the co-stimulatory molecule 
B7-1 (CD80) was decreased, but there was no change in C57BL/6 mice, which are 
resistant to Leishmania infection (Murphy et a l,  1997). After elimination of the 
parasites, however, CD80 was re-expressed, which paralleled the induction of a 
protective T cell-mediated immune response (Saha et a l, 1995).
CD86 (B70/B7-2) is an antigen of the immunoglobulin superfamily constitutively 
expressed on professional antigen-presenting cells such as monocytes, dendritic cells 
and activated B, T, and natural killer cells, while CD80 is inducible on those cells 
through CD40 ligation (Azuma et a l, 1993; Caux et a l, 1994; Larsen et a l, 1994). 
Thus, there is also a possibility that CD80 may not be sufficiently induced on APCs of 
the infected CD40-deficient mice, and may partly contribute to the induction of 
polarized CD4^Th2 responses (Larsen et a l, 1994). CD86 was recently identified as a 
second ligand for the T cell antigens CD28 and Cytotoxic T lymphocyte antigen-4 
(CTLA-4) (CD 152), and plays an important role in the co-stimulation of T cells in a 
primary immune response (Femandez-Ruiz et a l, 1995). CD86 provides signals for 
preferential induction of EL-4-secreting CD4^Th2 cells and the differences between 
usage of CD80 or CD86 relevant for the development of CD4^ Thl or CD4^ Th2 
response, respectively (Freeman et a l, 1995; Kuchroo et a l, 1995). Prolonged
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treatment of both C57BL/6 and BALB/c mice with antibody to CD86 but not to 
CD80, decreased parasite burden and decreased the production of CD4^ Th2 
cytokines (Brown et al., 1996b). Anti-CD86 mAb did not interfere with the early T 
cell activation, since the treatment on day 3 post-infection was as effective as 
beginning it on the day of infection (Muiphy et ah, 1997). Both CD80 and CD86 
interact with CD28 and CD 152 which are expressed on T cells. The binding affinity 
of CD 152 to CD80 and CD86 molecules, however, is significantly higher than that of 
the CD28 molecule. In contrast to CD28, CD 152 plays a role in the negative 
regulation of cell activation (Krummel and Allison, 1995; Walunas et al., 1994). 
Experiments using knockout mice indicated that co-stimulation through CD28 plays 
only a limited role in the development of CD4^ Thl or CD4^Th2 response to 
Leishmania. CD28-deficient and Wild Type BALB/c mice litter mates were equally 
susceptible to L. major infection. Similarly CD28-deficient C57BL/6 mice retained 
their resistance to the infection (Saha et al., 1995; Brown et al., 1996a). Treatment of 
mice with anti-CD 152 Fab-fragments ameliorated the disease in BALB/c animals but 
had no effect on the course of infection in C57BL/6 mice, suggesting that CD 152 
plays a significant role in the modulation of the immune response, mainly in 
susceptible mice. Since the same effect was also observed in CD28-deficient mice, it 
is likely that the effect of CD 152 on the course of infection is not dependent on 
CD28-mediated pre-activation. The observed amelioration of the disease was found to 
be associated with an increase in the number of cells secreting EFN-y as well as 
increased parasite-specific responses (Corry et al., 1994; Saha et al., 1998). A single 
dose of anti-CD 152 mAb injected on day 1 of infection significantly decreased the 
parasite burden in infected BALB/c mice (Murphy et al., 1998).
I.2.2.3. Cytokine determinants that shape the development of Th cells
T helper lymphocytes (CD4^ Th cells) can be divided into two distinct subsets of 
effector cells based on their functional capabilities and the profile of cytokines they 
produce. The CD4^Thl secretes cytokines usually associated with inflammation, such 
as EnSl-y and TNF-a and induces cell-mediated immune responses. The CD4^ Th2 
subset produces cytokines such as EL-4 and is associated with humoral-type immune
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responses (Abbas et a l, 1996; Constant and Bottomly, 1997). It is possible that CD4^ 
Th cells are involved in eliminating many pathogens, where a balance of both 
regulated cell-mediated immunity and an appropriate humoral response will eradicate 
an invading pathogen with minimum immunopathology (Sher and Coffman, 1992; 
Romagnani, 1994; Kelso, 1995). Most naive T cells have potential to mature into 
either CD4^ Thl or CD4^ Th2 subset and that critical role of cytokines to which the T 
cells are exposed at the time of priming mediate this differentiation (Mosmann and 
Coffman, 1989). Seder and colleagues (1992) reported that IL-4 has an important role 
for mediating Th2 development, while IL-12 (Trichieri, 1995; Romani et al., 1997) 
and EFN-y were described to have a critical role for Thl development and that both 
sets of cytokines are reciprocally active (Tanaka et al., 1993; Hsieh et al., 1995). With 
respect to the role of IL-4 in mediating both susceptibility and Th2 cell differentiation, 
it was shown that, in contrast to resistant C57BL/6 animals, BALB/c mice exhibited a 
burst of IL-4 mRNA in CD4^ T cells in the draining lymph node as early as 16 hours 
after subcutaneous infection with L. major promastigotes (Launois et al.,1995). The 
precursor CD4^ Th cell differentiates to a CD4^ Th2 cell in the presence of EL-4 at the 
initiation of an immune response (Swain et al., 1990; Seder and Paul, 1994). The 
effects of EL-4 in inducing CD4^ Th2 cell development are dominant over CD4^Thl 
polarizing cytokines (Hsieh et al., 1993; Seder and Paul, 1994). Therefore, in the 
presence of EL-4 at the beginning of an immune response, Th2 cells differentiate, 
progressively leading to increasing level of EL-4.
Several candidates that may be responsible for EL-4 production early in CD4^ Th2 
differentiation include:
i) Major histocompatibility complex (MHC) class Il-restricted CD4+ T cells 
(Constant et al., 1995; Hosken et al., 1995).
ii) NKl T cells that have the unique potential to very rapidly secrete large 
amounts of cytokines, providing early help for effector cells and regulating the 
Thl or Th2 differentiation of some immune responses (Bendelac et al,, 1997).
iii) Leishmania homologue of receptors for activated C kinase (LACK) specific 
CD4-f T cells expressing VB4, VB8 TCR (Julia et al., 1996).
iv) Non-T cell sources, such as mast cells, basophils, and eosinophils (Paul et al.,
1993).
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Several groups of researchers reported that the requirement for IL-4 in mediating both 
Th2 differentiation and susceptibility of mice to L. major was directed toward the 
early IL-4 produced in vivo (Sadick et al., 1990; Locksley and Scott, 1991; Scott et 
al, 1996).
It was suggested a critical role is played by NK1+ T cells in Th2 differentiation as a 
result of their ability to produce large amounts of IL-4 rapidly upon activation both in 
vitro and in vivo with anti-CD 1 antibody (Bendelac et a l, 1997). However, Smiley 
and colleagues (1997) reported that EL-4-secreting NK-like T cells are not required for 
Th2 responses. Thus, the precise role of NK1+ T cells in the development of Th2 
responses remains unclear.
The role of LACK-specific T cells in the development of a dominant Th2 response to 
L, major infection in BALB/c mice was demonstrated when mice were rendered 
unresponsive to LACK (Julia et a l, 1996). Due to expression of LACK as a 
transgene, BALB/c mice were made tolerant to this antigen and developed a reduced 
Th2 response and developed a protective Thl response when infected with L. major 
(Julia et a l, 1996).
Julia and Glaichenhaus, (1999) reported that in both the genetically susceptible and 
resistant mice to L. major, T cells, which react to the LACK antigen, produce EL-4 
rapidly and the production in resistant mice did not confer susceptibility but resulted 
in increased parasite burdens. Malherbe and colleagues (2000) reported that the T 
cells activated by LACK antigen from susceptible and resistant mice expressed low- 
and high-affinity TCR, respectively. Therefore, it has been suggested that differences 
in TCR usage between MHC in susceptible and resistant mice may influence the 
development of the antiparasite immune response (Malherbe et a l, 2000).
Non-T cells may also play a role in the initiation of Th2 responses against some 
pathogens in specific tissues, since mast cells, basophils, and eosinophils can produce 
cytokines such as EL-4 (Paul et a l, 1993).
1.3.2.4. Development o f CD4^ T helper cell subsets
The essential event that leads to Thl differentiation in mice infected with Leishmania 
spp. is the production of EL-12 within 24 hours of infection and this constitutes the 
most effective form of innate immunity (Coffman and von der Weid, 1997). The
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specific immune response of naive T cells to the parasite is initiated by EFN-y and EL- 
12 production. Thus, the effector functions of the innate response that are most 
important for the control of the pathogens are conserved in the subsequent antigen 
specific T cell response.
Although, the source of production of the initial EL-4, which is essential for CD4"  ^Th2 
differentiation, is not so clearly defined, T cells themselves can be the source of EL-4 
that leads to their own Th2 development, and EL-6 is a potent inducer of this EL-4 
(Rincon et al., 1997). Studies with LACK showed that L. major infected BALB/c 
mice make a strong early (6 days) Th2 response to LACK, although the response of 
the same mice to several other L. major antigens was predominately Thl-like 
(Mougneau et al., 1995; Julia et a l, 1996). Analysis of mRNA transcription for 
various cytokines showed draining lymph node cells from BALB/c mice infected with 
L. major contained elevated transcripts for EL-4, but not for EFN-y. In contrast, 
resistant C57BE76 mice expressed transcripts for EFN-y, but not transiently for EL-4 
(Locksley et al., 1987). In BALB/c mice, the expression of EL-4 mRNA remained 
elevated over time, whereas in C57BL/6 mice the IL-4 response returned to 
background levels after the initial phase of the infection (Henizel et at., 1989). These 
and other studies (Reiner and Locksley, 1995) emphasised the ability of CD4^ T cells 
to shape the immune response and the phenotype of the murine disease.
The ability of cytokines to stimulate different effector mechanisms and thus 
differential immune responses, is also reinforced by the production of cytokines by 
each subset, which cross-regulate each other’s function as well as development. For 
example, EFN-y production by Thl cells inhibits the development of Th2 cells (Fitch 
et al., 1993) as well as humoral responses, whereas the production of EL-4 and EL-10 
by Th2 cells inhibits Thl development and activation, as well as macrophage 
activation and bacteriacidal activity (Sher and Coffman, 1992; Moore et al., 1993).
In resistant mice Leishmania stimulaties active APCs and subsequently NK cells of 
the innate immune response to produce IL-12 and IFN-y (Hsieh et al., 1993; 
Trinchieri, 1995), which then drive the development of CD4^ Thl cells from naive 
antigen-specific CD4^ Th cells. This type of innate immune response is appropriate 
for the eradication of microbial pathogens (Sher and Coffman, 1992; Trinchieri,
1995).
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Several groups of researchers demonstrated that ligation of CD40 by the CD40 ligand 
{Celia et al., 1996; Koch et al., 1996) and / or MHC class II (Koch et ah, 1996) on 
dendritic cells can induce the production of high levels of IL-12. Both IL-4 and EL-10 
have the ability to inhibit both dendritic cell (Macatonia et al., 1995; Koch et al.,
1996) and macrophage (D’Andrea et al., 1993; Hsieh et al., 1993; Murphy et al.,
1994) EL-12 production and thus inhibit the development of Thl cells. IL-12 directs 
Thl development from antigen-stimulated naive CD4+ T cells (Hsieh et al., 1993; 
Manetti et al., 1993; Trinchieri, 1995).
I.3.2.4.I. Cytokine-induced CD4^ T h l development
Recovery from cutaneous lesions that was seen in mice following local inoculation 
with L. mexicana (Stamm et al., 1998) or L. major (Heinzel et al., 1991; Scott et al., 
1988) in genetically resistant mice such as C3H/HeN and C57BIV6 strains was 
associated with the expansion of the CD4^ Thl subset and production of cytokines 
such as EL-12, IFN-y, and EL-2. On the other hand, genetically resistant mice lacking 
EL-12 (Mattner et al., 1996; Mattner et a l, 1997) or IFN-y (Wang et ah, 1994) 
defaulted to a Th2-like response and were highly susceptible to cutaneous L. major 
infection. Interestingly, EFN-R-deficient 129/Sv/Ev mice were also susceptible to L. 
major, but did not develop a CD4^Th2-like response (Swihart et al., 1995). The 
susceptible mice lacking EFN-R defaulted towards a CD4^Thl-like response implying 
that IFN-y, although important in resistance to L. major, was not necessary for a 
CD4Urh 1-like response and that IL-12, instead, may be the critical cytokine 
responsible for CD4^ Thl cell development. Previous studies have clearly 
demonstrated that protective immunity against the L. mexicana complex, which 
includes L. mexicana and L. amazonensis, is ultimately dependent upon generation of 
a CD4^ Thl-like response and EFN-y production (Satoskar et al., 1995; Afonso and 
Scott, 1993; Guevara-Mendozaera/., 1997).
Non-infective promastigotes taken from the logarithmic phase of the promastigote 
cultures were good inducers of IL-12, IFN-y, TNF-a, and EL-10 production, whereas 
infective parasites from the metacyclic phase were poor inducers of EL-12 (Sartori et 
al., 1997). Both stages of parasites were inhibitory for IL-12 production induced by
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Staphylococcus aureus (Sartori et al, 1997) or IFN-y / LPS (Carrera et al., 1996). EL- 
12 secretion was suppressed by infected macrophages with amastigotes of L. 
mexicana', the parasites also inhibited XL-12 secretion inducible by phagocytosis of 
latex beads, CD40 cross-linking or cognate interaction with Thl cells (Weinheber et 
al., 1998). However, treatment with recombinant IFN-y failed to promote Thl cell 
expansion and cure L. major infection in susceptible BALB/c mice (Sadick et al.,
1990).
IL-12 plays a critical role for the development of Thl-like CD4^T cell responses 
following L. major infection in resistant mice (Mattner et al., 1996) and treatment of 
susceptible BALB/c mice with rIL-12 cures cutaneous L, major infection (Heinzel et 
al., 1993). Furthermore anti-EFN-y Ab had no effect on EL-12-induced CD4^Thl cell 
differentiation in vitro (McKnight et a i, 1994), whereas addition of rEL-12 during 
specific priming of CD4^ Th cells from transgenic mice expressing an Ag-specific 
TCR-resulted in the development of the CD4^ Thl-like phenotype (Seder et a l,
1993). Previous studies using the L. major model have indicated that genetic 
susceptibility of BALB/c mice to L. major is due to a loss of the ability to generate an 
IL-12-induced CD4^ Thl-like response (Launois et al., 1997).
Nonetheless, EL-4-deficient C57BL/6 x 129/Sv mice develop a CD4^ Thl-like 
response, as measured by an increase in EFN-y production, and cured L. mexicana 
infection (Satoskar et at., 1995). The role of EFN-y in the development of a CD4^Thl- 
like response and resistance to L. major are based upon observations that impaired 
CD4^ Thl-like responses followed treatment of genetically resistant C3H/HeN mice 
with anti-EFN-y antibody (Belosevic et al., 1989). In addition to its ability to down- 
regulate XL-12 and IFN-y production, IL-4 has been shown to inhibit also the 
production of the inflammatory cytokines IL-1 and TNF-a from macrophages (Hart et 
at., 1989). TNF-a plays a protective role in immunity against L. major infection 
(Liew and O'Donnell, 1993). For example, lymph node cells from mice resistant to L. 
major produce high level of TNF-a when stimulated in vitro, whereas cells from 
susceptible strains under the same conditions induce macrophages in the presence of 
EFN-y to increase nitric oxide production (Liew et al., 1990). Nashleanas and 
colleagues (1998) showed that mice deficient in both TNF-a receptors, p55 and p75, 
were able to control L. major infection, but failed to resolve lesions. Although a low 
level of TNF-a led to parasite killing (Titus et al., 1989), the role of the p75 TNF-a
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receptor was not found to be essential in L, major infection. Therefore, the p55 
receptor may be required for optimal macrophage activation (Nashleanas et al., 1998). 
In addition, IL-4-deficient mice infected with L. major displayed similar levels of 
TNF-a transcripts to wild-type mice (Kopf et al., 1996; Noben-Trauth et al., 1996). 
Although IL-2 production has often been associated with a CD4^ Thl phenotype, the 
production of this cytokine cannot be classified as a hallmark of CD4'*’Thl cells, since 
naive CD4'*' T cells as well as ThO cells (described below) also produce IL-2 in 
response to antigenic stimulation (Sher and Coffman, 1992; Romagnani, 1994; Abbas 
etal., 1996).
I.3.2.4.2. Cytokine-induced CD4^ Th2 development
Non-healing responses in susceptible BALB/c mice have been related to the 
expansion of the CD4^ Th2 cell subset and the production of cytokines such as IL-4 
and EL-10 (Heinzel et al., 1991; Scott et al., 1988). The disease-exacerbating role of 
EL-4 has been shown to be due to its ability to inhibit macrophage leishmanicidal 
activity and down-regulate the development of a C D 4^hl-like response (Sher and 
Coffman,1992; Oswald et al., 1992). It was found that genetically susceptible mice 
lacking EL-4 are protected from cutaneous infection with L. major (Kopf et al., 1996) 
as well as L. mexicana (Satoskar et al., 1995; Satoskar et al., 1997). However, other 
studies suggest that the inability of the host to generate an EL-12-initiated CD4^ Thl- 
like response and produce IFN-y rather than the induction of a Th2-like response and 
IL-4 production may be the crucial factor in determining susceptibility to L. major 
(Güler et al., 1996), L. amazonensis (Afonso and Scott, 1993), and L. mexicana 
(Guevara-Mendoza et al,, 1997).
The proposed mechanisms underlying the development of non-healing lesions in 
genetically susceptible mice following L. major infection have included the presence 
of an EL-4-driven Th2-like response suppressing Thl cell development (Chatelain et 
al., 1992; I^al et al., 1993) and a failure to produce EL-12 (Carrera et al., 1996; 
Reiner et al., 1994) and thereby mount an EL-12-induced CD4^ Thl-like response 
(Güler et al., 1996). Tanaka and colleagues (1993) reported that the production of EL- 
2 and EFN-y by CD4+ T cells and EFN-y production by CD8+ T cells were strikingly
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inhibited by culture in the presence of IL-4. Studies in EL-4-deficient BALB/c mice 
have shown that the lymph node cells produced little or no EFN-y and low levels of 
IL-4 following L. amazonensis (Afonso and Scott, 1993) and L. mexicana infection 
(Guevara-Mendoza et al., 1997; Satoskar et al., 1995). EL-10 is important for 
inhibition of monocyte-macrophage activation, and inhibits production of TNF- a, IL- 
1 and also EFN-y from lymphocytes acting at the level of accessory cells (D Andrea et 
al., 1993). IgGl production has also been shown to be regulated by, although not 
completely dependent upon, IL-4 and EL-4 signalling (Snapper and Paul, 1987). It has 
been reported that EL-4 signalling is also important in antibody class switching to 
IgGl following L. mexicana infection, whereas the IgE and IgGl isotypes are 
associated with the development of a Th2-like response, switching to the IgG2a 
isotype has been shown to be increased during Thl-like responses (Snapper and Paul,
1987).
L. major infection together with salivary gland lysates from P. papatasi showed an 
up-regulation of the Th2-like response and down-regulation of the Thl-like response 
in BALB/c mice. Interestingly, the saliva contents are able to inhibit oxidative 
metabolic processes and antigen presentation by macrophages in vitro (Theodos et al.,
1991).
I.3.2.5. Intracellular killing mechanisms:
It has been reported that less than 30 minutes after phagocytosis of promastigotes of 
L. mexicana or L. donovani, the PVs are acidified and reached pH 5 (Sturgill- 
Koszycki et al., 1994). In addition, the PVs acquire the lysosomal glycoproteins 
enzymes, macrosialin, and lysosomal-associated membrane proteins LAMP I and 
LAMP II within 2 hours post infection (Solbach and Laskay, 2000), Within 5-24 
hours post infection, acidic hydrolases and MHC class II molecules are acquired 
(Lang et al., 1994).
Leishmania spp. are exposed to two major effector mechanisms within PV of 
macrophages, reactive oxygen intermediates (ROI) and reactive nitrogen 
intermediates (RNI) (Murray and Nathan, 1999). Both neutrophils and macrophages 
produce superoxide (O2) using the NADPH oxidase pathway. Although superoxide
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production is the major anti-leishmanial effector mechanism o f neutrophils, this 
pathway may not be necessary for the killing o f the parasite within infected 
macrophages (Assreuy et al., 1994). Leishmania have developed mechanisms to avoid 
killing by O2 since the capacity of infected macrophages to produce oxygen radicals 
was significantly decreased after stimulation with phorbol esters (Passwell et al.,
1994). It is possible that LPG on the membrane o f Leishmania mediates this activity 
by inhibiting the activation of protein kinase C. NO is formed through the oxidation 
of the terminal guanidino nitrogen atom(s) of L-arginine by an NADPH-dependent 
enzyme (Assreuy et al., 1994).
In a study o f mice with the inducible nitric oxide synthase (lNOS) gene knockout, it 
was found that iNOS was required for the Thl-dependent healing of infections with 
intracellular microorganisms including Leishmania. At day 1 of infection, genetic 
deletion or functional inactivation of iNOS abolished the IFN-y and NK response, 
increased the expression of TGF-B, and facilitated the spread of the parasite from the 
skin and lymph node to the spleen, liver, bone marrow, and lung. Induction of type 2 
nitric oxide synthase (NOS2), also known as iNOS was dependent on IFN-a/B 
(Diefenbach et al., 1998).
The role o f TNF-a and its receptors for control of L. major infection is less clear. 
Undoubtedly, TNF-a participates in the induction of macrophage activation leading to 
parasite elimination (Nacy et al., 1991). IFN-y activation of macrophages from TNFR 
p75'^' animals resulted in NO production and parasite killing (Vieira et a l, 1996; 
Nashleanas et al., 1998). These results show that the TNFR p75 plays no essential 
role in murine L. major infection and that a mechanism exists by which macrophages 
can be primed in vivo to produce NO and kill L. major in the absence of signalling 
through either of the TNF-a receptors.
The killing of L. major by IFN-y-treated murine macrophages is attributable to NO 
and the enzyme producing it (Ding et al., 1988; Green et al., 1990). The molecular 
mechanism o f the action o f NO on Leishmania is unknown so far, early data 
suggested that NO is directly cytotoxic to L. major (Liew et al., 1990). In mice, 
resistance to Leishmania was clearly associated with the expression of iNOS and 
required the continuous presence of iNOS activity (Stenger et al., 1994). The NO- 
pathway appears to be a common mechanism o f Leishmania killing since not only 
murine but also human monocytes / macrophages were able to control L. major in a
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in a NO-dependent manner (Vouldoukis et ah, 1995). Murray and Nathan (1999) 
suggested that ROI and RNI probably act together especially in the early stage of 
leishmaniasis.
LPG and glycoinositolphospholipids (GIPLs) (glycolipids related to LPG) from L. 
major as well as intact L. major promastigotes strongly suppressed iNOS-activity 
when the interaction between the macrophages and Leishmania preceded the 
stimulation of macrophages by EFN-y (Proudfoot et ah, 1996). When, however, 
Leishmania and IFN-y were added simultaneously to macrophages, GIPLs and LPS 
synergized with IFN-y resulting in an increased production of NO (Proudfoot et al.,
1995). Therefore, Leishmania inhibits iNOS activity in the early stages of infection 
(i.e., when the parasites enter macrophages before the production of T-cell-derived 
macrophage-activating cytokines, such as IFN-y). In later stages of infection, 
however, Leishmania cause an increased iNOS production. In accordance with this 
presumption, high iNOS RNA levels were found in chronic, nonhealing lesions of 
mice infected with L. major (Nabors et a l, 1995). Therefore, local production of NO 
is a crucial mechanism for the elimination and control of parasites, but only if it 
occurs before the parasite burden becomes too high. From then on, elevated 
production of NO aggravates the inflammatory process (Giorgio et al., 1998).
1.3.2.6. Mechanisms of survival of Leishmania
I.3.2.6.I. Contribution of surface membrane molecules to survival o f the parasite 
within the PV
There are a number of surface membrane molecules that protect Leishmania spp. from 
the host immune response and increase their activity. The two most important 
molecules are LPG and gp63 (Alexander and Russell, 1992).
LPG is an abundant molecule, which is expressed much more on the surface of the 
promastigote than the amastigotes (Bogdan, 1997). LPG inhibits the phagosome- 
endosome fusion in the macrophage after invasion of the promastigotes (Desjardins 
and Descoteaux, 1997) and reduces endothelial adhesion and transendothelial 
migration of monocytes (Ho et al., 1996; Lo et al., 1998). This temporary inhibition
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of filsion of phagosome-endosome allows time for the promastigotes of L. major to 
begin to differentiate into the amastigote stage (Bogdan, 1997) which is better adapted 
to the enzymes and the acidic pH of the PV (Antoine et al., 1990).
The LPG plays an essential role in the attachment of promastigotes to host cells 
(Handman and Goding, 1985), and protection from digestion within the 
phagolysosome (Eilam et al., 1985; Handman et al., 1986). Studies with LPG showed 
that this molecule binds to the complement fragments and protects the parasite from 
complement-mediated lysis (Beverley and Turco, 1998). LPG aids the parasite entry 
into the host macrophage and protects the parasite from attack by reactive oxygen 
intermediates (ROIs) (Turco and Descoteaux, 1992; Beverley and Turco, 1998). 
Although a crucial role of LPG for the promastigote stages of Leishmania has been 
reported, its importance for the disease-causing amastigote stage in the mammalian 
host is less clear. Amastigotes of L. donovani and L. mexicana do not express LPG 
(McConville and Ralton, 1997).
Interestingly, although several groups of researchers emphasised that LPG is 
commonly regarded as a multifunctional Leishmania virulence factor required for 
survival and development of this parasite in macrophage. Ilg (2000) demonstrated that 
LPG, at least in L. mexicana, is not a virulence factor in the mammalian host.
Another important surface molecule that has been found abundant on the surface o f 
promastigotes is gp63. Several groups of researchers has been reported that gp63 
protects parasites within the PV of macrophages at acidic pH (Alexander and Russell, 
1992; Ilg et al., 1993; Seay et al., 1996), and is required for in vivo virulence 
(McMaster et al., 1997). Bogdan and Rollinghoff (1998) showed that gp63 has 
protease activity and inhibits the activity o f lysosomal enzymes. As mentioned before, 
gp63 has the ability to bind to complement receptors on the surface of macrophages 
(in the absence or presence o f complement fragments) and aids entry of the parasite 
into the host macrophages (Alexander and Russell, 1992; Bogdan and Rollinghoff,
1998). In amastigotes, gp63 was found within the flagellas pocket, whereas the 
expression of gp63 on the surface membrane was very weak (Bogdan and 
Rollinghoff, 1998). The proteolytic activity of gp63 is in the highest at acidic pH, and 
protects the parasite from intra-phagolysosomal degradation (Ilg et al., 1993; Seay et 
al., 1996).
Other outer membrane molecules have been identified but poorly described. These 
molecules may contribute to survival of parasites within PV and include GIPLs, non­
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inositol containing glycosphingolipids (GSLs), and protein kinase C (PKC) (Bogdan 
and Rollinghoff, 1998).
1.3.2 7. Suppression of the synthesis of anti-leishmanial molecules:
The two main antimicrobial effector mechanisms active against Leishmania include: 
ROI and RNI.
ROIs are highly toxic molecules and are thought to constitute an essential part of the 
defence mechanisms used by phagocytes to destroy invading parasites (Hughes,
1988). Ingestion of parasites by phagocytes usually activates the respiratory burst, 
which is characterized by increased oxygen uptake. NADPH oxidase in the 
phagosome membrane adds electrons to oxygen molecules. Thus, oxygen molecules 
are changed into reactive toxic molecules including superoxide (O2'), hydrogen 
peroxide (H2O2), hydroxyl radical (HO), and singlet oxygen (O2) (Robinson and 
Badway, 1994; Rosen et al., 1995). Murray (1982) demonstrated that the active 
generation of toxic oxygen intermediates including O2 and H2O2 play a crucial role in 
the eradication of the majority of ingested promastigotes.
LPG may protect the invading promastigotes against macrophage phagolysosome 
hydrolases (Turco and Descoteaux, 1992). The LPG down regulates protein kinase C 
(PKC) activity by inhibition o f the translocation o f the enzyme from the cytosol to the 
inner layer of the plasma membrane, which is a key requirement for the oxidative 
burst (Desjardins and Descoteaux, 1997).
Although ROIs are involved in intracellular killing, NO plays a crucial role in 
eradication o f Leishmania (Liew et al., 1990). NO is formed by at least three different 
iso forms of NOS, which convert L-arginine and molecular oxygen to L-citrulline and 
NO or NO metabolites (NO2 or NO3). LPG has a strong effect on the survival of 
amastigote of Leishmania by down-regulating the expression of iNOS in macrophages 
(Proudfoot et al, 1996).
Proudfoot and colleagues (1995) reported that GIPLs of L. major inhibit the 
induction of iNOS in macrophages in the presence of IFN-y and reduce leishmanicidal 
activity in murine macrophages. However, LPG and gp63 could be important for 
promastigote survival in the sandfly, there were no apparent correlation between LPG,
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at least in L. mexicana (Ilg, 2000), and gp63 (Camara et al., 1995) expression and 
promastigote survival in the macrophage. Therefore, in spite of the fact that LPG, 
gp63 and GIPLs are the most abundant molecules expressed on the surface of 
Leishmania, they are probably not the only modulators of the host defence machinery 
(Bogdam and Rollinghoff, 1998) which could influence the survival o f the parasite.
1.4. Vaccines
Vaccination is the induction or modulation of an antigen-specific immune response to 
prevent or cure the target disease. The term “antigen-specific” is essential for 
distinguishing vaccination from non-specific immune modulation. Most attempts to 
develop a vaccine against a parasite, either on pragmatic grounds or by identifying 
protective antigens have been unsuccessful, because parasites induce a complicated 
immunological processes (Cox, 1997). However, as individuals recovered from 
clinical leishmaniasis develop strong immunity against reinfection, it suggested that 
vaccination against leishmaniasis is feasible in principle (Liew and O'Donnell, 1993).
1.4.1. Summary of the history of vaccination
Vaccination was bom more than 200 years ago at a time when immunology was 
unknown and the concept of disease caused by transmission of microbes was not 
generally accepted. On June 21, 1798, Edward Jenner reported successful vaccination 
against smallpox using cowpox material (Hilleman, 1999). Before Jenner, the 
(ancient) Chinese inoculated pus from smallpox patinas in order to prevent severe 
natural smallpox. This knowledge was introduced into Europe in the early eighteenth 
century and during the nineteenth century, cowpox vaccination became a worldwide 
practice. Louis Pasteur, who set about attenuating microbes in the laboratory, further 
pursued this strategy of using attenuated viable microbes as vaccines. He successfully 
attenuated anthrax bacilli by means o f in vitro passages. It was Pasteur who, in honour
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of Jenner, generalized the term “vaccination” from the use of cowpox (vaccinia) to 
include similar strategies for controlling other infectious diseases (Hilleman, 1999). 
Pasteur’s emphasis was on the microbial agents, with less attention paid to the host’s 
immune response.
Louis Pasteur and Emil Von Behring clearly considered the therapy of infection an 
important aspect of vaccination. The rabies vaccine o f Louis Pasteur, as well as the 
tetanus and diphtheria vaccines of Behring, were aimed at preventing the disease in 
individuals who were already infected. However, in later times the concept of 
therapeutic vaccination became less attractive, and vaccination was considered to be 
primarily preventive, i.e., vaccination was used to induce a primary immune response 
in naive individuals.
1.4.2. Immunology of vaccination
As mentioned before, protective immunity in leishmaniasis depends on a cell- 
mediated immune response and not on antibodies. Moreover, whether resolution or 
progression of the disease ensues in humans and animal models depend on which 
subtypes of T lymphocytes are stimulated. CD4^ Thl and CD8^ T cells, through their 
secretion o f IL-2 and IFN-y, lead the response towards cell-mediated immunity 
involving macrophage activation, whereas CD4"  ^Th2 cells, through their products, IL- 
4 and IL-10, lead to antibody production. The two poles are counter-regulatory in that 
IFN-y inhibits antibody formation and IL-4 and IL-10 inhibit macrophage activation 
(Cox, 1997).
Therefore, it is reasonable to accept that vaccination against Leishmania should be 
through the activation of CD4^ Thl as effectors of vaccine-induced protection. It was 
previously described that T cells do not act directly and recognise antigen only after 
processing. This means that the parasite has already infected host cells, typically 
APCs, which serve as their major habitat. Consequently, whether certain antigens 
functions as preferred targets for T lymphocytes remains to be established. In the 
following, we will consider T cells as major mediator of vaccinations against 
Leishmania and follow the concept that full protection is best achieved by a
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combination o f different T cell populations that interact in a tightly controlled 
network. Moreover, it is important to consider the different T cell combinations to be 
activated by pre-infection vaccine.
1.4.3. Progress toward Leishmania vaccines
The current studies and the future prospects for a Leishmania vaccine are focused on 
the five types of vaccine including: live promastigotes Wild Type, attenuated 
promastigotes. Killed promastigotes, subunit vaccines based on Leishmania specific 
molecules, and DNA vaccines. Each o f these types of vaccine has some advantages 
and disadvantages.
1.4.3.1. Live virulent promastigotes
Vaccination with live Leishmania parasites to produce self-healing lesions at an 
inconspicuous site has been practised for a long time in the Middle East. This method 
induces resistance in at least 70% of the individuals treated, but serious clinical 
complications associated with the live vaccine emphasise the need for an attenuated or 
defined vaccine against cutaneous leishmaniasis (Liew et al,, 1993). The isolation of 
virulent Leishmania that protectively vaccinated mice against infection showed that 
an attenuated vaccine was possible (Handman et al., 1990), although, increased 
knowledge of the real hazards of the live organisms, such as persistence in the 
immune host, led to the cessation o f using o f the live virulent parasite (Modabber, 
1990). The advantage of the viable vaccine is that parasites can exist intracellularly in 
the macrophages and evade the consequences of host’s immune attacks. The result is 
that the parasite can survive in the mammalian host for a long time and causes a 
chronic disease, with unsuccessful immunological response (Liew, 1989). There are 
some disadvantages that made this approach unacceptable (Handman et. al., 1990).
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1.4.3.2. Live attenuated promastigotes
The generation of attenuated viable vaccine strains of Leishmania using genetic 
manipulation has made it possible to produce stable avirulent mutants that still induce 
an immune response but which have lost the capacity to cause disease in an immuno­
competent host.
The successful production of an attenuated line of L. mexicana mutants lacking 
cysteine proteinase (CP) genes cpa and cpb {IScpa/cpb) but which could limit lesion 
and parasite growth in BALB/c and C57BL/6 mice has been designed (Mottram et al., 
1997). L. mexicana txcpa/cpb are candidates for attenuated live vaccines (Alexander 
et aL, 1998). The vaccine potential o f L. major dihydrofolate reductase / thymidylate 
synthetase knock out (DHFR/TS“), which is avirulent in mice, has recently been 
studied in mice (Titus et aL, 1995).
One of the advantages of attenuated lines of Leishmania is that the parasite can 
survive in the mammalian host for a long time, without any pathogenicity and induces 
an immunological response. The parasite persisting for a long time induces long term 
memory in the process known as concomitant immunity (Aebischer et aL, 1993). An 
unfortunate feature o f this persistence is the possibility o f reactivating of disease in 
the immunocompromised individual. A vaccine should be molecularly defined and 
induce long term memory in the absence o f persistent live organisms. (Handman, 
1997).
Other disadvantages include the complicated and high price o f production and 
logistics o f delivery for large-scale vaccination (Handman, 1997). Attenuated 
Leishmania vaccine strains retain the inherent risk of causing disease in severely 
immunodeficient individuals, underlining the mutual impact of pathogen and host 
immune response on virulence.
I.4.3.3. Killed promastigotes
Unlike many other parasites, Leishmania can be easily grown in cell-free media. This 
simple cultivation and the use of killed parasites as skin-test antigen (leishmanin) for
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diagnosis in humans during the past decades has prompted scientists to try using the 
killed parasites, with or without adjuvant, as vaccines or for immunotherapy 
(Modabber, 1995). There are many studies from Iran, Israel, and Soviet Union that 
indicate that controlled infection led to significant protection from re-infection.
Clinical trails of prophylactic immunization with killed promastigotes of L  major 
began in early 1940, and have shown variable rates of protection, ranging from 82% 
to no effect at all. It has been reported that immunzation with killed leishmanial 
promastigotes plus BCG induced CD4+ T cells (Castes et aL, 1994). Cabrera et aL 
(2000) found that vaccination with BCG give a strong immunity against a virulent 
strain o f L. mexicana amazonensis. It has been reported that a single dose of killed 
autoclaved L. major promastigotes (ATM) plus BCG reduced the incidence of 
cutaneous leishmaniasis among schoolchildren compared with a group receiving BCG 
alone (Sharifi et. aL, 1998).
The killed parasites are unable to invade the reticuloendothelial cells but the viable 
parasite can exist intracellularly in macrophages and evade the consequences of host’s 
immune attacks.
1.4.3.4. Subunit vaccines
Subunit vaccines have focused primarily on protein antigens, because they can be 
easily identified, isolated genes cloned and studied. There has been significant 
progress towards the identification of molecular defined vaccine candidates, specially 
the surface protease gp63, the surface antigen gp46/M2 and a related parasite surface 
antigen 2 (PSA-2) (Xu, 1995), An interesting approach with gp63, which has 
provided promising results, has been the use of live vectors. It has been possible to 
induce protection in mice against the challenge with L. mexicana by immunising with 
attenuated S. typhimurium expressing gp63 (Gonzalez et aL, 1998). Abdelhak and 
colleagues (1995) reported that recombinant BCG expressing the Leishmania surface 
antigen gp63 induces protective immunity against L. major infection in BALB/c mice. 
It has been reported that recombinant vaccina virus carrying the gp46/M-2 gene of L. 
amazonensis is able to induce a protective immunity in mice against this parasite 
(McMahon-Pratt e/a/., 1993).
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One of disadvantages o f subunit vaccines is that T-cells do not recognise non- protein 
antigen and another is the possible existence o f non-responders to single antigens in 
the genetically diverse human population (Handman, 1997).
I.4.3.5. DNA vaccines
The protective responses induced with DNA vaccines against several pathogens have 
provided the genetic vaccination as a new approach for vaccination (reviewed by 
Thighe et al., 1998). The first Leishmania vaccine delivered as plasmid DNA has 
been gp63 (Xu and Liew, 1995). It was shown that 30% of the BALB/c mice 
recovered from L. major infection, when they were vaccinated intradermally with 
plasmid DNA expressing gp63 and that dendritic cells from immunised mice were 
able to transfer protection (Walker et al., 1998).
Vaccination studies, using a DNA construct encoding the surface antigen gp46/M2 
and related PSA-2 showed that it causes reduction in lesion size and promotes healing 
in both genetically resistance C3H/He mice and susceptible BALB/c mice (Handman 
et ah, 2000). PSA-2 DNA induced a protective immunity by inducing a defined 
population of CD4^ T cells to secrete Thl-like cytokines in susceptible mice 
(Sjolander et ah, 1998).
The only other example o f DNA-induced protection in leishmaniasis is the LACK Ag. 
Generation of long-term protective immunity against leishmaniasis must induce 
memory T cells, which upon encounter with the parasite are stimulated to secrete 
protective Thl-like response cytokines (Sjolander, 1998). It has been reported that 
using a construction of a cDNA library obtained from L. major promastigotes and 
expression in E.coli, a 24 kDa protein (p24) was identified sharing homology with 
intracellular receptors for activated protein C kinase (RACK) and was designated 
LACK (Mougneau et ah, 1995),
DNA vaccines have many advantages; no adjuvant required, easy and low cost of 
production, and with long term stability. The disadvantages of DNA vaccines are 
induction of autoimmune disorders, immune complex diseases or the down-regulation 
of immune response through the induction of tolerance (Wahren, 1996).
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2.1. Introduction
2.1.1. Leishmania
Protozoan parasites of the genus Leishmania are the causative agents o f a spectrum of 
human diseases. Leishmania has a digenetic life cycle that encompasses the 
extracellular promastigotes in the digestive tract of the parasite-transmitting insect 
vector, the sandfly, and the disease-causing intracellular amastigotes living in 
parasitophorous vacuoles (PV) of mammalian macrophages.
Some o f the components, which are very important in the pathogenesis by the 
parasite are cysteine proteinases (CPs). It was demonstrated that L. mexicana complex 
has CP activities, particularly in the amastigote stage (Coombs and Mottram, 1997), 
which contains multiple CPs of apparent size 22-28 kDa that are readily detectable 
using gelatin-SDS-PAGE (Robertson and Coombs, 1992). In addition, the stationary 
phase promastigotes which contain CPs, the majority of the CPs in the various 
Leishmania species are to a group of homologous cathepsin-L-like enzymes knows as 
CPA and CPB (Robertson and Coombs 1993). L. mexicana Acpa was generated by 
disrupting sequentially both alleles o f Imcpa using gene-targeting o f promastigotes 
with hygromycin- and phleomycin-resistance markers (Souza et al,, 1994). L. 
mexicana mutants deficient in cysteine proteinase genes cpa (Acpa) and cpb (Acpb) or 
both cpa and cpb (Acpa/cpb) have been created by targeted gene disruption (Mottram 
et ah, 1996; Frame et a l,  2000). Alexander and colleagues (1998) reported that they 
have vaccine protection.
2.1.2. Gentamicin
Gentamicin belongs to the aminoglycoside group, which was discovered by Wenistein 
in 1963 and isolated, purified, and characterized by Russell in 1964 (Chambers and 
Sande, 1996). Aminoglycosides were originally obtained fi*om various Streptomyces 
species and have similar chemical and toxic activities to commercial gentamicin 
(Chambers et a l,  1998). Gentamicin was isolated fi-om Micromonospora purpurea
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and has been used as a very effective bactericidal agent against both gram-positive 
and gram-negative bacteria (Chambers et al., 1998).
2.1.2.1, Chemical properties:
Gentamicin consists of a hexose ring, 2-deoxystreptamine, which is joined to two 
amino sugars by glycosidic linkages (Chambers and Sande, 1996) and is composed of 
three loosely related fractions: gentamicins Ci, C2 , and Cia- All fractions have similar 
molecular weights and the commercial preparation contains varying mixtures o f the 
three fractions (Figure 2.1).
HC— NH— R2 NHz
OH
/  CH, 
NH— CHjHO
R i R 2 Ra
Gentamicin C% CH3 CH3 H
Gentamicin C2 CH3 H H
Gentamicin Cia H H H
Figure 2.1, Structure of gentamicin
2.I.2.2. Mechanism of action
Gentamicin interacts with RNA molecules and any biological function involving 
RNA is a potential target of the compound. Walter and colleagues (1999) reported 
that aminoglycosides are very active towards RNA because RNA molecules are 
highly negative charged. However, the precise mechanism o f bactericidal activity of 
aminoglycosides is not yet fully understood. Some of the proposed actions (see Figure 
2.2) are follows:
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synthesis by fixing the 30-50 S ribosomal complex at the start codon (AUG) 
of mRNA (Chambers and Sande, 1996). 
ii) Misreading of mRNA during protein synthesis, resulting in either
(a) Premature termination of translation with detachment of the ribosomal 
complex and an incompletely synthesised protein.
Or
(b) Abnormal or non-functional proteins (Chambers and Sande, 1996).
mature protein
growing polypeptide ■
/ À  A 'io s
direction of
A
B
AUG,
5-
AUGi
5 -
AUG
mRNA translation +  aminoglycoside e 5
 ^ blocks initiation 
of protein synthesis
blocks further
 3* translation and elicits
premature termination
incorporation of 
incorrect amino acid
Figure 2.2. Effects o f aminoglycosides on protein synthesis (Chambers and 
Sande, 1996).
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2.2. Methods and materials
2.2.1. Parasites
L  mexicana wild type (WT) strain, designation MNYC/BZ/62/M379 and L. major 
(WT) strain, designation LV39 kindly provided by Prof. Coombs, Division of 
Infection and Immunity, Glasgow University and Prof. Liew, Department of 
Immunology, Glasgow University, respectively. The parasites were cultivated in 
HOMEM medium (GIBCO-BRL) with 10% (v/v) heat-inactivated foetal calf serum 
(HI-FCS) (Labtech International) (designated complete HOMEM medium). 
Promastigotes were grown in 25 cm  ^flat bottomed culture flasks at 25^C with air as the 
gas phase. The mid to late log-phase promastigotes were transferred routinely into fresh 
medium with a starting density of 10^  cells / ml and reached the infective promastigote- 
stage (stationary phase containing metacyclic promastigotes) with a density o f  1-2 x 10^  
cells/ml after 8-9 days incubation.
2.2.2. Preparation of JL. mexicana and L, mayor Hamid’s lines (H-lines)
L. mexicana H-line was generated in complete HOMEM medium supplemented with 
gentamicin (Sigma) at 20 pg/ml. The mid to late log-phase promastigotes of L  
mexicana WT were transferred into medium with gentamicin and incubated at 25'^C 
(for more details see section 2.2.1). L. mexicana was attenuated after some passages 
(for example 20).
The development of attenuated lines o f L. mexicana WT by this methodology was 
carried out on 4 separate occasions. On each occasion, amastigotes of L. mexicana 
WT from a BALB/c mouse lesion were transferred into complete HOMEM medium 
and incubated at 25°C. The amastigotes differentiated to promastigotes over 72 hours, 
which were then transferred into complete HOMEM supplemented with or without 
gentamicin and incubated at 25^C. The mid to late log-phase promastigotes were 
passaged into medium with gentamicin or gentamicin-free and this process continued 
for at least 20 passages.
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The development o f the attenuated line o f L  major WT used the same methodology 
except that only 11 passages with gentamicin were used just on one occasion.
2.2.3. Prepareation of promastigotes of L, mexicana H-Iine amastigote-derived 
through of BALB/c mice (Z. mexicana HAD-line).
Twelve weeks after inoculation of 5 x 10  ^ (cell / ml) stationary phase promastigotes 
of L. mexicana H-line into the shaven rump mice were killed and rinsed with 70% 
alcohol. The skin from the rump at the site, where the promastigotes were injected, 
was removed and the epidermal sheet carefully separated from the dermis. The skin 
was cut into 0.75 cm strips, floated dermal side down on RPMI medium 
supplemented with 1% trypsin in plastic dishes and incubated at 37”C for 90 min. The 
sheets were then shaken to release the cells. The cells were sedimented at 280 x g for 
10 min and washed twice in RPMI. The epidermal cells were resuspended in 
HOMEM medium supplemented with 10% FCS, plated in the 24-well plates and then 
incubated at 25°C. The cultures were examined daily for the presence of 
promastigotes.
2.2.4. Measuring the size of lesions induced by the two lines ofZ. mexicana
The stationary phase promastigotes of L. mexicana WT or L. mexicana H-line or L  
major WT or L  major H-line were harvested from a stationary culture (1-2 x 10  ^
cells/ml) after 6-7 days growth. Cells were washed 3 times in ice-cold PBS, the 
number of promastigotes adjusted to 2.5 x 10  ^ cells/ml in PBS, and 200 pi of this 
suspension was subcutaneously (s.c.) injected into the shaven rump of BALB/c mice. 
The lesion volume was measured weekly using a capillary micrometer (Royal) 
(Mottram gf. aL, 1996).
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2.2.5. Determination of parasite density by Formaldehyde fixation
Promastigotes were mixed with phosphate buffer saline (PBS) [NaCl 171.1 
mM/1, KCl 33.5 mM/1, Na2HP0 4  101.2 mM/1, and KH2PO4 18.3 mM/1 (all from 
Sigma)] supplemented with formaldehyde 4% (v/v) and incubated for 5 min at 
room temperature. The fixed promastigotes were counted using an improved 
Neubauer Haemocytometer. The number of promastigotes per ml was 
calculated.
2.2.6. The growth rate of L. mexicana H-line and Z. major H-line
Promastigotes o f Z. mexicana H-line or Z. major H-line were individually grown in 
complete HOMEM medium supplemented with 20 pg/ml gentamicin or without 
gentamicin. The mid to late log-phase promastigotes of each line were transferred into 
the medium to starting density of 1 x 10  ^ cell / ml and the numbers of promastigotes 
were counted using an improved Neubauer Haemocytometer daily. The pH o f the 
culture media was measured using a pH meter (Philips PW 9420).
2.2.7. Comparing the growth rate o f Z. mexicana H-line with Z. mexicana 
txcpa/cpb in vitro
Promastigotes of Z. mexicana H-line or Z. mexicana t^cpa/cpb or Z. mexicana WT 
were individually grown from a starting density of 5 x 10"^  cell / ml in complete 
HOMEM medium supplemented with 4 kinds of selective antibiotics or free of 
antibiotics. The mid to late log-phase promastigotes of each line were transferred into 
the medium with nourseothricin hydrosulfate (SAT) at 25 pg/ml (w/v) or puromycin 
(Pur) at 10 pg/ml (w/v) or zeocin (Ble) at 10 pg/ml (w/v) or hygromycin B (Hyg) at 
50 pg/ml (w/v) or a combination of these antibiotics, SAT 6.25 pg/ml, Pur 2.5 pg/ml.
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Ble 2.5 pg/ml, and Hyg 6.25 pg/ml (all antibiotics a gift from J, C. Mottram, 
Wellcome Centre of Molecular Parasitology, University o f Glasgow). The numbers of 
promastigotes were counted using an improved Neubauer Haemocytometer daily.
2.2.8. Staining parasites
Aliquots of cultures of stationary phase promastigotes (0.5 ml) were spread onto 
slides using a cytospin (Shandon centrifuge) at 1600 g for 5 minutes. The slides were 
quickly air dried, fixed in absolute methanol, and stained in 10% (v/v) Giemsa’s stain 
(Merck) in PBS (pH 7,2) for 10 minutes.
2.2.9. Cryopreservation of promastigotes
Parasites were cryopreserved in liquid nitrogen. 95 pi o f culture of mid to late log 
phase of promastigotes were mixed with 5 pi of dimethylsulfoxide (DMSO) in a 
cryotube (Bio Plas, Inc). The tube was wrapped in cotton wool, put inside a 
polystyrene box and placed in a -70° C freezer for overnight. The following day the 
cells were transferred into liquid nitrogen.
2.2.10. Sodium dodecyl sulphate-poly aery la mide gel electrophoresis (SDS- 
PAGE)
2.2.10.1. SDS-PAGE (mini gel)
2.2.10.1.1. Harvesting of promastigotes ofZ. mexicana.
When the promastigotes reached stationary phase, the cell density o f the culture was 
determined using an improved Neubauer Haemocytometer. The promastigotes were 
harvested by centrifugation at 750 g for 15 minutes at 4°C. The pellets were
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resuspended in 10 ml of 0.25 M sucrose solution. Centrifugation and resuspension 
were repeated twice. The pellets were finally resuspended to 2 x 10  ^ cell / ml. The 
suspension was aliquoted 20 pi per eppendorf tube, centrifuged, the supernatants 
discarded and the pellets stored at - 70° C.
2.2.10.1.2. Preparation of promastigote lysates
Extracts were prepared by addition of 0.25% (v/v) Triton X-100 in 0.25% M sucrose 
to frozen cell pellets. The cells were subsequently mixed by gentle aspirated with a 
Gilson pipette tip and then centrifuged at 1600 g for 10 minutes in a microfuge, and 
the supernatants collected. The samples were kept on ice before using.
2.2.10.1.3. Preparation of gel
SDS-PAGE was used for protein fractionation by vertical slab electrophoresis. The 
composition of separating and stacking gels are detailed in (Appendix, Tables 1-4). 
The separating gel was loaded and a little water added to the top of the gel to level it. 
Following setting o f the gel, the water was removed and the stacking gel was added, 
loaded, and setting allowed.
2.2.10.1.4. Total protein analysis (mini gel)
The samples from section 2.2.10.1.2 were mixed with an equal volume of sample 
buffer (see Appendix, Table 5), boiled for 10 min, and then centrifuged at 8500 g for 
1 min. The supernatants of promastigote lysates of two lines of L  mexicana were 
separated using SDS-PAGE with a 10% (w/v) acrylamide gel at 150 V for about 1 
hour. Subsequently, the gel was stamed overnight in Coomassie Blue.
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2.2.10.2. Proteinase detection using substrate SDS-PAGE
Cysteine proteinase activity o f stationary phase promastigotes o f two lines o f L. 
mexicana was analysed using SDS-PAGE gels (10% acrylamide) containing gelatin at 
0.2% (w/v) (Robertson and Coombs, 1990). The samples (see section 2.2.10.1.2) (10 
pi) were mixed with equal volume of sample buffer (see Appendix, Table 5) and 
centrifuged at 8500 g for 1 minute in a micro centrifuge. The samples were separated 
on the gel (as described in the section 2.2.10.1.4) and subsequently the gels were 
incubated in 2.5% Triton X-100 on a shaking table at 37°C for 30 minutes to remove 
SDS and reactivate the enzymes. The gels were then incubated at 37°C in 0.1 M 
sodium acetate, pH 5.5, with 1 mM DTT for 2 hours to allow hydrolysis o f the 
gelatin. Subsequently the gels were incubated overnight in Coomassie Blue Staining 
and destained in destaining buffer (see section 2.2.10.1.4)
2.2.10.3. 10-20% polyacrylamide gradient SDS-PAGE
2.2.10.3.1. Preparation of gel
To compare the protein levels of stationary and log phase promastigotes o f two lines 
of L  mexicana, the sample lysates were run on a SDS-PAGE gradient gel (10%-20% 
acrylamide (Hames, 1983). The cassettes were inserted into the slab gel casting 
apparatus (SGC) (Pharmacia) for casting 180 mm wide. The stock solutions (see 
Appendix, Tables 6 and 7) were prepared and at this stage were not mixed. The valve 
between the reservoirs was closed and a 20% (v/v in distilled water) methanol 
solution was poured in the chamber nearest the outlet o f the gradient mixer and 
allowed to run down into the SGC, leaving the connecting tube filled with liquid and 
free of air bubbles. Acrylamide 10% was poured into the lower chamber of the 
Gradient Mixer and the valve connecting the two reservoirs was opened just to 
remove air bubbles and then closed. Subsequently, acrylamide 20% was poured into 
the empty chamber and the requisite amounts of Tetramethylethylenediamine
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(TEMED) and Ammonium persulphate (APS) were added, mixed briefly, the stirrer 
placed into the lower chamber, and the paddle turned on. The connecting valve 
between the two reservoirs was opened. When the polymerizing solution had run 
through, the glycerol / water solution, with a little bromophenol blue, was 
immediately added to the lower chamber. The flow of glycerol /  water solution was 
stopped when the top of the polymerising mixture just reached the upper edge of the 
gel cassette. The gels were allowed to polymerized for at least one hour, the gel 
cassettes removed from the SGC, and the slabs stored in a humid atmosphere at 4- 
8°C.
2.2.10.3.2. Preparation of promastigote lysate
The stationary or log phase promastigotes were harvested (see section 2.2.10,1.1) and 
washed 4 times with ice-cold PBS at 4°C. The suspension of cells with a density of 2 
X 10  ^cells / ml was aliquoted (100 pi per each eppendorf tube), centrifuged, and the 
supernatant removed. The pellets were stored at -70°C until needed. Promastigote 
lysate was prepared by adding 50 pi sample buffer to the pellet, boiled at 100°C for 10 
minutes and centrifuged at 750 g for 5 minutes. 30 pi of supernatant was loaded to the 
SDS-PAGE gradient slab gel. The gel was run at a constant 230 voltage for 4 hours, 
stained with Coomassie blue stain, and destained (as previously described).
2. 2 .11 . Two Dimensional Electrophoresis (2-DE)
2.2.11.1. Sample preparation
In order to obtain optimal results in 2-DE, a high concentration of soluble 
promastigote proteins was required. Two methods for preparation of the soluble lysate 
promastigote proteins were initially used. The preliminary results showed that the 
number o f spots using the lysate from method 2 was higher than that from method 1. 
So method 2 was selected for remaining experiments.
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Method 1
Stationary phase promastigotes with a density o f 2 x 10  ^cells / ml were harvested (see 
section 2.2.10.3.2). The pellets were stored at -70°C until needed. Promastigote 
lysates were prepared by adding 40 pi lysate solution (see Appendix, Table 8) to the 
pellets which were the frozen and thawed 3 times using liquid nitrogen and then 
sonicated in a water bath for 5 minutes. 310 pi rehydration buffer stock (see 
Appendix, Table 10), DDT (Sigma) (10 mg/ml) and (immobilized pH gradient) IPG 
buffer (Pharmacia) (5pi / ml) [(IPGphor buffer 4-7 L) for IPGphor strip 4-7 and 
(IPGphor buffer 3-10 L) for IPGphor strip 3-10 were used] mixed (before using) and 
then added to the samples.
The promastigote lysates were mixed with a vortex for 4 minutes and then centrifuged 
at 1800 g at 4°C for 3 minutes. The supernatants were used.
Method 2
Promastigote lysates were prepared by adding 40 pi lysate solution (see Appendix, 
Table 9) to the pellets (see section 2.2.10.3.2) which were the frozen and thawed 3 
times using liquid nitrogen, sonicated in a water bath for 5 minutes, and then heated at 
95°C for 5 minutes. 310 pi rehydration buffer stock, DDT (10 mg / ml) and IPG 
buffer 4-7 L (5pl / ml) or IPGphor buffer 3-10 L were used mixed (before using) 
added to the samples. The promastigote lysates were mixed with a vortex for 4 
minutes, and then centrifuged at 1800 g at 4°C for 3 minutes. The supernatants were 
used.
2.2,11.2. First dimension isoelectric focusing (IFF)
2.2.11.2.1. Immobilised pH gradient (IPG) strip
Two kinds of ready-made IPG strips, Immobiline Drytrip gels, with the pH gradients 
3-10 L (linear) and 4-7 L (linear) were used. The pH 3-10 L IPG strips are analysed
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wide range of proteins on a single 2-DE gel and the pH 4-7 L IPG strips were used for 
higher resolution separations in the narrower pH range.
Following sample preparation (as described in method 2 from section 2.2.11.1), the 
protective film from the IPG Dry Strip gel was removed. The sample was placed in 
the IPGphor strip holder and the entire length of IPG strip soaked with sample by 
placing IPG strip in the strip holder (gel facing down). The IPG strip was 
subsequently put in the strip holder, placing the end o f the IPG strip over the cathode 
(electrode), and IPG cover fluid (Pharmacia) was added in the IPG strip holder length. 
The cover of the strip holder was placed on the strip holder and the strip holder 
assembled on the IPGphor platform.
2.2.11.2.2. IPGphor
This system is for the isoelectric focusing (lEF) dimension of 2-DE. The programme 
was designed for 13 cm pH 3-10 or 4-7 IPG Dry Strip gel with a sample buffer that 
was prepared as described before (section 2.2.11.2.1). The timetable and voltage used 
is shown in Table 2.1.
Table 2.1. The programme of IPGphor
Step Time Voltage (V)
1 15 hours 30
2 1 hour 500
3 Until reach to 1000 V 1000
4 30 minutes 8000
5 4 hours 8000
Total 35000
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2.2.11.2.3. Equilibration step
After completion o f the first dimension, the strip was washed and equilibrated. The 
equilibration buffers I and II were prepared according to the recipe in (see Appendix, 
Table 12). The IPG strip was placed in individual strip holders with the support film 
towards the strip holder wall. The equilibration buffer I was added to the strip holder 
and shaken for 15 minutes. Subsequently, the equilibration buffer I was removed and 
the strip was placed in the strip holder with equilibration II buffer for 15 minutes and 
then washed dd H2O.
2.2.11.3. Second dimension SDS-PAGE
2.2.11.3.1. Preparation SDS slab gel vertical system
Gels with a final concentration o f 10% acrylamide and with a 1.0 mm thick spacer 
were prepared for the second dimensional 2 DE-gel. Subsequent to pouring the gel 
(see Appendix, Table 14) the gel cassettes were filled with displaying solution (see 
Appendix, Table 15) until 3 to 10 mm below the top (no stacking gel layer is 
required). Immediately, the storage solution (see Appendix, Table 16) overlay was 
added to each gel to create a fiat surface. After allowing overnight polymerization, the 
overlay was removed and the gels were stored at 4°C for up to two weeks.
2.2.11.3.2. Placing the IPG strip on the gel.
The IPG strip (from section 2.2.10.3.3) was washed with the SDS electrophoresis 
buffer (see Appendix, Table 17) and placed between the plates on the surface o f the 
SDS gel. The strip was gently pushed down, with a thin plastic ruler, until contact was 
made before with the surface o f the gel and the lower edge o f the IPG strip. 
Immediately, the strip was sealed by agarose (see Appendix, Table 18) to prevent it 
from moving or floating during electrophoresis. The agarose was heated at lOO^C, 
allowed to cool to 50^C and the amount required for sealing the IPG strip slowly 
pipetted.
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2.2.11.3.3. Electrophoresis
The electrophoresis was performed at a constant current of 100 volts overnight at 4°C. 
After electrophoresis, the gel was removed fi-om its gel cassette in preparation for 
staining.
2,2.11.3.4. Silver staining
The gels were stained with the silver staining Kit (Pharmacia Biotech). 375 ml of the 
solutions detailed in Table 2.2 were needed per gel cassette (12.5 x 26 cm). These 
solutions were freshly made.
Table 2.2. Silver staining protocol for proteins for two gels (Pharmacia Biotech)
Step Solutions Amount Time
Fixation Ethanol
Acetic acid glacial
Make up to 750 ml with dd water
300 ml 
75 ml
30 min
Sensitising Ethanol
Sodium thio sulphate (5% w/v) 
Sodium acetate (17 g) 
Glutaradialdehyde (25% w/v)* 
Make up to 750 ml with dd water
225 ml 
30 ml 
3 packets 
1.75 ml/ gel
30 min
Washing dd water 3x5 min
Silver reaction Silver nitrate solution (2.5% w/v) 
Formaldehyde (37% w/v)*
Make up to 500 ml with dd water
75 ml
0.14 ml/ gel
20 min
Washing dd water 2x1 min
Developing Sodium carbonate (6.25 g) 
Formaldehyde (37% w/v)*
Make up to 750 ml with dd water
3 packets 
0.07 ml/ gel
2-5 min
Stopping EDTA-Na 2H2O (3.65 g)
Make up to 750 ml with dd water
3 packets 10 min
Washing dd water 3x5 min
Preserving gels Glycerol (87% w/w)
Make up to 750 ml with dd water
75 ml 30 min
Add components marked* immediately before use.
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2.3. Results
2.3.1. Establishing L. mexicana H-line and L. major H-line
The attenuated lines of L. mexicana (H-line) and L, major (H-line) were established 
by passaging in the presence of gentamicin. To prevent bacterial contamination 
gentamicin was routinely used in the culture medium. It was observed after culturing 
of promastigotes of L  mexicana in the presence of gentamicin, the length of some of 
promastigotes had been increased. This prompted the analysis of the line (detailed 
below).
In the following experiments, L  mexicana H-line had been generated from L. 
mexicana WT by more than 20 passages in complete HOMEM medium supplemented 
with gentamicin at 20 pg/ml. The generation o f the attenuated line of L. mexicana H- 
line was repeated on four occasions. There was not any restriction to do experiment 
with just one of them.
2.3.2. The size of lesions induced by the two lines of Z,. mexicana
Sub-cutaneous inoculation of L  mexicana WT in mice results in the development of a 
progressive non-healing lesion. To examine the ability of L. mexicana H-line to 
induce lesions, mice were injected (s.c.) with 5 x 1 0 ^  stationary phase promastigotes 
of L  mexicana H-line or WT. The mice which were injected with L  mexicana WT 
developed progressive non-healing lesions (Figure 2.3). In contrast, mice infected 
with L. mexicana H-line developed either no lesion during the period of study or a 
small lesion that was completely healed by 12 weeks post infection.
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Figure 2.3. The mean course of infection of two lines of L. mexicana in 2 
groups of BALB/c mice (5 mice / group). 5x 10^  stationary phase 
promastigotes of L. mexicana WT (35 passages) or L  mexicana H-line (32 
passages) were inoculated in the right side shaved rump of the mice. Lesion 
development was monitored by measuring the size of swelling and lesion 
diameter weekly. Each data point represents the mean group lesion size ± 
SEM.
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2.3.3. The size of lesions induced by the two lines of L. major
Sub-cutaneous inoculation of L. major WT in mice results in the development of a 
progressive non-healing lesion. Five BALB/c mice were infected with 5 x 10^  
stationary phase promastigotes of L  major H-line or WT as described in section 2.3.2. 
The mice that were injected with L. major WT developed progressive non-healing 
lesions (Figure 2.4). In contrast, mice infected with L. major H-line developed no 
lesion during 12 weeks post infection.
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Figure 2.4. The mean course of infection o f L  major WT and L  major 
H-line in 2 groups (5 mice per group) of BALB/c mice. The mice were 
subcutaneously injected with stationary phase promastigotes of the two 
lines of and the lesion development was monitored weekly. The values 
represent the mean + SEM.
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2.3.4. Growth rate of X. mexicana H-line
In order to compare thé growth rate of the two lines of promastigotes, L  mexicana H- 
line and L. mexicana WT were grown in complete HOMEM medium with a starting 
density 10  ^ cells / ml. As demonstrated in Figure 2.3, the number of promastigotes of 
the two lines rapidly increased and there was no significant difference (P>0.2) 
between the growth rates of promastigotes of the two lines of L. mexicana. There 
were no significant differences at any day between the growth rates of promastigotes 
of both lines. Promastigotes of the two lines reached stationary phase after 8-9 days. It 
has been reported that approximately 90% of promastigotes were considered to have 
reached stationary phase, usually after 8-9 days fi'om initiation of culture (Mallinson 
and Coombs, 1989).
2.3.5. Growth rate of L. major H-line
In order to compare the growth rate of the two lines of promastigotes, L  major H-line 
and L. major WT were grown in complete HOMEM medium with a starting density 
10  ^cells / ml. As demonstrated in Figuie 2.6, the number of promastigotes of the two 
lines rapidly increased and there was no significant difference in growth between 
them (P>0.5) on all days. Promastigotes o f the two lines reached stationary phase 
after 8-9 days. The pH of the stationary phase medium of the culturel of 
promastigotes of L  major H-line was 6.9, whereas that of the culturel of the 
stationary phase of promastigotes of L  major WT was more acidic (pH 6.3). The 
measuring of pH of media were repeated individually in three occasions.
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Figure 2.5. Example of in vitro growth of promastigotes of L  mexicana H- 
line and L. mexicana WT. Comparison of the growth rate of the two lines of L  
mexicana of the same age and culture history was made in parallel cultures. 
Cultures of promastigotes of the two lines of Z. mexicana were initiated at 10^  
cells / ml and counts made daily using an improved Neubauer 
Haemocytometer. The results are means ± SD from 3 independent cultures for 
each line.
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Figure 2.6. Example of in vitro growth rate of promastigotes of L. major IT- 
line and L. major WT. Comparison of the growth rate of the two lines o f L. 
major of the same age and culture history was made in parallel cultures. 
Cultures of promastigotes of the two lines of L  major initiated at 10^  cells / ml 
and counts made daily using an improved Neubauer Haemocytometer. 
Promastigotes of L. major H-line and L. major WT were grown on parallel 
cultures of the same age and culture history.
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2.3.6. Comparing the growth rate of L, mexicana H-line with L, mexicana 
Acpa/cpb,
To confirm that L. mexicana H-line has not been mixed up with the attenuated L. 
mexicana Acpa/cpb^ the promastigotes of these lines and L  mexicana WT were 
individually grown in the presence of 4 kinds o f selective antibiotics, SAT, Pur, Ble, 
and Hyg. Promastigotes of Leishmania mexicana Acpa/cpb have the ability to grow in 
the presence o f selective antibiotics because, L, mexicana Acpa was generated by 
disrupting sequentially both alleles of Imcpa using gene-targeting of promastigotes 
with hygromycin- and phleomycin-resistance markers (Souza et al., 1994). 
Promastigotes of the three lines of L. mexicana, with a starting density 5 x lO \ were 
passaged and incubated at 25^C. As Figure 2.5 shows, the grov^h rate of 
promastigotes of L. mexicana H-line in the presence of the selective antibiotics, SAT, 
Pur, Ble, and Hyg (individually or combined together) sharply decreased, but the 
number of promastigotes in the antibiotic-free medium increased and during 7 days 
incubation reached 10  ^ cells / ml. The log cell density of promastigotes of L. 
mexicana H-line in the media supplemented with hygromycin or puromycin at day 2 
and with other antibiotics after 3 or 4 days incubation was zero. These results 
indicated that promastigotes of L. mexicana H-line are sensitive to these antibiotics. 
Promastigotes of L. mexicana WT were grown in the media with antibiotics or 
antibiotics-ftee medium. As shown in Figure 2.8, the number of promastigotes in the 
media supplemented with hygromycin or puromycin rapidly decreased whereas in the 
antibiotic-fi*ee medium the number of promastigotes increased and during 7 days 
incubation reached 10  ^ cells / ml. Therefore X. mexicana WT was sensitive to these 
selective antibiotics.
To compare the growth of X. mexicana H-line or X. mexicana WT with X. mexicana 
àcpa/cpb, the same density of promastigotes o f X. mexicana Acpa/cpb were 
transferred to the media with or without antibiotics. In contrast to X. mexicana H-line 
or X. mexicana WT, the number of promastigotes in the media with antibiotics 
increased and there was no significant difference between the growth rates of 
promastigotes of X. mexicana cpa/cpb double knockout in the media, with or without 
antibiotics (Figure 2.9) (P>0.2).
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It was concluded that promastigotes of L. mexicana H-line and L mexicana WT are 
sensitive to four kinds of selective antibiotics, nourseothricin hydrosulphate, 
puromycin, zeocin, and hygromycin B (individually or combined together), whereas 
promastigotes of the L. mexicana cpa/cpb double knockout were resistant to these 
antibiotics, and that L. mexicana H-line was not contaminated with L. mexicana 
Acpa/cpb and which could contribute to its attenuated state.
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Figure 2.7. The growth rate of promastigotes of L mexicana H-line in media 
with or without selective antibiotics. Mid-log phase promastigotes of L. 
mexicana H-line were transferred into HOMEM medium supplemented with 
10% (v/v) PCS and SAT (25 pg/ml) or Pur (10 pg/ml) or Ble (lOpg/ml) or 
Hyg (50 pg/ml) or in a combination of these antibiotics (SAT 6.25 pg/ml. Pur 
2.5 pg/ml, Ble 2.5 pg/ml, and Hyg 6.25 pg/ml) or antibiotic-free. The results 
are means ± SD from 3 independent cultures for each line.
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Figure 2.8. The growth rate of promastigotes of L  mexicana WT in media 
with or without selective antibiotics. Mid-log phase promastigotes of L. 
mexicana WT were transferred into HOMEM medium supplemented with 
10% (v/v) PCS and SAT (25 pg/ml) or Pur (10 pg/ml) or Ble (lOpg/ml) or 
Hyg (50 pg/ml) or in combination of these antibiotics (6.25 pg/ml SAT, 2.5 p 
g/ml Pur, 2.5 pg/ml Ble, and 6.25 pg/ml Hyg) or antibiotic-free. The results 
are means ± SD from 3 independent cultures for each line.
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Figure 2.9. The growth rate of promastigotes of L  mexicana Acpa/cpb in media 
with or without selective antibiotics. Typical growth curves of promastigotes of L. 
mexicana Acpa/cpb in HOMEM medium supplemented with 4 kinds of selective 
antibiotics or in combination of antibiotics or antibiotic-free. The culture was 
initiated at 5 x I O'* cell / ml. Promastigotes in the mid-log phase of growth and cell 
density was determined daily using a Neubauer Haemocytometer. The results are 
means ± SD from 3 independent cultures for each line.
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2.3.7. Proteinase activity of L. mexicana H-line compared with L. mexicana WT
To confirm that the L. mexicana H-line was generated in the presence of gentamicin 
and was not derived through contamination with another attenuated line, L. mexicana 
Acpa/cpb, the proteinases of L  mexicana H-line and L mexicana WT were examined. 
The proteinases of stationary phase promastigotes of L. mexicana H-line and L  
mexicana WT were investigated by loading soluble lysates of the two lines of L. 
mexicana on the SDS-PAGE gel (10%) containing gelatin 0.2% (w/v). The result 
showed that multiple proteinases, the most active of which were between 22-24 kDa 
molecular mass (Figure 2.10). Several lower mobility bands ranging from 24-60 kDa 
were also active. The proteinase activities of the two lines were remarkably similar.
—  36
-  20
Figure 2.10. Comparison of proteinase activities of stationary phase 
promastigotes of two lines of L  mexicana. The lysate proteins were prepared 
from 2 x 1 0 ^  stationary phase promastigotes of L  mexicana H-line (lane 1) or 
L. mexicana WT (lane 2) and analysed on the gelatin-SDS-PAGE gel. The gel 
was subsequently washed and then incubated with 0.1 M sodium acetate, pH
5.5, with 1 mM DTT for 2 hours. It was then stained with Coomassie blue
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2.3.8. Morphology
2.3.8.I. Promastigotes o f f .  mexicana H-Iine
To compare the morphology of promastigotes of L. mexicana H-line with L. mexicana 
WT, the cells were fixed in methanol and stained with Giemsa's stain. As shown in 
Table 2.2, four categories of morphology (M) of promastigotes based on width and 
length were classified for the two lines of L. mexicana. Promastigotes with round cell 
bodies (morphology 1) and a small flagellum appeared in the stained smears of both 
lines. 12% of stationary phase promastigotes of L. mexicana H-line were longer than 
the promastigotes of L. mexicana WT at this stage. The percentage of different sizes 
of promastigotes o f the two lines o ff . mexicana is shown in Figure 2.11.
Table 2.3. The classification of stationary phase 
promastigotes according their sizes.
Morphology width length
Ml 2 < width < 3 jim 10 -12 pm
M2 1.5 -2 pm 10 -12 pm
M3 1.5 -2 pm 13 -18 pm
M4 1.5 -2 pm 19 -23 pm
2.3.8.2. Morphology of promastigotes o f L, mexicana H-line amastigote-derived 
from BALB/c mice ( f . mexicana HAD-line)
In order to compare the morphology of the two lines, the promastigotes of L. 
mexicana HAD-line or L. mexicana WT were grown in gentamicin-fi-ee medium. It 
was observed that L. mexicana HAD-line grew poorly in vitro and poor ability to 
transform. Smears of stationary phase promastigotes were prepared, fixed in methanol 
and stained with Giemsa's stain.
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Figure 2.11. The percentage according to cell lengths of stationary phase 
promastigotes of L  mexicana H-line and L. mexicana WT. Each 
promastigote was measured for body length and breadth measurements in 
Giemsa's stained smears. At least 300 promastigotes were examined from 
each culture. The results are means ± SD from 3 independent cultures for 
each line.
66
In the smear of L  mexicana H-line, 17% of cells were promastigote which some of 
them had a small size flagellum and 83% of them were amastigote form (Figures 
2.12), whereas the promastigotes of L. mexicana WT were slender forms with an 
anterior flagellum (Figure 2.13). The restriction of time prevents to do same analyses 
for both lines.
Figure 2.12. Light micrographs of cells from cultures of L. 
mexicana H-line 2. Cell culture of L. mexicana HAD-line was fixed 
in methanol and stained in 10% Giemsa’s stain. In L. mexicana H- 
line about 17% and 83% of cells were promastigote and 
amastigotes forms, respectively, and some of them had a small 
flagellum.
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Figure 2.13. Light micrographs of ceils from cultures of L  
mexicana WT. Cell culture of L. mexicana WT was fixed in 
methanol and stained in 10% Giemsa’s stain. The stationary 
phase promastigotes of L. mexicana WT were slender forms 
with a long flagellum.
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2.3.9. Protein analysis
To determine whether the adaptation o f L. mexicana H-line to grow in the 
presence of gentamicin involved changes in protein expression, lysates of 
promastigotes of L. mexicana H-line and WT were compared on a SDS-PAGE 
gel. Total lysate proteins of stationary or log phase promastigotes of L. mexicana 
H-line and WT were separately run on 10-20% SDS-PAGE gradient gels . As 
shown in Figure 2.14, a number o f differences in protein expression were 
observed. Two bands were detected around 66 kDa with stationary or log phase 
promastigotes of L  mexicana WT, whereas one (possible two) o f the bands was 
absent from stationary and log phase promastigotes of the L. mexicana H-line.
The stationary or log phase promastigotes o f the two lines of L. mexicana were 
adjusted to 2 x 10  ^cells / ml, pelleted and stored at -70°C. Promastigotes lysates 
were prepared by mixing pellet with 50 pi sample buffer and boiled at 100“C for 
10 min. 30 pi o f samples were loaded to the SDS-PAGE gradient slab gel. To 
compare the protein density of lysates of stationary phase promastigotes of two lines 
of L. mexicana, the samples were loaded in gel and stained with Coomassie blue 
stain.
The Lane profile graphs which are representative of protein concentrations of the 
lysates of stationary phase promastigotes o f the two lines o f L  mexicana are 
shown in Figures 2.15 and 2.16. The optical density o f protein on the SDS-PAGE 
gradient slab gel (Figure 2.14) was displayed with Lane profile graph using Lab 
Works image Acquisition and Analysis Software (UVP Laboratory products). The 
bands correspond to the numbered peaks in each line on the graph. Each peak 
represents a protein concentration for that band. To compare with L, mexicana WT, 
in the optical density of protein of promastigotes of L. mexicana H-line, three peaks 
were deleted (Figure 2.15) and there are just 5 peaks.
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Figure 2.14. Lysates of promastigotes of L. mexicana H-line (44 
passages) and WT (49 passages) compared on a 10-20% SDS-PAGE 
gradient gel. Markers (lane A) and 15 pi of lysate of stationary phase 
(lane B), log phase (lane C) promastigotes of L  mexicana H-line and 
stationary phase (lane D), log phase (lane E) promastigotes of L. 
mexicana WT were separately loaded on gel. Seven bands labelled on 
the gel between lane B and C are also shown in Figures 2.13 and 2.14. 
One (possibly two) of the bands absents from stationary phase 
promastigotes of L  mexicana H-line were shown with arrows.
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Figure 2.15. The Lane profile graph is representative of protein 
concentration in the lysate of stationary phase promastigotes of L. 
mexicana H-line. The samples were loaded in gradient-SDS-PAGE gel 
(10-20% acrylamide). The bands correspond to the numbered peaks in 
each line on the graph. Each peak represents a protein concentration for 
that band. The area under the peaks, surrounded by the small vertical 
marks in each valley, is the area used to calculate the volume of each 
band. In graph displays bands on the x (horizontal) axis that are 
representative of protein concentration, and the optical density on the y 
(vertical) axis.
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Figure 2.16. The Lane profile graph is representative of protein 
concentration in the lysate of stationary phase promastigotes of L. 
mexicana WT. The sample was loaded in gradient-SDS-PAGE gel 
(10-20% acrylamide). The bands in correspond to the numbered 
peaks on the graph. Each peak represents a protein concentration for 
that band. The area under the peaks, surrounded by the small 
vertical marks in each valley, is the area used to calculate the 
volume of each band. In graph displays bands on the x (horizontal) 
axis that are representative o f protein concentration, and the optical 
density on the y (vertical) axis.
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2.3.10. Two-dimensional electrophoresis (2-DE) used to diDerentiate two lines of 
L, mexicana
The protein analysis o f promastigotes on the SDS-PAGE gradient gel showed 
differences in protein expression between stationary and log phase of promastigotes 
of the two lines of L. mexicana. To investigate further differences between these lines, 
the protein of lysates of stationary phase promastigotes of two lines was analysed 
using 2-DE.
Whole cell preparation o f the two lines of L. mexicana was initially separated 
according to pH ranges 4-7 or 3-10 and then in the large-sized SDS PAGE gels (at 
least 20cm x 30cm). The proteins of L. mexicana H-line and L. mexicana WT were 
resolved on the large 2-DE gels (Figures 2.17 and 2.18 respectively) pi range 4-7, but 
the quality of gels pi 3-10 were poor (not shown). Approximately 160 spots were 
detected depending on silver-staining conditions. The comparison o f the two patterns 
reveals high similarity, with several main spots are being similarly positioned. The 
majority o f spots were numbered (Figures 2.19 and 2.20). The significant differences 
between attenuated line o f L. mexicana and L. mexicana WT pattern have been found. 
Spot 101 of pattern of L. mexicana WT (Figure 2.21b) was shifted to a less acidic 
position in the pattern of L. mexicana H-line (Figure 2.21a). As Figure 2.22 (a) shows 
spot 105 was absent from the pattern o f L. mexicana H-line. Two spots have been 
found in the spot in the pattern o f L  mexicana WT (Figure 2.23b), whereas the 
expression of these proteins by promastigotes of L. mexicana H-line decreased 
(Figure 2.23a). Therefore, in the total proteins o f L. mexicana H-line at least one 
protein was absent and the expression some of them decreased. However, this result is 
agreement with that o f gradient SDS-PAGE gel. This data is insufficient to conclude 
that these proteins are similar to the bands, which were absent from gradient SDS- 
PAGE gel. The restriction of time prevented to repeat this test and analyse the gels.
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Figure 2.17. Two-DE gel o f total protein o f lysate o f stationary phase promastigotes o f
L. mexicana H-line .
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Figure 2.18. Two-DE gel o f total protein o f lysate o f stationary phase promastigotes o f
L mexicana WT.
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Figure 2.19. Two-DE gel o f total protein o f lysate o f stationary phase promastigotes of
L. mexicana H-line and the majority o f spots were numbered.
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Figure 2.20. Two-DE gel o f total protein o f lysate o f stationary phase promastigotes
o f A. mexicana WT and the majority o f spots were numbered.
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Figure 2.21. Pattern sectors showing a difference between total proteins of lysates of 
promastigotes of L. mexicana H-line (a) and L. mexicana WT (b). Spot 101 of 
protein expression of promastigotes of L. mexicana WT was shifted to right side (less 
acidic position) in the protein expression of promastigotes of L. mexicana H-line.
78
(a) (b)
106
«
103
104
m
106
105
#
#
103
104
#
Figure 2.22. Pattern sectors showing another difference between total 
proteins of lysates of promastigotes of L. mexicana H-line (a) and L  
mexicana WT (b). Spot 105 from lysate of stationary phase promastigotes 
of L  mexicana H-line was absent.
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Figure 2.23. Pattern sectors showing other differences 
between total proteins of lysates of promastigotes of L. 
mexicana H-line (a) and L. mexicana WT (b). The region 
shown in (a) and (b) reveals two differences: the expression 
of two proteins (spots 109 and 110) decreased in the 
attenuated cell line.
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2.4. Discussion
It is generally accepted that the protection induced by using attenuated forms of 
microorganisms as vaccines against some diseases is more effective than that from 
using other forms o f vaccines (Hess et al., 2000). Recently several methods have been 
developed to attenuate Leishmania, such as disruption of a gene controlling virulence 
from the genome o f the wild type microorganism. For example, an attenuated line of 
L. mexicana t^cpaJcph (Mottram et ah, 1996) and an attenuated L. major lacking 
DHFR/TS gene (Titus et al., 1995) have been created. I have now produced an 
attenuated cell line o f L. mexicana by growing of L. mexicana WT in the presence of 
an antibiotic in vitro and an attenuated cell line o f L. major using the same technique. 
This suggests that this method can be used for attenuating other species of Leishmania 
and maybe other microorganisms.
The attenuated line of L. mexicana Wild Type known as L. mexicana H-line has been 
established under pressure of gentamicin which was routinely added to the medium to 
prevent bacterial contamination. The mechanism by which gentamicin, an 
aminoglycoside, attenuates L. mexicana WT is unknown. Disruption of ribosomal 
activity by breaking up polysomes or misreading o f mRNA during protein synthesis, 
resulting in incomplete protein synthesis, are possible mechanisms.
However there is not any evidence to show when the attenuated line L. mexicana 
formed. Attenuation required at least 20 passages in HOMEM medium supplemented 
with 10% (v/v) FCS and gentamicin at 20 pg/ml.
In the present study some experimental work has early been carried out with L. 
mexicana Acpa/cpb. It was, therefore, necessary to demonstrate that promastigotes of 
L. mexicana H-line were not contaminated with promastigotes of L. mexicana 
Acpa/cpb. Two different tests were set up:
i) Examination o f proteinase activity of L. mexicana H-line.
ii) Culturing o f L  mexicana H-line in the presence of 4 kinds of selective 
antibiotics, SAT or Pur or Ble or Hyg separately or in combination.
Robertson and Coombs (1992) reported that a high mobility band of cysteine 
proteinase (CP) activity can be detected in stationary phase promastigotes of L. 
mexicana using gelatin-SDS-PAGE. The proteinase activity o f stationary phase
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promastigotes of L. mexicana H-line and L  mexicana WT was investigated by 
loading lysates on gelatin-SDS-PAGE gels. Three bands were detected of which the 
molecular mass of the highest mobility band o f proteolytic activities was 20 kDa 
(Figure 2.11). These proteinases are cysteine proteinase is supported by the report that 
the analysis o f CPB isoenzymes expressed by stationary phase promastigotes of L. 
mexicana WT using Western blotting with anti-CPB antiserum detected two major 
proteins (25 and 29 kDa) (Mottram et al., 1997). This study therefore, demonstrated 
that promastigotes of L. mexicana H-line, at least, are not deficient in CPs.
Souza and colleagues (1994) reported L. mexicana Acpa was generated by disrupting 
sequentially both alleles of Imcpa using gene-targeting of promastigotes with 
hygromycin- and phleomycin-resistance markers. It has been shown that L. mexicana 
cysteine proteinase-deficient mutants are resistant to the selective antibiotics such as 
puromycin, zeocin, and hygromycin B (Souza et al., 1994). Therefore promastigotes 
of L. mexicana H-line, L. mexicana Acpa/cpb (positive control), and L. mexicana WT 
(negative control) were individually grown in the media with 4 kinds of selective 
antibiotics (separately or combinations o f them). As the graphs show (Figures 2.3 and 
2.4) promastigotes of both L. mexicana H-line and L. mexicana WT were unable to 
grow in the presence these antibiotics. In contrast, there were no significant 
differences among the growth rates of promastigotes of L. mexicana Acpa/cpb in the 
media with or without antibiotic. These results suggest that promastigotes of L. 
mexicana H-line are neither deficient in CPs, nor is this line mixed with L. mexicana 
cpa/cpb double knockout.
The length of 12% of stationary phase promastigotes of L. mexicana H-line was larger 
than promastigotes o f L. mexicana WT promastigotes. As Table 2.2 shows, the size of 
stationary phase of promastigotes of L. mexicana WT was 1.5-3 x 10-18 pm, whereas 
the size of 12% promastigotes ofL. mexicana H-line was 1.5-2 x 19-23 pm.
The ability o f the attenuated line of L. mexicana to survive in vivo for 3 months, was 
investigated by studying the epidermal cells fi'om where the parasite was injected. The 
cells were transferred into medium supplemented with or without gentamicin. In the 
epidermal cell some of the infected mice, amastigotes differentiated to promastigotes 
and this cell line was designed L. mexicana HAD-line. It was observed that 
promastigotes of L. mexicana HAD-line grew poorly in the medium with or without 
gentamicin. This suggests that the attenuated cell line maybe unable to survive in the
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midgut of sandfly and if so, this would reduce the risk of virulent reversion and spread 
of disease by infected sandflies.
The light micrographs of cells from cultures of L. mexicana HAD-line (Figure 2.11) 
showed that 17% of the cells were promastigotes and 83% o f them were amastigote- 
like although some of them had just a small flagellum. The morphology of 
promastigotes o f L  mexicana HAD-line were compared with promastigotes of L  
mexicana WT which were derived from amastigotes within epidermal cell o f infected 
mice at 3 months post infection (Figure 2.12). As the Figures 2.11 and 2.12 show, 
there are remarkable differences between the morphology of L. mexicana HAD-line 
and L. mexicana WT.
There was no significant difference between the growth rate of promastigotes of L. 
mexicana H-line and L. mexicana WT in vitro.
In the present study, it was demonstrated that the adaptation of L. mexicana H-line to 
grow in the presence of gentamicin involved changes o f protein expression. Total 
lysate protein o f stationary or log phase promastigotes of Z. mexicana H-line and WT 
were individually loaded on the 10-20% SDS-PAGE gradient gel. The result shows 
that a number of differences in protein expression observed. Two bands were 
detected around 66 kDa with stationary or log phase promastigotes o f Z. mexicana 
WT, whereas one (possible two) bands were absent with stationary and log phase 
promastigotes of Z. mexicana H-line.
The optical density o f protein expression o f the two lines of Z. mexicana in 10-20% 
SDS-PAGE gradient gel was displayed in a Lane profile graph, using Lab Works 
Image Acquisition and Analysis Software (UVP Laboratory products). The Lane 
profile graph indicates protein concentration in the lysates of stationary phase 
promastigotes of Z. mexicana H-line and Z. mexicana WT. The bands correspond to 
the numbered peaks on the graph. Each peak represents a protein concentration for 
that band. The graph of protein o f lysate of stationary phase promastigotes of Z. 
mexicana H-line showed two peaks to be present in Z. mexicana WT (3 and 4) which 
were absent inZ. mexicana H-line (Figures 13 and 14).
The results o f protein analysis of promastigotes of Z. mexicana H-line and Z. 
mexicana WT on the SDS-PAGE gradient gel have elicited a number of differences in 
protein expression. To confirm whether the differences between Z. mexicana 
attenuated line and WT, the protein from lysates o f stationary phase promastigotes of 
the two lines were analysed using immobilized pH gradients. The comparative
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proteome analysis of two lines o f L. mexicana using high-resolution techniques has 
been done using isoelectric focusing (lEF), which separate proteins according to their 
isoelectric points (pi) and SDS-PAGE, which separates proteins according to their 
molecular weights (MW). Both techniques were modified as high-resolution methods 
(Jungblut et ah, 1999).
The sample preparation is absolutely crucial for good 2-DE results; the samples were 
initially prepared using two methods and the number of spots on the gels were 
increased using method number 2. The protein lysates of 2 x 10® cell / ml stationary 
phase promastigotes o f L. mexicana H-line and L  mexicana WT were initially 
separated according to pH ranges 4-7 or 3-10 and then in the large-sized SDS PAGE 
gels (at least 20 cm x 30cm). Both lines of Leishmania comprise patterns with a high 
density o f spots in the range pH 4-7 of the gel. The position of spots in the gels of the 
two lines of L, mexicana revealed high similarity, and the main spots were compared 
easily. One hundred and fifty nine, that is the majority of spots, were labelled 
(Figures 2.19 and 2.20) and some differences between the patterns of the attenuated 
line ofZ. mexicana and L. mexicana WT were detected. Spot 101 in Z. mexicana WT 
gel (Figure 2.21 b) was shifted to a less acidic position in Z. mexicana H-line (Figure 
2.21a). As Figure 2.22 (a) shows spot 105 is absent in Z. mexicana H-line. Two spots 
(109 and 110) were found in the Z. mexicana WT gel (Figure 2.23 b), whereas the 
expression o f these proteins by promastigotes of Z. mexicana H-line decreased 
(Figure 2.23a).
The comparative proteome analysis of the two lines of Z. mexicana in the pH ranges 
3-10 (data not shown) and 4-7 indicates that further runs in the pH 4-7 range are 
required. To identifying proteins in the lysate of stationary phase promastigotes of Z. 
mexicana H-line, which were lost or reduced compared with Z. mexicana WT, mass 
spectrometry with database searching has been suggested (Beavis and Fenyo, 2000). 
Although, the data of 2DE of the two lines have been supported with the results of 
gradient SDS-PAGE gel. There are insufficient replicates to draw firm conclusions 
about the absence or decreased expression of the proteins in 2-DE.
An attenuated cell line of Z. major was developed using pressure of gentamicin by the 
same method that was described for attenuation o f Z. mexicana WT. The attenuated Z. 
major was generated by culturing of promastigotes of Z. major WT in the medium 
supplemented with 10% (v/v) HI-FCS and 20 pg / ml gentamicin after 11 passages.
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There was no significant difference (p>0.5) between the growth rates o f promastigotes 
of the two lines of L  major. The culture medium of stationary phase promastigotes of 
L  major WT (pH 6.3) was more acidic than that of L  major H-line (pH 6.9).
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3,1. Introduction
The leishmaniases comprise a group of diseases caused by the intracellular protozoan 
parasite Leishmania. In humans, the localized cutaneous infection caused by L. 
mexicana is often associated with chronic infection of the ear on the pinna (Peters et 
al., 1987).
It is generally accepted that immunity to Leishmania depends on the effective 
generation of cell-mediated immunity (CMI). This CMI has been associated with 
increasing leishmanicidal activity o f macrophages, the expansion of the CD4^ Thl 
cell subset in resistant mice, and the production of cytokines such as IL-12 and IFN-y 
(Heinzel et ah, 1991). On the other hand, non-healing responses in susceptible 
BALB/c mice have been related to the expansion of the CD4^ Th2 cell subset and the 
production of cytokines such as IL-4 and IL-10 (Scott et al., 1988). The role of IL-4 
was shown to be due to its ability to inhibit macrophage leishmanicidal activity and 
down-regulate the development of a Thl-like response (Oswald et al., 1992). It was 
demonstrated that normally genetically susceptible mice lacking IL-4 were protected 
from cutaneous infection with L. major (Kopf et al., 1996) as well as L. mexicana 
(Satoskar et a l, 1995; Satoskar et a l, 1997). However, other studies suggest that the 
inability of the host to generate an IL-12-initiated Thl-like response and produce IFN- 
y rather than the induction of a Th2-like response and IL-4 production may be the 
crucial factor in determining susceptibility to L. mexicana (Guevara-Mendoza et al, 
1997). C57BL/6 and 129Sv/Ev mice which are susceptible to L. mexicana (Alexander 
et a l, 1998) and produce a Th2-response, whereas IL-4-defîcient C57BL/6 and 
129Sv/Ev mice developed a Thl-like response, as measured by an increase in IFN-y 
production, and cure L. mexicana infection (Satoskar et a l, 1995).
It has been reported that both IFN-y and IL-2, only in combination, induce TNF-a- 
specific mRNA and secretion of TNF-a by macrophages. Development of 
intracellular killing activity by activated macrophages also requires the autocrine 
effects of TNF-a (Nacy et a l,  1991). Two consecutive signals are required to activate 
fully the nitric oxide synthase (NOS), which appears to be toxic for Leishmania (Liew 
et ah, 1990; James, 1995). The first signal is IFN-y and TNF-a is a common second 
signal that mediates microbicidal functions as was shown in IFN-y-primed 
macrophages exposed to microbial products (James, 1995). Neutralization o f either 
TNF-a or IFN-y, or inhibition of nitric oxide production, leads to the exacerbation of
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disease (Liew et al., 1990; Evans et. al., 1993). Proteophosphoglycan (PPG) which is 
present on the surface of amastigotes of several Leishmania species, inhibits the 
production of TNF-a and thus reduces nitric oxide by macrophages generation (Piani 
et al., 1999).
The effects of IFN-y on Thl development may be mediated via action on the 
macrophages thus up-regulating IL-12 production or by direct effects on T cells 
(Trinchieri, 1995). Susceptible BALB/c mice infected with L. mexicana WT, produce 
a substantial amount of IL-4 and IL-10 (Guler et al., 1996).
Laskay and colleagues (1993) showed that NK cells play a crucial role in the early 
control of leishmaniasis in resistant mice. The local restriction of the parasite in the 
early phase of the infection is mediated by the innate immune system and this 
function is important in the subsequent development of a protective T cell response 
(Laskay et al., 1995). Moreover, Diefenbach and colleagues (1998) found that in the 
presence of INOS and IFN-a/p, L. major was localized in the skin and the draining 
LN o f susceptible mice. In contrast, in NOS2'^' mice or Wild Type resistant mice 
treated with the N0S2 inhibitor, the parasite disseminated in the spleen, bone marrow, 
lungs, and liver from day one of infection.
In other studies it has been reported that the production of the IgGl antibody isotype, 
although not completely dependent on IL-4 and IL-4 signalling (Snapper and Paul, 
1987) is associated with the development of a Th2-like response. Generation of IgG2a 
is dependent on IFN-y, whereas IL-4 is important for the production o f high level o f 
IgGl in BALB/c mice infected with the Leishmania (Kuchroo et al., 1995).
In summary, several groups o f researchers have clearly demonstrated that protective 
immunity against the L. mexicana complex, is ultimately dependent upon generation 
of a Thl-like response and IFN-y production (Satoskar et al., 1995; Guevara-Mendoza 
et al., 1997)..
88
3.2. Materials and Methods
3.2.1. Mice
Female BALB/c mice age 4-6 weeks, were purchased from HARLAN/OLAC and 
maintained at the Joint Animal Facility o f Glasgow University. The mice were 
approximately 12 weeks old at the start of each experiment.
3.2.2. Parasite
Promastigotes of L. mexicana WT or L  major WT were grown in HOMEM medium 
supplemented with 10% FCS (see section 2.2.1). Promastigotes of L. mexicana H-line 
or L  major H-line, which were established in the presence of gentamicin, grown in 
the same medium supplemented with 20 pg/ml gentamicin and incubated at 25°C (see 
section 2.2.2).
3.2.3. Stability of L, mexicana H-line in medium free of gentamicin
To determine whether the L  mexicana H-line is stable in gentamicin-free medium in 
vitro, promastigotes of the L. mexicana H-line were on two occasions transferred into 
HOMEM with or without gentamicin and incubated at 25®C. The mid to late log- 
phase promastigotes of L. mexicana H-line, after 58 passages in the presence of 
gentamicin, were transferred into medium with or without gentamicin (for more detail 
see section 2.2.1). The ability of promastigotes to infect macrophages and their 
survival within macrophages was examined after 37 and 40 passages in the medium 
with or without gentamicin.
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3.2.4. Preparation of bone marrow-derived macrophages (BMM)
BMM were obtained from a culture of bone marrow cells collected from the femurs 
and tibias of naive mice. The bones were removed from BALB/c mice and the 
proximal end of the femur and the distal end o f the tibia were cut, leaving the opposite 
ends intact. A 26 gauge needle was inserted into the intact ends and the bone marrow 
flushed out through the cut end with 5 ml ice-cold Dulbecco's modified Eagle's 
medium (DMEM) (Gibco). The cells were collected and centrifuged (600 g for 10 
min at 4°C). The pellets were resuspended in DMEM supplemented with 20% FCS, 
penicillin (100 U/ml), streptomycin (100 jug/ml) (Life Technologies, Grand Island, 
NY), 2-P-mercaptoethanol (2ME) (50 pM) (Life Technologies, Grand Island, NY), 
supernatant from L-929 cell cultured (30%), L-glutamine (2 pM), and pyruvate (1 
pM) (Sigma). The cells were transferred to a 100 mm tissue culture dish (Greiner) and 
incubated at 37”C in 5% CO2 in air for 7 days. Following removal of the non-adherent 
cells, the adherent cells were collected by rinsing the dish with ice-cold PBS for 10 
min. The adherent cells were centrifuged at 600 g for 10 min, resuspended in 
completed DMEM, and transferred into the individual wells o f a chamber slide (Nalge 
Nunc, Lab Tek) (2-3 x 10  ^ cells /  well). Following incubation overnight, the non­
adherent cells were removed and the supernatant was refreshed with complete DMEM 
without the L-929 cell supernatant supplement.
3.2.5. L-929 ceB fibroblast medium
L-929 cells (European collection of animal cultures, No: 85011425) were grown in 
DMEM supplemented with 2 mM L-glutamine, 100 pg/ml streptomycin, 100 U/ml 
penicillin, and 10% FCS, and incubated at 37°C in 5% CO2 in air. Supernatant from 
the cultured L-929 cells was collected after 2-3 days and the floating cells were 
discarded. The bottom of the flask was covered with 2 ml ice cold 10% trypsin for 30 
sec. The excess trypsin was removed and the flask incubated for 5-15 min. Following 
two washes, the pellets were resuspended in the medium and incubated at 37°C in 5% 
CO2 in air. The supernatant of L-929 cell line was added to bone marrow cultures as 
described above to enhance maturation of BMM (Wolfram et al., 1996).
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3.2.6. Preparation of IFN-y-primed BMM
Following preparation of BMM (see section 3.2.5) the number o f viable cells was 
estimated by trypan blue exclusion using a Neubauer Haemocytometer, which were 
transferred to the wells of chamber slides (2-3 x 10  ^ cells per well), and incubated 
overnight at 37°C in 5% CO2 in air. The supernatants were replaced with 100 pi / well 
of DMEM supplemented with 10% FCS and 10 U/ml of Recombinant cytokine (rlFN- 
y) (PharMingen) and incubated at 37°C in 5% CO2 in air for 6 h. The supernatants 
were discarded and the IFN-y-primed BMMs were exposed to stationary phase 
promastigotes of the two lines of L. mexicana.
3.2.7. Interaction between promastigotes of L, mexicana and BMM
Stationary phase promastigotes of L. mexicana WT or L. mexicana H-line were 
harvested and washed 3 times with PBS. The cells were resuspended in complete 
DMEM at a concentration o f 5 x 10  ^promastigotes / ml and transferred into wells o f 
chamber slides containing BMM (400 pFwell). The infection ratio of macrophage / 
promastigote was 1:1. The culture slides were incubated at 32°C in 5% CO2 in air for 
3 h. Following removal of non-adherent promastigotes by replacing the overlying 
medium with fresh complete DMEM the cells were incubated for the appropriate time 
at 32°C in 5% CO2 in air. At the end of the incubation period the supernatant was 
collected and stored at -70°C. The macrophages were stained with Giemsa's stain and 
the percentage of infected macrophages determined by microscopy.
3.2.8. Nitric oxide activity measured by nitrite assay
Nitrite concentration in the tissue culture supernatants was measured by the Greiss 
reaction. Supernatant from BMM culture was collected and centrifiiged (Beckman 
Microfuge TJ6-R) at 600 g. The Greiss reagent consist of 1 part 0.1% 
naphthylethylene diaminedihydrochloride (Merck) in distilled water plus 1 part 1% 
sulfanilamide (Merck) in 14% concentrated HCl, the 2 parts being mixed together
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within 12 h o f using and kept chilled. Each part may be stored refrigerated for up to 2 
months. 50 or 100 pi aliquots were removed from conditioned medium and incubated 
with an equal volume of Greiss reaction at room temperature for 10 min. The 
absorbance at 550 nm was measured in an ELISA reader (Dynatech Laboratories). 
Nitrite concentration was calculated from a standard curve, which was normally linear 
between 0 and 100 pM sodium nitrite.
3.2.9. T cell proliferation assay
T cell proliferation assays were performed as described by Satoskar and colleagues 
(1997). Briefly, the infected mice were killed at 12 weeks post infection and their 
spleens removed aseptically. Single cell suspensions were prepared from each spleen 
by gently teasing them in DMEM supplemented with 10% FCS, 100 U/ml penicillm, 
100 pg/ml streptomycin, and 2-p-mercaptoethanol (2ME) (50 pM) (Life 
Technologies). The cell suspension was centrifuged at 600 g for 10 min at 4°C, and 
resuspended in 3 ml o f Boyle's solution (0.17 M Tris-HCl, pH 7.2 and 0.16 M 
ammonium chloride) to lyse the erythrocytes. After 3 min incubation at 3TC  the 
spleen cells were centriftiged at 200 g for 10 min at 4^C, washed three times with 
PBS, and the pellets resuspended in 3 ml o f complete DMEM. The number o f viable 
splenocytes was estimated by trypan blue exclusion using a Neubauer 
Haemocytometer and the cell concentration adjusted to 5 x 10  ^viable cells / ml. The 
cell suspension (100 pi / well) was transferred into triplicate wells of sterile 96-well 
flat-bottom tissue cultuie plates (Falcon). An equal volume of stationary phase 
promastigotes at a concentration of 5 x 10  ^ cells / ml was added, the ratio of 
promastigote / splenocyte was 1:10. Con A (5 pg / ml) (Sigma) was used as a positive 
control for cell proliferation, while complete DMEM alone was used as a negative 
control. The cells were initially incubated at 32°C for 4 hr and then transferred to 
3TC  for 56 h in 5 % CO2 in air. After 56 h [^H] thymidine (1 pCi / well) (Amersham) 
was added to each well and the plate incubated at 37°C for a further 12 h. The cells 
were harvested onto filter paper (Tomtec, Hamden, CT), and [^H]-uptake was 
measured by liquid scintillation in a beta-scintillation counter. Supernatants were
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collected from parallel cultures after 72 hr o f incubation for ELISA quantification of 
cytokine production.
3.2.10. Cytokine ELISA
Supernatants collected from spleen cell cultures were assayed for the presence of IL- 
2, IL-4, IL-10, and IFN-y using ELISA, as previously described (Satoskar et aL, 
1995). In brief, wells of a 96-well flat-bottom microplate (Nunc) were coated with 50 
pi of the appropriate capture mAb (purified rat anti-mouse IL-2, IL-4, IL-10, and 
IFN-y) (all from PharMingen) at a concentration of 2 pg / ml in coating buffer (0.1 M 
of Na2HP0 4 , pH 9.0) and incubated at 4°C overnight. Following 3 washes with 
washing buffer (PBS / 0.05% Tween-20), the wells were blocked with 200 pi of 
blocking buffer (10% FCS in PBS, pH 7.4) and incubated at 37°C for 1 h. The culture 
supernatants and serial dilutions o f Recombinant cytokine standards (rIL-2, rIL-4, 
rILlO, and rIFN-y) (PharMingen) were added to the wells in 50 pi volumes in 
triplicate. The cells were incubated at 37®C for 3h and the wells were washed 4 times 
in washing buffer. Biotinylated rat anti-mouse cytokine (IL-2, IL-4, IL-10, and IFN-y 
) (2 pg / well) (all from PharMingen) antibodies were added and incubated for 1 h at 
37°C. 100 pi streptavidin-linked peroxidase (1/1000 dilution in 10 % FCS-PBS) 
(Diagnostics Scotland) were added and the cells incubated at 37°C for 1 h. After the 
final washing with washing buffer, 100 pi o f tetramethylbenzidine (TMB) substrate 
(Dynatech labs) were added to each well. The OD of the wells was read at 630 nm on 
an ELISA reader. The concentration of cytokines in the samples was calculated by 
reference to the standard curve.
3.2.11. Preparation of Leishmania lysate antigen (LLA)
LLA was prepared by a freeze-thaw method as described by Reed and colleagues 
(1986). In brief, the stationary phase promastigotes of two lines of X. mexicana were 
washed with ice-cold PBS 3 times. The promastigotes were disrupted by freezing at 
-70°C and thawing at 37°C for 3 times. They were centrifuged for 30 min at 200 g at
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4°C for 10 min. The supernatant was aliquoted and stored at -20°C until just prior to 
use.
3.2.12. Protein concentration
The protein concentration of lysate was determined using Coomassie plus Reagent 
(Sedmark and Grossberg, 1977). 150 pi of albumin standard (Pierce U.S.A.) or 
sample was added to the micro well plate and 150 pi o f PBS for blank wells. 
Coomassie Plus Reagent (150 pi) was added to each well and the plate mixed on the 
plate shaker for 30 sec. The absorbence was measured at 595 nm on a plate reader.
3.2.13. Determination of specific antibodies (Abs) in the serum
The Leishmania-sçQciîic levels o f the Th2-assoclated IgGl Ab and the Thl-associated 
IgG2a Ab (Snapper and Paul, 1987) were measured by ELISA as described by 
Satoskar and colleagues (1995). Peripheral blood was obtained from mice infected 
with two lines of L. mexicana by tail bleeding into Eppendorf tubes and then 
centrifuged at 200 g. The sera were collected and stored at -70°C until just prior to 
use. Each well o f a flat-bottom microtitle plate (Nunc, Roskilde, Denmark) was 
coated vrith 1 pg of LLA (from section 3.2.12) in 0.1 M carbonate buffer pH 9.6 and 
incubated at 4°C overnight. Following washing 3 times with PBS and 0.05% Tween 
20 (Sigma, St Louis, MO), the plates were blocked with 200 pi in blocking buffer 
(PBS / FCS 10%), and incubated at 37°C for 1 h. After 3 washes, 50 pi o f serially 
diluted serum samples (1/100 in PBS / 10% FCS) were added to wells, incubated for 2 
h at 37°C, and washed 4 times. Bound Abs were detected by 50pl / well of 
biotinylated anti-mouse either IgGl or IgG2a (PharMingen, San Diego, CA) (2 
pg/ml), incubated at 3TC  for Ih and washed 6 times. 100 pi streptavidin-linked 
peroxidase (1/1000 dilution in 10 % FCS-PBS) (Diagnostics Scotland) were added 
and incubated at 37°C for 1 h. After the final washing with washing buffer, 100 pi of 
tetramethylbenzidine (TMB) substrate (Dynatech labs) were added to each well. The
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OD of the wells was read on an ELISA reader at 630 nm with a reference filter at 405 
nm.
3.2.14. Preparation of murine rump epidermal cells (ECs) to investigate the 
presence of the parasite
Twelve weeks after inoculation of 5 x 10  ^ (cell / ml) stationary phase promastigotes 
of L. mexicana H-line or L. mexicana WT into the shaven rump mice were killed and 
the Ecs prerared as described in section 2.2.7. The number of viable ECs was 
estimated by trypan blue exclusion using a Neubauer Haemocytometer, the cell 
concentration adjusted to 5 x 10  ^viable cells / ml in DMEM medium supplemented 
with 10% (v/v) HI-FCS, and incubated at 25®C,
3.2.15. Preparation of murine ear ECs
ECs suspensions were prepared from mouse ear skin by trypsinization. BALB/c mice 
were killed, the whole ears rinsed with 70% ethanol for 5 min, and dried. The ears 
were cut off and the skin sheet was then carefrilly separated. The skin, dermal side 
down, was floated on 1% trypsin (90 min) for processing thick ventral ear halves and 
0.6% trypsin (45 min) for thin dorsal ear halves. The epidermis was separated from 
the dermis and the exposed basal layer of the loosened epidermis was covered with 
RPMI 1640 medium. Single EC suspensions were prepared with the aid of a cell 
scraper. The cells were washed twice in RPMI and the number o f viable ECs was 
estimated by trypan blue exclusion using a Neubauer Haemocytometer. The cell 
concentration was adjusted to 5 x IQ^  viable cells / ml of DMEM supplemented with 
10 % (v/v) HI-FCS, penicillin (100 U / ml) and streptomycin (100 pg/ml) (Life 
Technologies, Grand Island, NY), 2ME (50 pM) (Life Technologies, Grand Island, 
NY), supernatant L-929 cells (30%), L-glutamine (2 pM), and pyruvate (1 pM) 
(Sigma). The suspension was transferred into the individual wells of a chamber slide 
(Nalge Nunc, Lab Tek) at 5 x 10  ^cells /well and incubated at 25°C.
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3.2.16. Interaction between ECs and promastigotes of two lines of Z. mexicana
Stationary phase promastigotes of L  mexicana WT or L. mexicana H-line were 
harvested and washed 3 times with PBS. The cells were resuspended in complete 
DMEM at a concentration of 5 x 10  ^promastigotes / ml and transferred into wells of 
chamber slides containing ECs (100 pi / well). The infection ratio of epiderma cell / 
promastigote was 10:1. The culture slides were incubated at 32°C in 5% CO2 in air 
for 24 h. For depletion of extracellular parasites, the cultures of parasites and adherent 
macrophages were washed. The cells were stained with acridine orange / ethidium 
bromide (3.2.18) and the chamber slides were quickly air dried, fixed in absolute 
methanol, and stained in 10% (v/v) Giemsa’s stain (Merck) in Giemsa’s buffer (pH
7.2) for 10 min. The number of infected macrophages was determined by microscopy.
3.2.17. Staining with acridine orange and ethidium bromide
The supernatants of cultures (from section 3.2.17) were collected and centrifuged at 
600 g for 10 min. The cells were resuspended in a mixture of acridine orange (5 
pg/ml) (Michrome, Edward Gurr, Ltd) and ethidium bromide (50 pg/ml) (Sigma) and 
incubated for 10 min at room temperature. Following washing with PBS, the cells 
were resuspended in para-formaldehyde (1%) (Sigma) and incubated for 15 min at 
room temperature. Aliquots of suspension (0.5 ml) were centrifuged on the Cytospin 
(Shandon) at 1600 g for 5 minutes. The smears were analysed by fluorescence 
microscopy.
3.2.18. Preparation of tissues, and culture in vitro of L. mexicana isolated from 
infected mice.
Following injection of 5 x 10  ^ stationary phase of promastigotes of L  mexicana WT 
or L. mexicana H-line, the parasite loads in the mice were determined by limiting
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dilution analysis. Briefly, visceral organs o f the mice infected with the two lines of L. 
mexicana were removed aseptically and single cell suspensions prepared. For each 
mouse the liver, draining lymph node, lung and spleen were homogenized separately 
in HOMEM medium supplemented with 10% FCS. Bone marrow cells were collected 
from the femurs and tibias of infected mice (see section 3.2.5.) A limiting dilution 
(LD) of the cell suspensions in vitro culture was used to determine the number of 
viable parasites in these organs (Laskay et a/., 1995). The serial twofold dilutions of 
the cell suspensions from the organs were plated in the 24-well plates. The cells were 
then incubated at 25°C for 14 days. The cultures were examined daily for the presence 
of promastigotes.
3.2.19. Statistical analysis
Data are expressed as the mean ±  standard error mean (SEM) for each group. 
Statistical analysis was performed using Student t test (for the final deterrnination o f  
significance testing the effects of treatments).
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3.3. Results
3.3.1. Preparation of bone marrow derived macrophages
In this study, bone marrow macrophages were obtained from adherent mononuclear 
cells in the bone marrow (1.8 x 10  ^cells per mouse). In the presence o f granulocyte- 
macrophage-colony stimulating factor (GM-CSF), non-adherent precursor cells 
differentiate into adherent mononuclear phagocytes. Mononuclear phagocytes at 
various stages of differentiation represent approximately 4% of all nucleated bone 
marrow cells (Guilbert et al., 1980 and Byrne et al., 1981).
3.3.2. Interactions between stationary phase promastigotes of L. mexicana H-line 
or Z. mexicana WT with BMM
To determine whether L. mexicana H-line has the ability to infect macrophages, an in 
vitro culture system was used. Stationary phase promastigotes of L. mexicana H-line 
or L  mexicana WT were incubated with BMM for 3 h, after which non-attached 
promastigotes were washed off. The macrophage culture was incubated for up to 96 h 
and the rate of infection o f macrophages was determined. As shown in Figure 3.1, 
53% of BMM were infected with L. mexicana H-line at 9 h post infection. The 
percentage of infected cells decreased over time to 0.4% at 96 h post infection (Figure
3.1). The initial infection of macrophages with Z. mexicana WT was similar to that 
with Z. mexicana H-line (50%), but in contrast to the Z. mexicana H-line, the 
percentage of infected macrophages increased to 72% at 96 h post infection. As 
regards the numbers of amastigotes surviving and growing within the macrophage, 
after 9 h. these were 98 amastigotes /100 macrophage for Z. mexicana H-line. This 
rapidly decreased to 2 amastigotes/100 macrophages at 96 h post infection (Figure
3.2). This was in direct contrast to the observed increase in number of amastigotes of 
Z. mexicana WT.
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Figure 3.1. Infection of BMM with stationary phase promastigotes of L. 
mexicana H-line or L  mexicana WT. The promastigotes of the two lines 
were grown on parallel cultures with the same ages. Macrophages were 
exposed to promastigotes at 32°C for 3 h and subsequently infected 
macrophages incubated at 32°C for appropriate times. The initial infection 
ratio of macrophage / promastigote was 1:1 and the percentage of infected 
macrophages was detected after Giemsa's staining of the culture slide. The 
infected cells were detected among at least 300 cells for each line.
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Figure 3.2. The number of amastigotes within infected macrophages 
with two lines of L. mexicana. BMM were infected with stationary phase 
promastigotes of L. mexicana H-line or L. mexicana WT. Macrophages 
were exposed to promastigotes at 32®C for 3 h and subsequently infected 
macrophages incubated at 32®C for appropriate times. The initial 
infection ratio of macrophage / promastigote was 1:1 and the percentage 
of infected macrophages was detected after Giemsa's staining of the 
culture slide. The infected cells were detected among at least 300 cells 
for each line.
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3,3.3. Interactions between stationary phase promastigotes o f L, major H-line or 
L. major WT with BMM
To determine whether L. major H-line has the ability to infect macrophages, an in 
vitro culture system was used. Stationary phase promastigotes of T. major H-line or L  
major WT were incubated with BMM for 3 h, after which non-attached promastigotes 
were washed off The macrophage culture was incubated for up to 96 h and the 
percentage of infected macrophages was determined. As shown in Figure 3.3, 41% of 
BMM were infected with L. major H-line at 8 h post infection. The percentage of 
infected ceils decreased over time to 10.5% at 96 h post infection (Figure 3.3). The 
initial infection o f macrophages with L. major WT was 46.5%, but in contrast to the 
L. major H-line, the percentage of infected macrophages increased to 65% at 96 h 
post infection. The number of amastigotes of L. major H-line within infected 
macrophages after 9 h incubation was 94 amastigotes / ICO macrophages. This rapidly 
decreased to 14 amastigotes/100 macrophages at 96 h post infection (Figure 3.4). This 
was in direct contrast to the observed increase in the number of amastigotes of L. 
major WT. BMMs were exposed to promastigotes o f each line in two chamber slides 
individually on just one occasion. The restriction of time did not permit this 
experiment to be repeated.
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Figure 3.3. Macrophages were infected with stationary phase promastigotes 
of L. major H-line or L. major WT. The promastigotes of the two lines were 
grown on parallel cultures with the same ages. Macrophages were exposed 
to promastigotes at 32°C for 3 h and infected macrophages incubated at 
32°C for appropriate times. The initial infection ratio of parasite/ 
macrophage was 1:1 and the percentage of infected macrophages was 
detected after Giemsa's staining of the culture slide.
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Figure 3.4. The number of amastigotes within infected macrophages 
with two lines of L  major. BMM were infected with stationary phase 
promastigotes of L. major H-line or L. major WT. Macrophages were 
exposed to promastigotes at 32°C for 3 h and subsequently infected 
macrophages incubated at 32°C for appropriate times. The initial 
infection ratio of macrophage / pro mast igote was 1:1 and the 
percentage of infected macrophages was detected after Giemsa's 
staining of the culture slide. The infected cells were detected among at 
least 300 cells for each line.
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3.3.4, Parasite burden per macrophage following interactions between stationary 
phase promastigotes ofL. mexicana H-line o r f .  mexicana WT with BMM
To determine the number of parasite within infected macrophages, in vitro culture 
system was used. BMM of BALB/c mice were infected with stationary phase 
promastigotes of L  mexicana H-line or L  mexicana WT as previously described (see 
section 3.3.2). The distribution o f amastigotes of L  mexicana H-line within infected 
BMM was similar to that of L  mexicana WT at 9 h post infection as also shown in 
Figure 3.1 and 3.2. 22% of BMM were infected with one amastigote of L. mexicana 
H-line at 9 h post infection. The percentage of infected cells decreased over time to 
0.4% at 96 h post infection. The initial infection of macrophages with L. mexicana 
WT was similar to that with H-line (21%), but in contrast to the L. mexicana H-line, 
the percentage of infected macrophages with a burden of more than 5 amastigotes 
increased to 18% at 96 h post infection. The number of amastigotes of L. mexicana H- 
line within infected macrophages after 9 h post incubation was 100 amastigotes / 100 
macrophages and rapidly decreased to 2 amastigotes / 100 macrophages at 96 h post 
infection (Figure 3.5). In contrast to that, the number of amastigotes of L. mexicana 
WT within infected macrophages increased to more than 250 amastigotes/100 
macrophages (Figure 3.6).
3.3.5. Interaction between IFN-y- primed BMM with L. mexicana H-line or L, 
mexicana WT
The results of interaction between stationary phase promastiotes of L. mexicana H-line 
with BMM suggest that L. mexicana H-line does not survive within murine macrophages 
beyond 96 h, whereas the number of amastigotes of L. mexicana WT within infected 
macrophages increased. To consider the ability of amastigotes of the two lines of L. 
mexicana to survive within IFN-y-primed BMM, macrophages were incubated in the 
presence of IFN-y (10 U / ml) for 6 h and then exposed to stationary phase of 
promastigotes L  mexicana H-line or L. mexicana WT for 3 h. The cells were then 
incubated for up to 96 h and the rate of infection of macrophages was determined. As 
shown in Figure 3.7, at 8 h incubation the percentage of macrophages infected with
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Figure 3.5. The percentage of infected BMM with different numbers 
of amastigotes of L. mexicana H-line. BMM were infected with 
stationary phase promastigotes of L. mexicana H-line. Macrophages 
were exposed to promastigotes at 32°C for 3 h and infected 
macrophages incubated at 32°C for appropriate times. The initial 
infection ratio of macrophage / promastigote was 1:1 and the 
percentage of infected macrophages was detected after Giemsa's 
staining of the culture slide. The infected cells were detected among at 
least 300 cells for each line.
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Figure 3.6. The percentage of infected BMM with different numbers of 
amastigotes of L. mexicana WT. BMM were infected with stationary phase 
promastigotes of L. mexicana WT. Macrophages were exposed to 
promastigotes at 32°C for 3 h and infected macrophages incubated at 32“C for 
appropriate times. The initial infection ratio of macrophage / promastigote 
was 1:1 and the percentage of infected macrophages was detected after 
Giemsa's staining of the culture slide. The infected cells were detected among 
at least 300 cells for each line.
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promastigote of L. mexicana WT was 49% and decreased to 47% after 30 h 
incubation. In contrast, the percentage of IFN-y-primed macrophages infected with L. 
mexicana WT at 8 h incubation was 51% decreased over time to 35% at 30 h post 
infection. The percentage o f IFN-y-primed macrophages and unprimed macrophages 
infected with L. mexicana H-Iine rapidly reduced with time.
The initial number of amastigotes o f H-line within infected macrophages in the 
presence or absence of IFN-y was 90 amastigotes / 100 macrophages at 8 h post 
infection decreasing to 4 amastigotes / 100 macrophages at 72 h post infection. The 
number of amastigotes of L. mexicana WT within infected IFN-y-primed 
macrophages decreased to 37 amastigotes / 100 macrophages at 24 h post infection, 
whereas it was 67 amastigotes /  100 macrophages in the unprimed macrophages at the 
same time. In contrast to L  mexicana H-Iine, the number of amastigotes of L. 
mexicana WT within infected macrophages in the presence or absence of IFN-y 
increased over time to more than 250 amastigotes / 100 macrophages at 72 h post 
infection (Figure 3.8).
3.3.6. Investigation of the stability of Z. mexicana H-line in gentamicin-free 
medium
To determine whether L. mexicana H-line is stable in medium lacking gentamicin in 
vitro, promastigotes o f L  mexicana H-Iine were transferred into HOMEM medium 
with or without gentamicin. The stationary phase promastigotes were harvested after 
40 passages and incubated with macrophages for 3 h. Non-attached promastigotes 
were removed and the macrophage culture was incubated for 9, 24, 48, and 96 h and 
the rate of infected macrophages was determined. As shown in Figure 3.9 the 
percentage of infected macrophages with L  mexicana H-line grown in medium with 
or without gentamicin decreased over time to 2 or 4% at 96 h post infection. In 
contrast to the L  mexicana H-line, the percentage of macrophages with L. mexicana 
WT increased to 89.5%.
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Figure 3.7. BMM or IFN-y-primed BMM (*) infected with stationary 
phase promastigotes of L. mexicana H-line or L. mexicana WT. BMM 
were incubated in the presence of IFN-y (10 U/ml) for 6 h. The IFN-y- 
primed BMM or unprimed-BMM were exposed to stationary phase 
promastigotes of L. mexicana H-line or L. mexicana WT at 32°C for 3 
h and infected macrophages incubated at 32®C for appropriate times. 
The initial infection ratio of macrophage / promastigote was 1:1 and 
the percentage of infected macrophages was detected after Giemsa's 
staining of the culture slide. The infected cells were detected among at 
least 300 cells for each line.
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Figure 3.8. The number of amastigotes within 100 BMM or unprimed 
IFN-y-primed BMM (*) infected with stationary phase promastigotes of L. 
mexicana H-line or L. mexicana WT. BMM were incubated in the 
presence of IFN-y (10 U/ml) for 6 h. The IFN-y-primed BMM or BMM 
were exposed to stationary phase promastigotes of L. mexicana H-line or 
L. mexicana WT at 32°C for 3 h and infected macrophages incubated at 
32”C for appropriate times. The initial infection ratio of macrophage / 
promastigote was 1:1 and the percentage of infected macrophages was 
detected after Giemsa's staining of the culture slide. The infected cells 
were detected among at least 300 cells for each line.
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Figure 3.9. BMM infected with stationary phase promastigotes of L  
mexicana H-line which were grown in gentamicin-ffee medium for 
40 passages (H-line*). Stationary phase promastigotes of L  
mexicana WT were grown in gentamicin-free medium. Macrophages 
were exposed to promastigotes at 32°C for 3 h and infected 
macrophages incubated at 37”C for appropriate times. The infection 
ratio of macrophage / promastigote was 1:1 and the percentage of 
infected macrophages was detected after Giemsa's stain of the 
culture slide. The infected cells were detected among at least 300 
cells for each line.
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3.3.7. Analysis of NOS induced by the two lines of X. mexicana
In order to determine whether the two lines of L. mexicana are able to induce NOS, BMM 
were infected with stationary phase promastigotes of L. mexicana H-line or L. mexicana 
WT. An investigation of NOS over the first 48 h of infection showed an increased level 
of nitrite in the supernatants o f infected macrophages with the two lines of L  
mexicana. As Figure 3.10 shows unstimulated macrophages were used as a negative 
control and a small but detectable level o f nitrite was present in their supernatants. 
Macrophages stimulated with IFN-y (100 U/ml) plus LPS (10 ng/ml) were used as a 
positive control and demonstrated that the activation of cells led to an increase in the 
amount o f nitric oxide production.
Comparison o f the amount o f nitrite in the supernatants of different cultures 
demonstrated that there was no significant difference between the amount produced in 
various infections over 48 h post infection (P< 0.7). These results show that L. 
mexicana H-line gave rise to similar levels o f nitric oxide production by the host cells 
as L. mexicana WT.
This suggests that the death of L. mexicana H-line within the infected macrophages in 
vitro is not due to change in the capacity o f L. mexicana H-line to induce NO 
production.
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Figure 3.10. The concentration of nitric oxide measured as nitrite in the 
supernatant of BMM infected with stationary phase promastigotes of L. 
mexicana over 48 h post infection. Macrophages were stimulated with IFN-y 
(100 U/ml) plus LPS (10 ng/ml) as positive control. Unstimulated macrophages 
were used as a negative control. The macrophages were incubated with 
promastigotes of L. mexicana H-line or L. mexicana WT at 32”C. The infection 
ratio of macrophages / promastigote was 1:1. Bars represent the standard error 
mean (SEM) (n = 3).
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3.3.8. Investigation of dissemination of the two lines of X. mexicana in the 
peripheral and visceral organs of infected BALB/c mice
The in vitro results suggest that X. mexicana H-line does not survive within murine 
macrophages beyond 96 h. To consider the in vivo survival and possible dispersion of 
the L  major H-line beyond the site o f inoculation, the mice were injected with L. 
major WT or X. major H-line into right side rump and then examined for the presence 
of parasites in the peripheral and visceral organs. Stationary phase promastigotes of 
the two lines o f X. mexicana were subcutanously injected in the BALB/c mice, and 
visceral organs including the liver, spleen, lung, bone marrow (BM), draining right 
popliteal lymph node (LN), and ECs from the site of injection were removed 
aseptically at appropriate times and cell suspensions prepared. The cell suspensions 
were cultured in HOMEM medium and incubated at 25°C over 14 days. The cultures 
were examined daily for the presence of live promastigotes (Table 3.1). X. mexicana 
WT was detected in cultures originating from ECs at each time point post infection 
indicating that these organisms are able to survive within resident macrophages for 
long periods. In addition, the draining LN contained parasites within one day of 
infection, and these remained infected throughout the period of study (12 weeks). 
Over the course of the study X. mexicana WT spread to BM, spleen and lung and it 
was observed that infection of visceral organs correlated with an increase in skin 
lesion size. In comparison, X. mexicana H-line remained localized in the skin and 
draining LN for up to 12 weeks post infection without evidence of dissemination into 
other visceral organs of BALB/c mice.
These results suggest that X. mexicana WT disseminated into the visceral organs o f 
susceptible mice and the number of parasites increased post infection. In contrast to X. 
mexicana WT, the attenuated line o f X. mexicana was restricted with a decreased 
number of amastigotes in the draining LN and skin.
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Table 3.1. Comparative distribution o f L. mexicana WT and L. mexicana H-line in 
various organs of BALB/c mice. The promastigotes of the two lines were grown on 
parallel cultures with the same ages. The presence of viable parasites in the tissues of 
infected mice was determined by culturing in vitro.
Organ
1 d 14 d 21 d 28 d 90 d
WT H WT H WT H WT H WT H
EC +4-4- +-H- +-H- +4-+ ++ -H-+ + 4-++ ++
Right
popliteal LN
+-}-+ +++ -H"+ — -H-+ ++ +++ ++ -H-+ +
Left
popliteal LN
— — — — — - - - - -
Right 
femur LN
+-H- — ++ 4-++ - +++ - +4H- -
Spleen + — — — + - -H- — 4-++ -
Bone
marrow
++ — + — - - ++ - -H-+ —
Liver — — - - - - - - -
Lung — — — — - - + - -H-+ -
(d): Days since infection of mice.
(-H-+): Represents high number o f promastigotes.
(+): Represents low number of promastigotes.
(-): Represents no promastigote growth in the tissue culture.
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3.3.9. Investigation o f disemination o f the two lines o f X. major in the peripheral 
and visceral organs o f infected BALB/c mice
Experiments were carried out to determine whether stationary phase promastigotes of 
L. major H-line are able to disseminate into visceral organs of susceptible mice and 
how long they can survive within epidermal cells and infected organs. To examine the 
in vivo survival and possible dispersion of the L  major H-line beyond the site of 
inoculation, two groups of BALB/c mice (3 mice per group) were injected with L. 
major WT or L. major H-line and then examined for the presence of parasites in the 
peripheral and visceral organs at 12 weeks post infection. The cell suspensions from 
liver, spleen, lung, BM, draining popliteal LN, and ECs from the site of injection were 
prepared and cultured (as described in section 3.3.8). The cultures were examined 
daily for the presence of live promastigotes. As Table 3.2 shows X. major WT spread 
to BM, spleen, lung, popliteal LN, and skin. In contrast, X. major H-line remained 
localized in the ECs and draining LN o f two mice and promastigotes grew in the 
spleen culture of mouse No 2 after 8 days incubation.
These results suggest that X. major WT disseminated into the visceral organs o f 
susceptible mice and the number o f parasites increased post infection. In contrast to X. 
major WT, the attenuated line of X. major H-line was restricted with a decreased 
number of amastigotes in the draining LN and skin of two mice. Promastigotes grew 
in the skin and draining LN culture from third mice infected with X. major H-line. In 
addition, in the spleen cell culture o f this mouse a low number of promastigotes was 
observed after 8 days incubation.
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Table 3.2. Comparative distribution o f L. major WT and L  major H-line in various 
organs of BALB/c mice at 12 weeks post infection. The presence o f viable parasites 
in the tissues of infected mice was determined by culturing in vitro.
EC
Right side 
popliteal LN Spleen BM Lung Liver
H-line (1) + -f - - — -
WT(1) +++ -H-+ +++ +++ ++ -
H-line (2) ++ ++ + - - -
WT(2) + + + +-f—f- + + + + + ++ -
H-line (3) + + + - - - —
WT(3) + + + + + + + + + —
+++: Represents a high number o f promastigotes in tissue culture. 
+: Represents a low number o f promastigotes in tissue culture. 
Represents no promastigote growth in tissue culture.
3.3.10. Anû-Leishmania immunoglobulins induced in mice infected with L. 
mexicana WT or X. mexicana H-line
To examine whether L. mexicana H-line and X. mexicana WT induced similar levels 
of subclasses of anti-Xew/zmuf«fl-specific Ab, BALB/c mice were infected with either 
of the two lines of X. mexicana by sub-cutaneous injection of stationary phase 
promastigotes. Blood was obtained from the mice at 12 weeks post infection. An 
investigation of anti-Xew/ïw^zwa-specific IgGl and IgG2a production in the mice 
infected with X. mexicana WT showed the level o f IgGl Ab was significantly higher 
than the level of JgG2 Ab (p < 0.03). As Figure 3.11 shows the amounts o f IgGl and 
IgG2a Abs in the serum o f mice infected with X. mexicana H-line were lower than 
those in the serum of mice infected with X. mexicana WT. In addition the amount of 
IgGl Ab produced in the mice infected with X. mexicana H-line is significantly lower 
than that in the mice infected with X. mexicana WT (p < 0.05). There was no
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significant difference between the amount of IgGl and IgG2a Ab in the serum of mice 
infected with L. mexicana H-line (p < 0.3).
Figure 3.11. IgGl and IgG2a production by BALB/c mice infected 
with the two lines of L. mexicana. Two groups of mice (5 mice per 
group) were injected with 5 x 1 0 ^  stationary phase of L  mexicana 
WT or L. mexicana H-line into the shaved rumps as described 
before. Mice were bled at 12 weeks post infection. Their sera were 
pooled and analysed by ELISA for the presence of IgGl and IgG2a. 
Note the sera were diluted 1/100 for IgGl and IgG2a assay.
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3.3.11. Interaction of promastigotes o f the two lines o f X. mexicana with 
epidermal cells in vitro
Experiments were carried out to determine whether stationary phase promastigotes of 
L  mexicana WT or L. mexicana H-line are able to infect epidermal cells and if so, the 
immune response of epidermal cells infected with the two lines of X. mexicana. 
Epidermal cells were prepared from the skin o f the ears o f BALB/c mice by a 
trypsinization procedure (see section 3.2.15). These preparations contained 
Langerhans cells (LCs) that constitutively express MHC class II as well as MHC class 
Il-negative kératinocytes, a source of GM-CSF that is essential for LC differentiation, 
and were absolutely devoid of macrophages (Black et a/., 1996). Epidermal cells were 
exposed to stationary phase promastigotes of the two lines of X. mexicana and 
incubated at 32^C in CO2 5% in air for 24 h. The infection ratio of epidermal cell / 
promastigote was 10:1. The supernatants o f cultures were collected, stored at -70°C, 
and the cells were centrifuged on the cytospin. These slides and the chamber slides 
were stained with Giemsa’s stain or acridine orange and ethidium bromide. The 
infected ECs, which were stained with acridine orange determined by fluorescence 
microscopy.
The results showed that no epidermal cells were infected with stationary phase 
promastigotes of X. mexicana H-line or X. mexicana WT, whereas adherent 
macrophages on the chamber slides were infected with stationary phase promastigotes 
of X. mexicana WT at 24 h post infection.
3.3.12. T-cell proliferation of splenocytes from BALB/c mice infected with the 
two lines o f X. mexicana
Studies were carried out to determine whether the splenocytes of BALB/c mice 
infected with X. mexicana H-line or X. mexicana WT at 12 weeks post infection were 
sensitized to stationary phase promastigotes of X. mexicana WT. The splenocytes 
were exposed to promastigotes, at 32°C for 4h and then incubated at 37°C for 68 h. 
The cell: parasite ratio was 10/1 .  The splenocytes were exposed with promastigotes, 
as this in an attempt to simulate the situation when immune mice are exposed to a
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normal challenge. The proliferation of the T cells was confirmed with Con-A (5 
pg/ml) as a stimulation control and unstimulated cells as negative controls. As Figure 
3.12 shows the splenocytes from mice infected with L  mexicana WT displayed Con- 
A-stimulated proliferative responses higher than those of splenocytes from mice 
infected with L  mexicana H-line. Splenocytes from mice infected with either L. 
mexicana H-line or L. mexicana WT both proliferated when exposed to promastigotes 
of L  mexicana WT or promastigotes of L. mexicana H-line (not shown) but this was 
markedly below that of the Con A- stimulated splenocytes.
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Figure 3.12. T-cell proliferation responses of splenocyte from the 
mice infected with the two lines of L. mexicana. BALB/c mice 
were infected with L. mexicana H-line (6 mice) or L  mexicana WT 
(4 mice) at week 12 post infection, induced by Con A (5 pg/ml) 
and stationary phase promastigotes of L. mexicana WT (the ratio of 
splenocyte: promastigote was 10 / 1). The stimulation index was 
calculated as the count per minute (CPM) of stimulated cells / CPM 
of unstimulated cells and error bars are represented the means 
stimulation index ± standard error mean.
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3.3.13. IFN-y, ÎL-2, IL-4, and IL-10 production by splenocytes o f mice infected 
with the two lines of X. mexicana
To examine whether the L. mexicana H-line and L. mexicana WT induced a similar 
cytokine response, mice were infected with either of the two lines by sub-cutaneous 
injection of parasites. Spleens were harvested at 12 weeks post infection and cells re­
stimulated in vitro with stationary phase promastigotes of L. mexicana WT. Cell 
culture supernatants were collected and assayed for the presence o f the Thl type 
cytokines, IFN-y and IL-2.
Spleen cells taken from mice infected with L. mexicana WT secreted a low level of 
IFN-y when restimulated with stationary phase promastigotes. In comparison, cells 
taken from mice infected with L  mexicana H-line secreted a higher amount o f IFN-y 
(P<0.05). In both cases, the level o f IFN-y was detected from cells cultured in medium 
alone (Figure 3.13).
The IL-2 production by these cells presented a similar profile. Spleen cells from L. 
mexicana WT infected mice did not increase IL-2 production when cultured in the 
presence o f stationary phase promastigotes. However, cells taken from mice infected 
with L  mexicana H-line secreted IL-2 when cultured with promastigotes of X. 
mexicana WT. This level o f IL-2 production was significantly higher than the level 
produced by spleen cells fromX. mexicana WT infected mice (P<0.05) (Figure 3.14). 
Supernatants harvested from in vitro cultures of spleen cells taken from infected mice 
and restimulated with stationary phase X. mexicana WT promastigotes were also 
assayed for cytokines characteristic of Th-2 type responses. As shown in Figure 7, 
spleen cells taken from X. mexicana WT infected mice responded to culture with 
parasite antigen. The production o f IL-4 in the supernatant o f Ag-stimulated 
splenocytes from the mice infected with X. mexicana WT was significantly higher 
than that of mice infected with X. mexicana H-line (P<0.05). In comparison, spleen 
cells recovered from mice infected with X. mexicana H-line did not produce IL-4 in 
response to Leishmania (Figure 3.15)
Spleen cells from the mice infected with X. mexicana WT also produced increased 
levels o f IL-10 when cultured with parasite antigen compared with mice infected with 
X. mexicana H-line (P<0.02). No such increase was observed in cells taken from mice 
infected with X. mexicana H-line (Figure 3.16).
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Figure 3.13. The level of IFN-y in the supernatants of cultured 
splenocytes from mice infected with stationary phase promastigotes 
of L  mexicana H-line or L  mexicana WT. The comparison between 
the two lines was made on parallel cultures with the same ages. The 
splenocytes were taken from the infected mice at 12 week post 
infection and stimulated with stationary phase promastigotes of L. 
mexicana WT at a ratio of 1 parasite / 10 splenocytes. Bar represent 
SEM (n = 4).
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Figure 3.14. The level of IL-2 in the supernatants of cultured 
splenocytes from mice infected with stationary phase 
promastigotes of L. mexicana H-line or L. mexicana WT. The 
comparison between the two lines was made on parallel cultures 
with the same ages. The splenocytes were taken from the 
infected mice at 12 weeks post infection and stimulated with 
stationary phase promastigotes of L. mexicana WT at a ratio of 1 
parasite / 10 splenocytes. Bar represent SEM (n = 4).
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Figure 3.15. The level o f IL-4 in the supernatants of cultured 
splenocytes from mice infected with stationary phase promastigotes 
of L  mexicana H-line or L  mexicana WT. The comparison between 
the two lines was made on parallel cultures with the same ages. The 
splenocytes were taken from the infected mice at 12 week post 
infection and stimulated with stationary phase promastigotes of L. 
mexicana WT at a ratio of 1 parasite / 10 splenocytes. Bar represent 
SEM (n = 4).
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Figure 3.16. The level of IL-10 in the supernatants of cultured 
splenocytes from mice infected with stationary phase promastigotes 
of L  mexicana H-line or L. mexicana WT. The comparison between 
the two lines was made on parallel cultures with the same ages. The 
splenocytes were taken from the infected mice at 12 week post 
infection and stimulated with stationary phase promastigotes of L  
mexicana WT at a ratio of 1 parasite / 10 splenocytes. Bar represent 
SEM (n = 4).
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3.4. Discussion
The attenuated cell line of Leishmania was generated by culturing L. mexicana WT 
under pressure of gentamicin and the preliminary results showed that L. major could 
be attenuated using to the same protocol (see Chapter 1).
The ability o f L. mexicana to infect macrophages was investigated through exposure 
of stationary phase promastigotes of L. mexicana H-line to bone marrow derived 
macrophages from BALB/c mice. The results showed that the percentage of 
macrophages infected with L. mexicana H-line was similar to that of L. mexicana WT 
at 9 h post infection but decreased to 0.4% at 96 h post infection. In contrast, the 
percentage of infected macrophages infected with L  mexicana WT increased to 72% 
at 96 h post infection. Only a small population of amastigotes of L. mexicana H-line 
survived within infected macrophages after 96 h post infection in vitro. It has been 
purposed that the ability o f amastigotes of Leishmania to survive within macrophages 
is a primary mechanism for evading parasite the immune responses of their vertebrate 
host (Alexander and Russell, 1992).
In this study, it was shown that 21% macrophages were infected with one amastigote 
of L. mexicana WT at 9 h post infection and this percentage over time decreased to 
10% at 72 h post infection. As Figure 3.6 shows, 18% of macrophages carried more 
than 5 amastigotes at 72 h post infection. This indicates that following interaction of 
L. mexicana WT promastigotes with macrophages, some of them, probably not in 
stationary phase, were unable to survive within infected macrophage. This suggestion 
is agreement with the reports that stationary phase promastigotes of L. major (Sacks et 
al., 1985) or L. mexicana (Robertson and Coombs 1992) were able to establish 
intracellular infections whereas some o f them appeared to be transformed into 
infective-stage promastigotes, as determined by their ability to survive within normal 
resident mouse peritoneal macrophages in vitro. Therefore, the percentage o f 
macrophage infected with one amastigote sharply decreased, whereas the percentage 
of macrophages with more then one amastigote present increased over the 96 h. In 
contrast to L. mexicana WT, after interaction of promastigotes of L. mexicana H-line, 
the vast majority of promastigotes were unable to survive within the parasitophorous 
vacuole (PV) of infected macrophages (Figure 3.5).
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The mechanism of the microbicidal activity of gentamicin, which has been added to 
the culture medium, to attenuate L. mexicana, in particular, killing amastigotes and 
the regulation of immune response against these parasites has yet to be elucidated.
The mechanism which leads to activation and killing of the parasites within the PV 
could be important evidence not only for Leishmania, but also all intracellular 
microorganisms for which the macrophage is one of the critical components of the 
defence (Bogdan ct a/., 1996).
L. mexicana H-line was developed on four separate occasions with the same 
procedure and the stability o f this attenuated cell line in the antibiotic-free medium 
was investigated through culturing promastigotes in the antibiotic-free medium for an 
extended period (40 passages). Stationary phase promastigotes o f L. mexicana H-line 
were grown in the medium without gentamicin and exposed to macrophages. The 
result showed that that attenuated line o f L  mexicana H-line remained unaltered and 
is therefore stable for a long time in vitro in medium free of the antibiotic.
The activation state of macrophages and T cells is dependent on the availability o f 
stimulatory and inhibitory cytokines, the production of which can be altered by the 
parasite (Bogdan et aL, 1999). The survival o f amastigotes within the macrophage is 
prevented when the macrophages are stimulated by specific T-cell-derived 
lymphokines and IFN-y is the most important component among these macrophage- 
activating mediators (Nathan et aL, 1983). IFN-y plays a crucial role in the 
lymphokine response leading to the elimination of Leishmania from the macrophage. 
IFN-y-production is associated with the expansion of CD4^ T cells. Here it has been 
shown that L. mexicana H-line is eliminated by macrophages, whereas amastigotes of 
L  mexicana WT are able to survive for prolonged periods within macrophages.
The levels o f IFN-y, IL-2, IL-4, and IL-10 in the supernatants of cultured splenocytes 
from the mice infected with L. mexicana WT or L  mexicana WT were measured. The 
splenocytes from infected mice at 12 weeks post infection were aseptically removed 
and restimulated with stationary phase promastigotes of L  mexicana WT. It was 
found that the levels o f IFN-y and IL-2 in the supernatant of cultured Ag-stimulated- 
splenocytes of mice infected with L. mexicana H-line were significantly higher than 
those o f mice infected with L. mexicana WT (P<0.05). In contrast the level of IL-4 in 
the supernatant of splenocytes from the mice infected with L. mexicana H-line was 
significantly lower than that of mice infected with L. mexicana WT (P<0.05).
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The high levels of IL-2, IFN-y and low amount of IL-4 in the supernatant of 
splenocytes from mice infected with L  mexicana H-line is agreement with the report 
that low levels o f IL-4 have been associated with IL-2 and IFN-y productions (Tanaka 
et aL, 1993). Several groups o f researchers reported that induction of protective 
immunity against the L. mexicana is ultimately dependent on generation of a Thl-like 
response and IFN-y production (Satoskar et aL, 1995 and Guevara-Mendoza et aL, 
1997). In contrast IL-4 is important for the suppression of the Thl-like responses that 
are required for control of cutaneous lesions after L. mexicana WT infection (Oswald 
et aL, 1992). Satoskar et aL (1997) showed that genetically susceptible mice lacking 
IL-4 are protected from cutaneous infection with L. mexicana WT.
The amount of IL-10 in the supernatant of cultured Ag-stimulated-splenocytes from 
the mice infected with L. mexicana WT or X. mexicana H-line were measured. The 
level of IL-10 production by splenocytes from mice infected with L  mexicana WT 
was significantly higher than that of mice infected with L  mexicana H-line (P<0.02). 
IL-10, which is typically induced by L  major counteracts the development of a 
protective Thl immune response by acting on antigen presenting cells (Bogdan et aL, 
1993). This is characterized by the down-regulation of the expression of MHC class II 
molecules or the suppression o f the production o f parasiticidal metabolites and 
various inflammatory mediators (Howard et. aL, 1992). In addition IL-10 is important 
in inhibiting monocyte-macrophage activation and the production of TNF- a , IL-1 
and IFN-y (D'Andrea et aL, 1993).
In another study, was shown that L. mexicana H-line has the ability to induce IFN-y 
and TNF-a production by macrophages, whereas activation of IFN-y-primed 
macrophages was prevented by L. mexicana WT. The percentage of infected IFN-y- 
primed or unstimulated macrophages and the number o f amastigotes per 100 
unstimulated or IFN-y-primed macrophages infected with L  mexicana H-line or L  
mexicana WT were investigated. The percentage o f infected unsthnulated 
macrophages was 46.6%, whereas 33% o f IFN-y-primed macrophages were infected 
with L  mexicana WT at 24 h post infection with 67 amastigotes per 100 unstimulated 
macrophages decreasing to 33 amastigotes per 100 IFN-y-primed macrophages. This 
was due to activation of macrophages with IFN-y, which was prevented by L. 
mexicana WT.
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Previously, it was shown that stimulated splenocytes from mice infected with L. 
mexicana WT produced high levels o f  IL-4 and IL-10. This suggests that IL-4 or IL- 
10 alone or in combination may interact with activated macrophages, and is supported 
by the report that IL-4 and IL-10 are ability to reduce IFN-y production and therefore 
leishmanicidal activity (Oswald et aL, 1992; Bogdan et aL, 1993).
In the present study it has been shown that L  mexicana H-line is equally susceptible 
to killing by unprimed and IFN-y activated macrophages. This suggests that TNF-a 
induces L. mexicana H-line killing by macrophages in the presence of IFN-y and is 
supported by reports that for activation of macrophages two consecutive signals are 
required, the first signal is IFN-y whereas TNF-a is second signal that mediates 
microbicidal functions exhibited by IFN-y primed macrophages exposed to microbial 
products (James, 1995; Liew et aL, 1990). Bogdan and colleagues (1990) found that 
TNF-a induced rapid Leishmania degradation by the macrophage in the presence of 
very low dosages o f IFN-y, whereas TNF-a in combination with IL-4 supported 
intracellular parasite survival.
The results showed that the L. mexicana H-line induced high levels of IFN-y and 
TNF-a. Schaible and colleagues (1998) reported that activation of macrophages by 
IFN-y and TNF-a leads to the maturation of the phagosome to an acidic 
phagolysosome (pH 5). It is possible that infection with L. mexicana H-line leads to 
the maturation o f the phagosome and increase the acidity o f the phagolysosome. Thus 
amastigotes are unable to survive in phagolysosome at this condition.
It was shown that the majority of the mice infected with L. mexicana H-line failed to 
develop cutaneous lesions and just 1 / 5  mice developed a small and healing lesion 
during the 12 weeks post infection. In contrast to L. mexicana H-line, all infected 
mice with L. mexicana WT went on to grow non-healing lesion at the same time. 
Possible mechanisms underlying the development of non-healing lesions in 
genetically susceptible mice are probably under the control of some kind of cytokines, 
including IL-12, IFN-y, IL-4, and IL-10 (Scharton-Kersten and Scott, 1995; Heinzel et 
aL, 1995). Each of these cytokines has positive effects on the production of the other 
(Gazzinelli et aL, 1993; Macatonia et aL, 1993).
Macrophages infected with stationary phase promastigotes of either L  mexicana WT 
or L. mexicana H-line, produced no significant difference in nitric oxide production. 
The fact that L  mexicana H-line gave rise to similar levels of nitric oxide production
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as L. mexicana WT indicates that the attenuation o f the H-line's virulence is not due to 
NO production. However the Greiss reaction measures the nitrite concentration in the 
supernatant o f infected cultures. In order to determine accurately the production o f 
NO at specific time points, it would be necessary to measure NOS with other 
methods. Vectors are available containing the inducible NOS genes (iNOS) which 
would allow application of the competitive reverse transcription polymerase chain 
reaction (CRT-PCR) (Reiner and Locksley, 1993), for determination mRNA 
expression for INOS within cells which would allow a more accurate measure o f 
NOS. Unfortunately, time limitation and prioritisation prevented further investigation 
by this method.
Dissemination of the parasite in the visceral organs of susceptible mice is result o f the 
development of Th2 response that is not protective (Liew and Donnell, 1993). The 
local restriction of the parasite prior to the development of T cell responses appears to 
be mediated by the innate immune system and this activity is considered to play an 
important role in the subsequent development of a protective T cell response (Laskay 
et aL, 1995). In this study it was found that L. mexicana H-Iine was localized in the 
skin where the promastigotes were injected and in the draining popliteal LN after 120 
days post infection, without any dissemination to the visceral organs. In contrast, 
infection with L  mexicana WT led to the parasite rapidly spreading to the bone 
marrow, spleen, draining popliteal LN and femur, and lungs. Our results indicate that 
L  mexicana H-line can survive in the skin for a long time and thus it could generate 
long term memory or concomitant immunity (Aebischer, et aL, 1993).
It was found that the amounts of both IgGl and IgG2a Abs in the serum o f mice 
infected with L  mexicana H-line were less than those of mice infected with L. 
mexicana WT. The level of IgGI was significantly increased compared with the level 
of IgG2a in the serum o f mice infected with L. mexicana WT (p<0.03). In contrast, 
there was no significant difference between the amounts of IgGl and IgG2a Abs in 
the serum of the mice infected with L  mexicana H-line (p<0.3). In fact, the level of 
IgGl in the serum of mice infected with X. mexicana WT was increased compared 
with that in the serum of infected mice with X. mexicana H-line. On the other hand, 
the production o f IgGl Abs that is promoted by Th2 cells was markedly suppressed in 
the mice infected with X. mexicana H-line, compared with that in X. mexicana WT 
treated mice, indicating possible inhibition o f Th2 function by X. mexicana H-line.
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This data is in agreement with the report that IgGl regulation is not completely 
dependent upon IL-4 signalling (Snapper and Scott, 1987).
Langerhans cells (LCs) play a crucial role in the induction of the immune response in 
the early Leishmania infection because only infected LCs are able to carry parasites 
from the infected skin to the draining LN for primary antigen presentation to T cells 
(Moll et aL, 1993) and produce IL-12 immediately following X. donovani infection 
(Gorak et aL, 1998). It was interesting to determine the immune response of LC 
infected with X. mexicana WT or X. mexicana H-line. The isolated epidermal cells 
were incubated with promastigotes o f the two lines o f X. mexicana in vitro. Blank and 
colleagues (1993) reported that only LC, but no other epidermal cells, are able to take 
up X. major. The presence of intracellular parasites was assessed by staining the cells 
with acridine orange / ethidium bromide (Channon et aL, 1984). It was found that no 
epidermal cells were infected with stationary phase promastigotes of X. mexicana H- 
line or X. mexicana WT in vitro, whereas macrophages stuck on the chamber slides 
were infected with stationary phase promastigotes of X. mexicana WT over 24 h post 
infection. This suggests that stationary phase promastigotes of X. mexicana WT or X. 
mexicana H-line were unable to infect Langerhans cells in vitro.
The present results indicate that the X. mexicana H-line has attenuated virulence for 
BALB/c mice and promotes a Thl cells response.
X. major H-line was stabilised in the presence of gentamicin after 11 passages using 
the same method described for generation o f the X, mexicana H-line. The results of 
the interaction between stationary phase promastigotes of X, major H-line and 
macrophages showed that the attenuated cell line of X. major was able to infect 
macrophages similar to that of X. major WT. In contrast to X. major WT, the 
percentage of macrophages infected by the attenuated line decreased from 41% at 8 h 
post infection to 10.5% at 96 h post infection. The initial infection of macrophages 
with X. major WT was 46.5%, but in contrast to the X. major H-line, the percentage of 
infected macrophages increased to 65% at 96 h post infection.
Comparison o f number of amastigotes of X. mexicana H-line or X. major H-line 
which survived within infected macrophages at 96 h shows that the capability of 
amastigotes of X. major H-line to survive within infected macrophage is greater than 
that of X. mexicana H-line. There are two possible reasons:
1- There are some differences between the resistance of each attenuated line to 
survive within the PV of macrophages.
130
2- The promastigotes of L. major H-line after 11 passages were exposed to 
macrophages whereas L. mexicana H-line after 20 passages.
In this study it has been shown that five BALB/c mice infected with L  major H-line 
failed to develop cutaneous lesion during 12 weeks post infection. In contrast to L. 
major H-line, all mice infected with L. major WT went to grow non-healing lesion at 
the same time.
Unfortunately, prioritisation and time limitation prevented more work with the 
attenuated L. major. The preliminary results of interaction between stationary phase 
promastigotes of L. major H-line and macrophages (m vitro) and the failure of lesions 
to develop in the susceptible mice indicate that the attenuated cell line of L. major was 
generated in the presence o f gentamicin. L. major H-line is non-virulent for 
susceptible BALB/c mice, at least 12 weeks post infection.
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4.1. Introduction
Leishmania are responsible a wide spectrum diseases in humans and there has been 
much recent activity in the attempts to vaccine against Leishmania because of the 
problem of an increased incidence o f resistance following chemotherapy that is based 
on pentavalent antimony compounds. Unfortunately these drugs frequently have 
unpleasant side effects, and are not very effective against cutaneous leishmaniasis. 
Another problem of chemotherapy is the development of drug resistance in various 
endemic regions of the world (Jackson et aL, 1990; Rangel et aL, 1997).
The conventional approach to vaccine development has used five methods: live, 
killed, and attenuated promastigotes, subunit vaccines, and DNA vaccines. There is 
no safe and effective vaccine against any form of leishmaniasis (Piedrafita et aL, 
1999).
Killed parasites are unable to invade reticuloendothelial cells but the viable parasite 
can exist intracellularly in the macrophages, and evade the consequences of host’s 
immune attacks. The result is that the parasite can survive in the mammalian host for 
a long time and causes a chronic disease, with unsuccessful immunological response 
(Liew 1989). Persisting parasites offer a continual stimulus to the immune system and 
induce effective immunological memory in the process known as concomitant 
immunity (Aebischer et aL, 1993). An unfortunate feature of this persistence is that 
parasites may grow out o f control reactivating in immunocompromised people. 
Ideally a vaccine should be molecularly defined and induce long term memory in the 
absence of persistent live organisms (Handman, 1997), but this may not be readily 
achievable.
The current conventional approach to leishmanial vaccine development uses two 
methods: the first, attenuation of promastigotes by serial passages in vitro to obtain 
live-attenuated strains (to be used as vaccines), and second, subunit vaccines by 
identification of protective antigens (to be used as non-living vaccines) (Rappuoli, and 
Del Giudice, 1999).
The stable immunity following recovery from cutaneous leishmaniasis has prompted 
scientists during the past several decades to try using the live attenuated cell lines for 
development of prophylactic vaccines. This immunity is driven by the induction of T- 
cell responses involving the production of cytokines, which activate macrophages to 
kill the parasites (Liew and O’Donnell, 1993).
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Reiner and Locksley (1995) reported that resistance to Leishmania in various mouse 
strains strongly correlates with the development of a Thl-like cytokine secretion 
profile. Induction of an immune response with mixed Thl-like and Th2-like is unable 
to confer protection. A Thl response is sufficient to cause protection against disease 
in experimental cutaneous leishmaniasis, but this protection is abrogated if a Th2 
response is simultaneously induced (Sjolander, 1998). The importance o f IL-4 is 
supported by several other studies suggesting that susceptibility to leishmaniasis 
correlates with the production of IL-4 rather than the lack of IFN-y (Erb et aL, 1996; 
Morris et aL, 1993).
4.2. Materials and methods
4.2,1. Parasite
Promastigotes of L. mexicana WT or L major were grown in HOMEM medium 
supplemented with 10% (v/v) HI-FCS. Promastigotes of L. mexicana H-line or L  
major H-line were grown in the same medium supplemented with 20 pg/ml 
gentamicin and incubated at 25^C (see section 2.2.1). In this chapter, the comparisons 
of immune response o f mice induced by L. mexicana WT and X. mexicana H-line 
were made with same age parasites.
4. 2. 2. Immunization of mice with X. mexicana H-line
One group BALB/c mice (14 mice / group) was injected (s.c.) with 5 x 1 0 ^  stationary 
phase promastigotes o f X. mexicana H-line into their shaven right side rump and 
another group injected with PBS. After 12 weeks, the immunised mice and control
group were infected (s.c.) with 5 x 1 0 ^  stationary phase promastigotes o f X. mexicana 
WT into the opposite side rump. The same number of mice were injected with PBS as 
controls. The swelling or lesion growth was monitored weekly.
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4. 2. 3. Immunization of mice with X. major H-iine and challenged with X. major 
WT
Five mice immunized with 5 X1 0 ^  stationary phase promastigotes of X. major H-line 
and 5 non-vaccinated controls were infected with 5 x IQ^  stationary phase 
promastigotes of X. major WT (as described in section 4.2.1). The swelling or lesion 
growth was monitored weekly.
4. 2. 4. Protection studies-immunization and challenge at the same time
The first group of mice (10 mice / group) was injected (s.c.) with 2.5 x IQ*^  stationary 
phase promastigotes of X. mexicana H-line into their shaven left side rump and 2.5 x 
10^  stationary phase promastigotes of X. mexicana WT in the opposite side. The 
second group of mice was injected (s.c.) with a mixture of 2.5 x IQ^  stationary phase 
promastigotes of X. mexicana H-line and the same number o f stationary phase 
promastigotes of X. mexicana WT into their shaven right side rumps. The third group 
of control mice was infected with 2.5 x 10  ^ stationary phase promastigotes of X. 
mexicana WT into their right side. The swelling or lesion growth at the site of X. 
mexicana WT inoculation was monitored weekly over a period of 13 weeks.
4. 2. 5. Lesion size
Suspension o f stationary phase promastigotes of X. mexicana H-line or X. mexicana 
WT or X. major WT or X. major H-line at concentration 2.5 x 10  ^cells/ml in PBS was 
prepared, and 200 pi of these suspensions were injected (s.c.) into the shaven rump of 
BALB/c mice. The lesion volume was measured weekly (for full details see section 
3.2.10).
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4. 2. 6. T cell proliferation assay
T cell proliferation assays were performed as previously described in section 3.2.10. 
Briefly, the mice were vaccinated with stationary phase promastigotes of L. mexicana 
H-line and control mice injected PBS. Three months later the control and vaccinated 
mice were infected with stationary phase promastigotes of L  mexicana WT. The mice 
were killed at 12 weeks post infection and their spleens removed aseptically. Single 
cell suspensions were prepared (for more detail see section 3.2.11) and then exposed 
by adding an equal volume of stationary phase promastigotes at a concentration of 5 x 
10  ^ cells / ml, giving a parasite: cell ratio of 1:10. Supernatants were collected from 
parallel cultures after 72 h of incubation for ELISA quantification o f cytokine 
production.
4. 2. 7. Cytokine ELISA
Supernatants collected from spleen cell cultures from mice immunized with L. 
mexicana H-line and challenged with L. mexicana WT and infected mice were 
assayed for the presence of IFN-y and IL-4 using ELISA, as previously described (see 
in section 3.2,13).
4. 2. 8. Preparation of tissues, and culture in vitro of L  mexicana isolated from 
infected mice.
Following injection o f 5 x 10  ^ stationary phase o f promastigotes of L  mexicana WT, 
the parasite loads in the 6 mice were determined by limiting dilution to measure the 
number of viable promastigotes in the tissues o f challenged and infected mice (using 
the same methods described in section 3.2.20). Briefly, the livers, draining lymph 
nodes, lungs and spleens were homogenized in HOMEM medium supplemented with 
FCS 10% and bone marrow cells collected from the femurs and tibias o f infected 
mice. A limiting dilution (LD) cell suspensions in vitro culture assay was used to 
determine the number of viable parasites in these organs. The serial twofold dilutions 
of cell suspensions were plated in the 24-well plates. The cells were then incubated at
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25°C for 14 days. The cultures were examined for the presence of promastigote 
production every day.
4.3. R esu lts
4.3.1. Vaccine potential of X. mexicana H-line
The cytokine production results (see Chapter 3) indicated that infection of mice with 
X. mexicana H-line induced a Thl response, which is a protective response against X. 
mexicana infection (Satoskar et ah, 1995). Therefore, it was examined whether 
pretreatment of mice with the attenuated cell line could protect susceptible BALB/c 
mice from infection with X. mexicana WT. Mice were immunized with X. mexicana 
H-line and challenged with X. mexicana WT at 12 weeks post immunization. All non­
vaccinated mice developed progressive non-healing lesions and the mean lesion size 
at 14 weeks post infection this time was more than 2600 mm^. In contrast to non­
vaccinated mice, the lesion developed slowly in vaccinated mice and as Figure 4.1 
shows the mean of lesion size at 22 weeks post infection was only about 200 mm^.
4.3.2. Protection potential of X. mexicana H-line - immunization and challenge at 
the same time
The results indicated that the X. mexicana H-line induced protection in susceptible 
mice against X. mexicana WT. Next it was examined whether the attenuated cell line 
is able to induce protection when promastigotes of the two lines were injected (s.c.) at 
the same time (Figure 4.2).
The first group of mice was injected with 2.5 x 10  ^stationary phase promastigotes of 
X. mexicana H-line in the left side rump and the same number of stationary phase of 
X. mexicana WT in the right side rump. The lesions that developed in the right side 
rumps were initially the same size as lesions that developed in the control mice, but 
after about 13 weeks the lesion growth slowed. No lesion or swelling was observed in 
the left side rump where promastigotes of X. mexicana H-line were injected.
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The second group of mice was injected with a mixture of 2.5 x 10  ^stationary phase 
promastigotes of L. mexicana H-line and the same number of stationary phase
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Figure 4.1. The course of lesion size following L  mexicana WT infection 
in 2 groups of BALB/c mice (14 mice / group). One group had been 
vaccinated with 5x 1 0 ^  stationary phase promastigotes of L  mexicana H- 
line. 5 x 1 0 ^  stationary phase promastigotes of L  mexicana WT were 
inoculated in the shaven right side rump of the vaccinated or non­
vaccinated mice. Lesion development was monitored by measuring the 
lesions weekly. Each data point represents the mean lesion size ± SEM (n 
=14).
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promastigotes of L. mexicana WT both at the same side in the right side rump. The 
results showed that 2 out of the 10 mice developed very slowly growing lesions, 
whereas the other 8 mice had no lesions. The control group of mice was infected with 
2.5 X 10  ^ stationary phase promastigotes of L  mexicana WT. All mice developed 
progressive non-healing lesions. These results shows that the L. mexicana H-line 
induced a protection that led to control of L. mexicana WT infecting at the same time.
1800 
^  1600 
I  1400
'ST 1200
”  1000 
§ 800
'Z 600 
S 400
200
-  "
3 4 5 6 7 8 9 10 11 12 13
Time (week)
-♦— H-line and W r 
on separate 
sides, H-line no 
lesion
-A- -  H-line+WT 
mi)4ure
- - WT alone
Figure 4.2. The course of infection of three groups in BALB/c mice (10 mice / group) 
infected with both L. mexicana WT and L. mexicana H-line or L. mexicana WT alone. Lesion 
development was monitored by measuring the lesions weekly. Each data point represents the 
mean lesion size ± SEM (n =10).
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4.3.3. Lesion development in mice vaccinated with L. mexicana H-line and 
infected with L. major WT
In order to determine whether L. mexicana H-line has the potential to protect BALB/c 
mice from L  major, the mice immunized with L  mexicana H-line were challenged at 
week 12 with stationary phase promastigotes of L  major WT. The lesion size in the 
vaccinated mice was compared with non-vaccinated mice. As the figure 4.3 shows, 
there is no significant difference between the two groups of mice. This result suggests 
that there was no protection in the mice vaccinated with L  mexicana H-line against L  
major.
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Figure 4.3. The course of lesion size following L  major WT infection in 2 groups 
of BALB/c mice (14 mice / group). One group had been vaccinated with 5 x 10^  
stationary phase promastigotes of L. mexicana H-line. 5 x 10  ^ stationary phase 
promastigotes of L. major WT were inoculated in the right side shaven rump of the 
vaccinated or non-vaccinated mice. Lesion development was monitored by 
measuring the lesions weekly. Each data point represents the mean lesion size ± 
SEM (n=  14).
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4.3.4. Vaccine potential of £. major H-line
To determine whether the L. major H-line has the ability to protect susceptible mice 
against infection with L  major WT, 5 BALB/c mice were immunized with L  major 
H-line. The mice were challenged at 12 weeks with L. major WT. All non-vaccinated 
mice developed progressive non-healing lesions up to 12 weeks post infection and the 
mean lesion size at this time was more than 2000 mm^. In contrast to non-vaccinated 
mice, lesions developed slowly in vaccinated mice and as Figure 4.4 shows the mean 
of lesion size at 12 weeks post infection was less than 1000 mm^.
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Figure 4.4. The course of lesion size following L  major WT infection in 2 
groups of BALB/c mice (5 mice / group). One group had been vaccinated 
with 5 X 10  ^ stationary phase promastigotes of L  major H-line. 5 x lo^ 
stationary phase promastigotes of L. major WT were inoculated in the 
right side shaven rump of the vaccinated or non-vaccinated mice. Lesion 
development was monitored by measuring the lesions weekly. Each data 
point represents the mean lesion size ± SEM (n = 5).
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4.3.5. T-cell proliferation of splenocytes from vaccinated or non-vaccinated 
BALB/c mice infected with the two lines of L. mexicana
Studies were carried out to determine whether the splenocytes of vaccinated and non- 
vaccinated BALB/c mice infected with 5 x 1 0 ^  stationary phase promastigotes of L. 
mexicana WT 12 weeks post infection were stimulated with stationary phase 
promastigotes of L  mexicana WT. The splenocytes were exposed to promastigotes, at 
32®C for 4 h, and then incubated at 37°C for 68 h. The splenocyte: parasite ratio was 
1 0 / 1 .  The splenocytes were stimulated with promastigotes, because this simulated 
the situation when the immune mice are exposed to a normal challenge. The 
proliferation of the T cells was confirmed with Con-A (5 pg/ml) as a positive control 
and non-stimulated cells as negative controls. As Figure 4.5 shows the Con-A- 
stimulated proliferative response of splenocytes from non-vaccinated mice was 
significantly higher than that of promastigotes-stimulated (P<0.02). Promastigotes of 
L  mexicana WT induced proliferation o f splenocytes of the vaccinated mice 
significantly less that of the Con A-stimulated splenocytes (P<0.04).
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Figure 4.5. T-cell proliferation responses of splenocytes from non- 
vaccinated mice and mice vaccinated with L  mexicana H-line and 
infected with L. mexicana WT. The mice vaccinated with L. mexicana 
H-line and non-vaccinated mice were challenged with 5x10^ stationary 
promastigotes of L  mexicana WT at 12 weeks post immunization. T- 
cell proliferation responses o f spleen cells from mice at week 12 post 
infection were induced by Con A (5 pg/ml) and stationary phase 
promastigotes of L. mexicana WT (the ratio of splenocytes: 
promastigotes was 10 / 1). The stimulation index was calculated as 
count per minute (CPM) of stimulated cells / CPM of unstimulated 
cells. The bar represent SEM (n = 5).
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4.3.6. IFN-y and IL-4 production by splenocytes of challenged mice
To determine whether the vaccination with L. mexicana H-line had an effect on the 
cytokine production of mice vaccinated with L. mexicana H-line and at 12 weeks post 
immunization challenged with L. mexicana WT, splenocyte cultures were established 
from mice at 12 weeks post challenge. The splenocytes were restimulated with 
stationary phase promastigotes of L. mexicana WT and supernatants harvested after 
72 h culture. Spleen cells from mice which were injected with L  mexicana H-line and 
after 12 weeks were challenged with L. mexicana WT, produced levels of IFN-y 
which were significantly greater than these produced by mice which did not receive 
the vaccination (P<0.005) (Figure 4.6).
IL-4 levels were increased in supernatants harvested from Ag-stimulated spleen cells 
set up from mice receiving the single L  mexicana WT challenge. In contrast, no IL-4 
was produced by cells taken from the mice which had received the pre-treatment with 
L  mexicana H-line (Figure 4.7).
The relative production of these cytokines can thus be used as a marker for the 
induction of Thl-like and Th2-Iike immune responses, respectively. The spleen cells 
from mice immunized with L. mexicana H-line secreted high concentrations of IFN-y 
but no detectable IL-4. The stationary phase promastigotes o f L. mexicana WT 
induced spleen cells producing high concentrations of IL-4. Spleen cells were 
stimulated in vitro with stationary phase promastigotes of L  mexicana WT for 72 h. 
In contrast to the mice vaccinated with L. mexicana H-line and challenged with L. 
mexicana WT, the amount o f IL-4 in the supernatant of splenocyte cultures of non- 
vaccinated mice was significantly increased higher than that with challenged mice (P< 
0.005) (Figure 4.7).
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Figure 4.6. IFN-y production by cultured splenocytes taken 
from mice 12 weeks post infection with stationary phase 
promastigotes WT or mice vaccinated with L. mexicana H-line 
and at 12 weeks post immunization challenged with L. 
mexicana WT. The mice were immunized with L. mexicana H- 
line and at 12 weeks challenged with L. mexicana WT. The 
splenocytes were restimulated with stationary phase 
promastigotes of L. mexicana WT and supernatants harvested 
after 72 h culture. The infection ratio of parasite / splenocyte 
was 1:10. Bars represents SEM (n = 3).
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Figure 4.7. IL-4 production by cultured splenocytes taken from mice 12 
weeks post infection with stationary phase promastigotes WT or mice 
vaccinated with L. mexicana H-line and at 12 weeks post immunization 
challenged with L  mexicana WT. The mice were immunized with L  
mexicana H-line and at 12 weeks challenged with L  mexicana WT. The 
splenocytes were restimulated with stationary phase promastigotes of L. 
mexicana WT and supernatants harvested after 72 h culture. The 
infection ratio of parasite / splenocyte was 1: 10. Bars represent SEM 
(n = 3).
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4.3.7, Investigation of the spreading of X. mexicana to the visceral organs of mice 
vaccinated with X. mexicana H-line
The in vitro results suggest that the X. mexicana H-line may be capable of protecting 
susceptible mice against X. mexicana WT. To consider the in vivo survival and 
possible dispersion of the X. mexicana WT beyond site of inoculation, the vaccinated 
mice were injected with X. mexicana WT and then examined for the presence of 
parasites in the peripheral and visceral organs. Stationary phase promastigotes of X. 
mexicana WT were subcutanously injected and then the spreading of parasites in the 
skin and visceral organs of 6 challenged mice was investigated at 12 weeks post 
infection. The visceral organs were removed asceptically. These included liver, 
spleen, lung, bone marrow (BM), draining popliteal lymph node (LN), and ECs from 
the site o f injection at the appropriate times. The cell suspensions were cultured in 
HOMEM medium supplemented with 10% (v/v) FCS and incubated at 25°C over 14 
days. The cultures were examined daily for the presence of live promastigotes (Table
4.1). Promastigotes of X. mexicana H-line grew in cell cultures from LN and ECs, 
where X. mexicana H-line were injected, o f challenged mice numbers 1, 2, and 6, 
whereas no promastigotes of X. mexicana WT grew in the cell cultures obtained from 
visceral organs o f these mice. No promastigote of X. mexicana H-line grew in the cell 
culture derived from LN and ECs, where X. mexicana H-line were injected, of mice 
numbers 3, 4, and 5. In contrast, in the absence of X. mexicana H-line, promastigotes 
of X. mexicana WT were observed in the tissue cultured o f these mice to survive 
within resident macrophages for long periods.
In addition, throughout the period of study (24 weeks) no lesion developed in the right 
side of mice where the promastigotes of X. mexicana H-line were injected. Two mice 
(numbers 4 and 5), developed a lesion in the left side where promastigotes o f X. 
mexicana WT were injected and no lesions were observed in the rest of mice (Table
4.2). The draining LN contained parasites within one day o f infection, and remained 
infected throughout the period of study (12 weeks). It was shown that X. mexicana 
WT spread to BM, spleen and lung and it was observed that infection of visceral 
organs correlated with an increase in lesion size (see section 3.3.12).
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Table 4.1. Distribution of the two lines of L.mexicana in the skin and visceral 
organs o f challenged mice.
Mouse 1 2 3 4 5 6
Epidermal cell ” + + - - +
Epidermal cell ^ - - + + +
Spleen - - - + +
Lung - - + -t- +
(a); The site where stationary phase promastigotes of L. mexicana H-line were 
injected.
(b): The site where stationary phase promastigotes ofX. mexicana WT were injected. 
(+): Indicates that promastigotes were observed in the tissue culture.
(-): Indicates that no promastigotes were observed in the tissue culture.
Table 4.2. Cutaneous lesion development in the challenged mice 12 weeks post 
infection.
Mouse 1 2 3 4 5 6
Lesion (right side) ® N  ^ N N N N N
Lesion (left side) N N N L^ * L" N
(a): The site where stationary phase promastigotes of X. mexicana H-line were 
injected.
(b): The site where stationary phase promastigotes of X. mexicana WT were injected.
(c) : No lesion developed.
(d): Small size lesion developed.
(e): Large size lesion developed.
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4.4, Discussion
L  mexicana H-line is capable of inducing a CD4+ Thl response, which was 
demonstrated by elevated IFN-y and IL-2 production by cultured splenocytes of 
BALB/c mice infected with L  mexicana H-line (for more detail see Chapter 3). To 
determine whether the attenuated line could induce protection against L. mexicana 
WT, the mice vaccinated with stationary phase promastigotes of L  mexicana H-line 
were challenged at week 12 post immunization with L. mexicana WT. All non- 
vaccinated mice developed large size, non-healing lesions, whereas the vaccinated 
mice developed small and in some cases healing lesions over 22 weeks post infection. 
This result suggested that immunization with X. mexicana H-line induced a protective 
Thl response and immunized mice were significantly resistant to X. mexicana WT 
compared with non-immunized mice. In a fiirther study it was shown that IFN-y 
production was elevated in the supernatant of cultured splenocytes of mice challenged 
with X. mexicana H-line. The present results are supported by the reports that 
recovery from cutaneous lesions in mice resistant to X. mexicana was associated with 
the expansion o f the CD4^ Thl subset and production of cytokines such as IL-12, 
IFN-y, and IL-2 (Stamm et al, 1998). Resistance to X. major in various mouse strains 
strongly correlates with the development of a Thl-like cytokine secretion profile 
(Reiner and Locksley 1995). In contrast to X. mexicana H-line, injection of X. 
mexicana WT induced a Th2 immune response and an exacerbated disease. 
Therefore, the attenuated line o f X. mexicana holds considerable promise for 
vaccination against leishmaniasis in which Thl responses are desirable.
In addition, the present results indicated that a Thl response alone can protect 
against X. mexicana WT, in agreement with the report that induction of an immune 
response with mixed Thl-like and Th2-like elements is unable to confer protection 
and that a Thl response is sufficient to protect against disease in experimental 
cutaneous leishmaniasis and the induction of a simultaneous Th2 response abrogates 
the Thl effector function (Sjolander, 1998). Furthermore, there is considerable 
evidence that Th2-type responses and the production of IL-4 results in the inability to 
control disease, or results in disease exacerbation (Heinzel et aL, 1991). The severity 
o f disease in murine cutaneous leishmaniasis is better correlated with the presence of 
IL-4 than the lack of production of IFN-y (Erb et aL, 1996; Morris et al., 1993a). This 
observation shows that X. mexicana H-line preferentially induces a Thl-like immune
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response and down-regulate the Th2 response. In murine leishmaniasis, the 
genetically resistant mice display a Thl phenotype, whereas the susceptible BALB/c 
mice develop a clear Th2 cytokine phenotype (Heinzel et aL, 1989; Heinzel et al., 
1991).
Alexander and Phillips (1980) reported that mice infected with L. major were 
immune to subsequent infection with L. mexicana. To determine whether mice 
vaccinated with L. mexicana H-line were capable of protection mice against L. major, 
the mice vaccinated with L. mexicana H-line were challenged with L. major. The 
results showed that the attenuated line of L  mexicana generated no protection against 
L. major. In this case there is no cross immunity between L  mexicana and L. major.
The local restriction of the parasites prior to the development of T cell responses 
appears to be mediated by the innate immune system and this activity is considered to 
play an important role in the development of protective T cell responses (Laskay et 
aL, 1995). Dissemination of the parasite to the visceral organs in susceptible mice is 
result of the development of a non-protective Th2 response (Leiw et aL, 1993). In the 
present study it has been demonstrated that in the presence of the attenuated cell line 
of L  mexicana, L. mexicana WT was not found in the draining LN, skin and other 
organs. In contrast, L. mexicana WT disseminated into the visceral organs of 
challenged mice in the absence o f the attenuate cell line. Therefore the presence of L. 
mexicana H-line in the host led to the elimination L. mexicana WT.
In Chapter 3, it was shown that L. mexicana H-line remained localized in the EC of 
skin where the promastigotes were injected and in the draining popliteal LN, without 
evidence of dissemination to the visceral organs throughout the period o f study. In 
contrast, L  mexicana WT disseminated to the bone marrow, spleen, draining popliteal 
LN, and lungs. Therefore, it is very unlikely that the parasites, which were 
disseminated in the visceral organs of challenged mice, belong to attenuated cell line. 
The protection o f L. mexicana H-line against L. mexicana WT at the same time was 
investigated by following the result o f injecting of the same number of stationary 
phase promastigotes of the two lines of L, mexicana in the same side or the same 
number o f L. mexicana WT or L  mexicana H-line on separate sides in the same mice. 
The control mice which were infected with L. mexicana WT alone developed 
progressive non-healing lesions. In contrast, some of the mice that were infected with 
mixed L. mexicana H-line and L. mexicana WT developed very slowly growing 
lesions. In the mice, which were injected with the two lines of parasites on the
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separate sides, growth o f Z. mexicana WT growth eventually slowed. There was good 
evidence of control of L. mexicana WT.
The preliminary results also showed that L. major H-line induced protection in 
susceptible mice against infection with L. major WT. All non-vaccinated mice 
developed progressive non-healing lesions that peaked in size at 12 weeks post 
infection and the mean lesion size at this time was 2000 mm^. In contrast to non­
vaccinated mice the lesion developed slowly in vaccinated mice and as Figure 4.4 
shows the mean of lesion size at 12 weeks post infection was about 1000 mm^. 
Unfortunately, time limitation and prioritisation prevented further investigation by 
other methods.
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The Leishmania species belong to the kinetoplastid protozoa, which are 
responsible for a wide spectrum of disease including cutaneous, mucocutaneous, and 
visceral leishmaniasis (Pearson and Sousa, 1996). The worldwide prevalence of 
leishmaniasis is approximately 12 million, mostly children and young adults (WHO 
report, http://www.who.int/ctd/htnn/leish.html. 2000). Although treatment with 
leishmanicidal drugs is available, chemotherapy has only a moderate effect and the 
available drugs frequently have unwanted side effects. Some are losing their 
effectiveness and drug resistance is becoming a significant problem in various 
endemic regions of the world (Jackson et al., 1990). Although there has been much 
recent interest in attempts to vaccinate against Leishmania infection, there is no 
effective and safe vaccine against any form of leishmaniasis (Piedrafita et al., 1999). 
Individuals who have recovered from clinical leishmaniasis develop strong immunity 
against reinfection, and therefore it has been suggested that vaccination against 
leishmaniasis is feasible in principle (Liew and O'Donnell, 1993). Conventional 
vaccine development against leishmaniasis is focused on five approaches: killed 
promastigotes, live promastigotes (wild type), live attenuated promastigotes, subunit 
vaccines, and DNA vaccines. Rappuoli and Giudice (1999) argued that leishmanial 
vaccine development is most likely to be successful through use o f attenuated 
promastigotes and subunit vaccines based on the identification of protective antigens. 
All subunit vaccines tested (for example gp63, gp46) however have given only partial 
protection and their efficacy has often required the use of clinically unacceptable 
adjuvants (Piedrafita et at., 1999).
In this study the development of an attenuated cell line of L. mexicana in the 
presence of an antibiotic is described. In a preliminary investigation, this technique 
was also extended to attenuate L. major. Therefore, this method for inducing 
attenuation might be applicable to other species of Leishmania and possibly other 
microorganisms. Aebischer and colleagues (1993) suggested that an attenuated cell 
line of L. major, which persisted for a prolonged period in vivo, stimulated clinically 
protective immunological memory in a process known as concomitant immunity. It is 
clear that while several kinds o f vaccine against leishmaniasis have been generated, 
the protection induced by the use of attenuated promastigotes has to date proved to be 
the most effective. These findings are consistent with reports that attenuated forms of 
many microorganisms can serve as highly effective vaccines (Hess et al., 2000).
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Attenuated lines of Leishmania species have been created using several methods, such 
as disruption of (controlling) virulence genes from the genome of wild type 
Leishmania. For example, L. mexicana tscpa/cpb is an attenuated line (Souza et al., 
1994) and is candidate for vaccines (Alexander et al., 1998). An attenuated L. major 
line lacking a DHFR/TS gene (Titus et al., 1995) has also been developed.
For the first time attenuated cell lines of L. mexicana WT and L. major WT have 
been generated in vitro in the presence of an antibiotic. The attenuated lines o f T. 
mexicana WT and L. major WT known as L. mexicana H-line and L. major H-line, 
respectively, have been established under antibiotic pressure (gentamicin), which was 
routinely added to the medium to prevent bacterial contamination. The attenuated 
parasites were characterised in vivo and in vitro. The ability of the L. mexicana H-line 
to survive within infected macrophages was examined by exposure o f stationary 
phase promastigotes from the L. mexicana H-line to bone marrow -derived 
macrophages (BMMs). The results showed that the percentage of macrophages 
infected with the L. mexicana H-line was similar to that of L. mexicana WT at 9 h 
post infection. In contrast to L. mexicana WT, only a small population of amastigotes 
of L. mexicana H-line survived within infected macrophages after 96 h post infection 
in vitro. The ability o f L. mexicana H-line to induce cutaneous leishmaniasis was 
examined by injection (subcutaneously) of stationary phase promastigotes of L. 
mexicana H-line. It was shown that the majority of BALB/c mice, which are 
susceptible to L. mexicana WT, when infected with L. mexicana H-line failed to 
develop cutaneous lesions. Over the whole study over 40 mice were infected with L. 
mexicana H-line and only one developed a healing lesion. In contrast to the L. 
mexicana H-line, all mice infected with L. mexicana WT, which was grown in parallel 
cultures of the same age as L. mexicana H-line in medium without gentamicin, 
developed non-healing lesions. Therefore, it was concluded that the L. mexicana H- 
line is an attenuated line, which has been generated in the pressure of gentamicin. The 
mechanism by which gentamicin, an aminoglycoside, attenuates L. mexicana WT is 
unknown. Several groups of researchers determined the sequence requirements of 
ribosomal RNA for aminoglycoside interaction with prokaryotes and eukaryotes 
(Werstuck and Green, 1998; Yoshizawa et al., 1998; Recht et ah, 1999). Disruption of 
ribosomal activity by breaking up of polysomes or inducing misreading of mRNA 
during protein synthesis resulting in incomplete protein synthesis, are possible
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mechanisms (Chambers and Sande, 1996). It was found that the adaptation of L  
mexicana H-line under pressure of gentamicin has involved an alteration in protein 
expression. Two bands were detected around 66 kDa in stationary or log phase 
promastigotes of L. mexicana WT, whereas one (possibly two) o f these bands were 
absent in the stationary and log phase promastigotes of L  mexicana H-line. In other 
experiments, the comparative proteome analysis of the two lines of L. mexicana using 
high-resolution techniques was carried out using isoelectric focusing and SDS-PAGE. 
It was demonstrated that both lines of Leishmania comprise patterns with a high 
density o f spots in the range pH 4-7 of the gel. The position of spots in the gels of the 
two lines of L. mexicana revealed high similarity, and the main spots were compared 
easily. One spot in the L. mexicana WT gel was shifted to a less acidic position in the 
L. mexicana H-line and one spot was absent in L. mexicana H-line. In addition, two 
spots were found in the L  mexicana WT gel, whereas the expression of these proteins 
by promastigotes of L. mexicana H-line decreased. Although, the data have shown 
significant differences between the two lines of L. mexicana, there are insufficient 
replicates to draw firm conclusions about the absence or decreased expression of the 
proteins in 2-DE. To identify proteins in the lysate of stationary phase promastigotes 
of L. mexicana H-line, which were lost or reduced compared with L. mexicana WT, 
mass spectrometry with database searching has been suggested (Beavis and Fenyo, 
2000). In conclusion, the results of protein analysis using SDS-PAGE gradient gels 
and proteome analysis using 2-DE of the two lines of L. mexicana demonstrate that 
the attenuation procedure under pressure of gentamicin affected protein expression in 
promastigotes of L. mexicana H-line (following growing the parasites in the presence 
of gentamicin).
On the basis o f these experiments, promastigotes of L. mexicana WT passaged at 
least 20 times in HOMEM medium supplemented with 10% (v/v) FCS and 
gentamicin at 20 pg/ml, were shown to become attenuated during this process. The 
precise timing of any changes induced in the parasite by gentamicin that led to 
parasite attenuation has yet to be determined. It was shown that L. mexicana H-line 
was stable in the absence of gentamicin. Promastigotes of L. mexicana H-line were 
grown in antibiotic-free medium for 40 passages and then exposed to bone marrow 
macrophages. The ability of the attenuated line to invade and survive within infected 
macrophages was examined over a 96 h incubation. The results showed that the 
attenuated line is stable in antibiotic-free medium in vitro for more than 23 weeks.
155
Therefore, the differentiation of L. mexicana WT to the attenuated line of L. mexicana 
is stable in the absence of gentamicin in medium. It was demonstrated that the 
adaptation of L. mexicana H-line under pressure of gentamicin has not involved 
cysteine proteinase (CP) production by stationary phase promastigotes of L. mexicana 
H-line. The proteinase activity o f stationary phase promastigotes o f L  mexicana H- 
line and L. mexicana WT was investigated by loading lysates on gelatin-SDS-PAGE 
gel. Robertson and Coombs (1992) reported that a high mobility band o f CP activity 
can be detected in stationary phase promastigotes of L. mexicana using gelatin-SDS- 
PAGE. Three bands were detected of which the molecular mass of the highest 
mobility band of proteolytic activities was 20 kDa. That these proteinases are cysteine 
proteinase is supported by the report of an analysis of CPB isoenzymes expressed in 
of stationary phase promastigotes of L. mexicana WT. Using Western blotting, anti- 
CPB antiserum detected two major proteins (25 and 29 kDa) (Mottram et al., 1997). 
Therefore, the stationary phase promastigotes of L. mexicana H-line are not deficient 
in CP. During the present study some experimental work has been carried out with L. 
mexicana Acpa/cpb which had been created by targeted gene disruption (Mottram et 
al., 1997). It was therefore, necessary to demonstrate that promastigotes of L. 
mexicana H-Iine were not contaminated with L. mexicana Acpa/cpb. The 
promastigotes of L. mexicana H-Iine were grown in the presence of 4 kinds of 
selective antibiotics, nourseothricin hydrosulfate (Sat), puromycin (Pur), zeocin (Ble) 
or hygromycin B (Hyg) separately or in combination. The results demonstrated that 
promastigotes of L. mexicana H-line were sensitive to these selective antibiotics and 
did not grow in the media supplemented with these antibiotics. In contrast, 
promastigotes of L. mexicana Acpa/cpb grew in these media. This result was in 
agreement with the report that L. mexicana Acpa was generated by disrupting 
sequentially both alleles of Imcpa using gene-targeting of promastigotes with 
hygromycin- and phleomycin-resistance markers and promastigotes of L. mexicana 
Acpa/cpb are able to grow in the presence of these selective antibiotics (Souza et al., 
1994). Therefore promastigotes o f L. mexicana H-line were neither deficient in CPs, 
nor contaminated with promastigotes of L. mexicana Acpa/cpb. L. mexicana H-line 
has been generated on four separate occasions by the same procedure. On each 
occasion promastigotes were derived from amastigotes, and grown in parallel in 
media with or without gentamicin for at least 20 passages. It was demonstrated that 
the attenuation procedure did not effect on the growth rate of promastigotes of L.
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mexicana H-line. There was no significant difference between the growth rate of 
promastigotes of L. mexicana H-line and L. mexicana WT in vitro.
There are two observations show that L. mexicana H-line is non-infective. First, the 
attenuated line of L. mexicana H-line was unable to survive within BMM in vitro. 
Alexander and Russell (1992) reported that the ability o f amastigotes of Leishmania 
to survive within macrophages is a primary mechanism for evading the immune 
response of their vertebrate host. Secondly, over 40 mice infected with L. mexicana 
H-line failed to develop cutaneous lesions and only one developed a healing lesion 
during 12 weeks post infection. It is proposed that the mechanisms underlying the 
development of non-healing lesions, in genetically susceptible mice, is under control 
of specific cytokines, including IL-12, IFN-y, IL-4, and IL-10 (Heinzel et al., 1995; 
Scharton-Kersten and Scott, 1995). Satoskar and colleagues (1997) showed that 
genetically susceptible mice lacking IL-4 are protected from cutaneous infection with 
L. mexicana WT. IL-4 and IL-IO induce non-healing lesions, whereas in the presence 
of IFN-y and IL-12 cutaneous lesions fail to develop or heal lesions. The activation 
state of macrophages and T cells is dependent on the availability of stimulatory and 
inhibitory cytokines, the production of which can be altered by the parasite (Bogdan 
et al., 1999). The levels o f IFN-y, IL-2, IL-4, and IL-10 in the supernatant of cultured 
splenocytes from the mice infected with L. mexicana H-line or L. mexicana WT were 
measured. It was found that the levels of IFN-y IL-2 in the supernatant of cultured 
Ag-stimulated-splenocytes of mice infected with L. mexicana H-line were 
significantly higher than those of splenocytes of mice infected with L. mexicana WT 
(P<0.05). As a result L. mexicana H-line amastigotes were ehminated by 
macrophages, whereas amastigotes of L. mexicana WT are able to survive for 
prolonged periods within these cells. The survival of L. mexicana WT amastigotes 
within the macrophage is prevented when the macrophages are stimulated by specific 
T-cell-derived lymphokines and IFN-y is the most important component among these 
macrophage-activating mediators (Nathan et al., 1983). It was found that the level o f 
IL-4 in the supernatant of splenocytes from the mice infected with L. mexicana H-line 
was significantly lower than that of mice infected with L. mexicana WT (P<0.05). IL- 
4 plays a crucial role in inhibiting macrophage leishmanicidal activity and down- 
regulating the development of a Thl-like response (Oswald et al., 1992). The amount 
of IL-10 in the supernatant of cultured Ag-stimulated-splenocytes from the mice 
infected with L. mexicana WT or L. mexicana H-line was measured. The level of IL-
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10 production by splenocytes from mice infected with L. mexicana WT was 
significantly higher than that o f mice infected with L. mexicana H-line (P<0.02), IL- 
10, which is typically induced by the parasite, inhibits killing of Leishmania species 
and counteracts the development of a protective ThI immune response (Bogdan et al., 
1993) by its action on antigen presenting cells. The level of IL-2 in the supernatants of 
cultured splenocytes from BALB/c mice infected with stationary phase promastigotes 
o f L. mexicana H-line was significantly higher than that of promastigotes from L. 
mexicana WT (P<0.05). Nacy and colleagues (1991) reported both IFN-y and IL-2, 
induce TNF-a production and secretion of this cytokiue by macrophages. Thus L. 
mexicana WT induces IL-4 and IL-10 whereas L. mexicana H-line presumably has 
the capacity to induce IFN-y, TNF-a, and IL-2, in susceptible mice. This is consist 
with the proposition that IFN-y production by Thl cells inhibits the development of 
Th2 cells (Fitch et at., 1993), whereas the production of IL-4 and IL-10 by Th2 cells 
inhibits Thl development and activation, as well as macrophage activation and 
bactericidal activity (Sher and Coffrnan, 1992; Moore et al., 1993).
Following inoculation of 5 x 10  ^stationary phase promastigotes of the two cell 
lines, dissemination and survival o f the two lines in the skin and visceral organs of 
BALB/c mice were investigated. Other studies have shown that dissemination of the 
parasite in the visceral organs of susceptible mice is the result of the development of a 
non-protective Th2 response (Liew and Donnell, 1993). The local restriction of the 
parasite prior to the development of T cell responses appears to be mediated by the 
innate immune system and this activity is considered to play an important role in the 
subsequent development of a protective T cell response (Laskay et al., 1995). In the 
present study it was found that L  mexicana H-line was localized in the skin at the site 
where the promastigotes were injected and the draining popliteal LN, after 120 days 
post infection without any dissemination to the visceral organs. In contrast, infection 
with L. mexicana WT led to rapid parasite spread to the bone marrow, spleen, drain 
popliteal LN, and lungs. The fact that L. mexicana H-line parasites can survive in the 
skin for an extended period would sustain long term memory. All these results show 
that L. mexicana H-line has reduced virulence for susceptible mice and induces a Thl- 
like immune response.
It was demonstrated that the attenuated L. mexicana H-line was capable o f protecting 
mice against L. mexicana WT. Mice were vaccinated with stationary phase 
promastigotes of L. mexicana H-line and 12 weeks post immunization were
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challenged with L. mexicana WT. All the non-vaccinated mice developed progressive, 
non-healing lesions, whereas the mice vaccinated with L  mexicana H-line developed 
small but in some cases healing lesions over 22 weeks post infection. Thus, the 
attenuated line of L  mexicana holds considerable promise for vaccination against 
leishmaniasis in which Thl responses are desirable. The levels of IFN-y and IL-4 in 
the supernatants of cultured splenocytes from the vaccinated mice and mice 
challenged with L. mexicana WT were measured. It was found that the level of IFN-y 
in the supernatant o f cultured Ag-stimulated-splenocytes of challenged mice at 12 
weeks post challenge was significantly greater than that of non-vaccinated mice 
infected with L. mexicana WT (P<0.005). In contrast to the vaccinated mice, the 
amount of IL-4 in the supernatant of Ag-stimulated-splenocytes cultured from non­
vaccinated mice infected with L  mexicana WT was higher than that of vaccinated 
mice challenged with L. mexicana WT at the same time. Therefore, it can be 
concluded that L. mexicana H-line preferentially induces Thl-like immune responses 
and down-regulates Th2 response in BALB/c mice. This result is in agreement with 
reports that a Thl response protects against cutaneous leishmaniasis, but the induction 
of a simultaneous Th2 response abrogates the protective Thl effector function 
(Sjolander, 1998; Reiner and Locksley, 1995). EarUer in the study, it was shown that 
L  mexicana WT disseminated in the skin and visceral organs, whereas L  mexicana 
H-line localized in the skin and draining LN. Dissemination o f L  mexicana WT in the 
skin and visceral organs of mice vaccinated with L, mexicana H-line was investigated. 
L  mexicana WT was disseminated in the skin or visceral organs of 3 vaccinated mice 
when L. mexicana H-line was apparently absent. In contrast, in the presence of L. 
mexicana H-line in the skin of 3 vaccinated mice, L  mexicana WT was unable to 
survive in the skin and visceral organs. Therefore, the presence of L. mexicana H-line 
in the host led to elimination o f L. mexicana WT in the skin and visceral organs of 
vaccinated mice. The protection induced by L  mexicana H-line when challenged 
simultaneously with L  mexicana WT, was investigated. The same number of 
stationary phase promastigotes of the two lines of L. mexicana were injected either 
together in the same side of the rump or the same number of L  mexicana WT or L  
mexicana H-line injected in opposites side of the rump of the mice. The control mice, 
which were infected with L. mexicana WT only developed progressive non-healing 
lesions. In contrast, some of the mice that were infected with a mixture of L  mexicana 
H-line and L. mexicana WT developed very slowly growing lesions. In the mice that
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were injected with the two lines o f parasites on the separate sides, growth of L. 
mexicana WT was slowed. This indicated that the presence of the attenuated cell line 
in the susceptible mice induced immune responses that led to the control of L. 
mexicana WT. These results showed that the attenuated L  mexicana H-line was able 
to control the immune system of the host even when it was inoculated with L. 
mexicana WT at the same time. In comparison with the control mice, the immune 
response of the mice that were injected two lines of L  mexicana in the same side were 
able to reduce the virulence o f X. mexicana WT. This suggests that L  mexicana H- 
line could be used in therapeutically.
From some o f the mice vaccinated with L  mexicana H-line, culturing the epidermal 
cells from the site where the parasite was injected, amastigotes differentiated to 
promastigotes and this cell line was designated L. mexicana HAD-line. It was 
observed that promastigotes of L. mexicana HAD-line grew poorly in medium with or 
without gentamicin. The morphology of cell cultures of L  mexicana HAD-line 
showed that 17% of the cells were promastigotes of which some o f them had a 
reduced flagellum and 83% of them were amastigote-like. This suggests that the 
attenuated cell line maybe be unable to survive in the midgut of sandfly and if so, this 
would reduce the risk of virulence reversion and spread of disease by infected 
sandflies.
Preliminary results showed that an attenuated cell line of L  major could be 
generated under antibiotic pressure of using the same technique as for the generation 
L. mexicana H-line. Comparisons between L  major WT and L. major H-line were 
made on parallel cultures o f the same age. It was found that the medium after 
culturing stationary phase promastigotes of L  major WT was more acidic (pH 6.3) 
than that of L  major H-line (pH 6.9). The results showed the percentage of 
macrophages infected with promastigotes of L. major H-line was 41% at 8 h and 
decreased to 10.5% at 96 h post infection. In contrast to L. major H-line, the initial 
infection of macrophages with L. major WT was 46.5% and increased to 65% at 96 h 
post infection. It was shown that L  major H-line failed to develop cutaneous lesions 
during 12 weeks post infection. In contrast to L  major H-line, all mice infected with 
L  major WT went on to grow non-healing lesions the over same period. The 
dissemination of L  major H-line and L  major WT from the skin where the 
promastigotes were injected to visceral organs of BALB/c mice was investigated at 12 
weeks post infection. It was found that L. major WT spread to BM, spleen, lung.
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popliteal LN, and skin. In contrast, L. major H-line was localized in the skin and 
draining LN of two mice. The initial result showed that L. major H-line induced 
protection in vaccinated mice against infection with L  major WT. All non-vaccinated 
mice developed progressive non-healing lesions that peaked in size at about 12 weeks 
post infection. In contrast to non-vaccinated mice the lesions developed slowly in 
vaccinated mice. In the present study, all biological and immunological data on the 
immune response o f L  mexicana H-line and the preliminary results on L. major H- 
line provide strong encouragement that X. mexicana H-line and X. major H-line 
induce a Thl type of immune response, control cutaneous leishmaniasis, and are 
candidate live attenuated vaccines.
While this work has given exciting results in terms o f the prospects for 
vaccination much remains to be done. Several aspects of the work need to be 
confirmed or extended. These are listed below:
1. Confirmation of the effect of the attenuation procedure on X. mexicana and X. 
major.
2. Extension o f the attenuation effect to other clinically important Leishmania species 
including X. infantum and X. donovani.
3. Identification o f the effect o f attenuation on Leishmania parasites by proteomics 
and mass spectrometry. It will be essential to determine the difference between the 
two lines. Identification of the molecule (or molecules) which was (were) absent or 
present in the attenuated lines of X, mexicana or X. major could be important for 
activation of macrophages.
4. Optimisation of the dose and number of attenuated vaccine boosts needed to induce 
complete protection against challenge infection.
5. Investigation of the ability o f animals immunised with attenuated Leishmania to 
resist challenge infections delivered by sandfly bites. The mice vaccinated with the 
attenuated line o f X. mexicana or X. major should be exposed to parasites, which are 
delivered by sandfly.
6. Investigation of the capacity o f attenuated, heat-killed parasites to induce 
protection. Determination of the ability o f killed promastigotes of X. mexicana H-line 
or X. major H-line to protect mice against wild type parasites will be important. If the 
killed promastigotes of the attenuated lines can induce protection, this kind of vaccine 
will be safer than live attenuated cell lines.
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7. Comparison o f the levels of protection induced by attenuated parasites with levels 
of protection obtained with other vaccine strategies.
8. Examination of the effectiveness of vaccination with attenuated parasites during 
ongoing infection. Confirmation that the attenuated line of L. mexicana is able to 
activate macrophages infected with L. mexicana WT. If so, the L  mexicana H-line 
can be used for therapeutic purposes.
9. Assessment of the ability of attenuated parasites to undergo sandfly passage. It has 
been shown that L. mexicana H-line was stable in the medium without gentamicin for 
a long time. Assessment o f the stability of the attenuated line o f L  mexicana H-line in 
the guts of sandflies can be important for spreading the disease.
10. Do sandfly passaged attenuated parasites induce protection against challenge 
infection? If  so, it should be a positive point for encouraging the use of L  mexicana 
H-line for vaccination.
11. Extension of the immunisation experiments to other species, including dogs.
12. Early isolation and attenuation of new clinical Leishmania isolates that could be 
attenuated under food and drug administration (FDA) approved guidelines for use as 
vaccines in humans.
13. Phase I clinical trials of attenuated Leishmania vaccines.
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Table 1. Recipe for separating gel
Reagents Amount
Bis / Acrylamide (30%) 3.0 ml
Resolving buffer (see Table 2) 1.25 ml
Sodium dodecyl sulphate (SDS) (10% w/v) 0.1ml
double distilled water (dd Water) 4.14 ml
Ammonium persulphate (APS) (1.5% w/v) 0.5 ml
TEMED 0.015 ml
Table 2. Resolving buffer*
Reagent Final Concentration Amount
Tris base 3M 36.3 g
ddHzO 60 ml
HCl (1 M) pH was adjusted to 8.8
ddHzO exactly to 100 ml final
* Store at 4^C
Table 3. Recipe for stacking gel
Reagents Amount
Bis / Acrylamide (30%) 0.665 ml
Stacking buffer (see Table 4) 1.25 ml
SDS (10% w/v) 0.05 ml
dd Water 2.780 ml
APS (1.5% w/v) 0.25 ml
TEMED 0.007 ml
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Table 4. Electrophoresis buffer*
Reagent Final Concentration Amount
Tris base 0.5 M 6 g
ddHzO 60 ml
HCl (1 M) pH was adjusted to 6.8
ddHzO exactly 100 ml
* Store at r^c
Table 5, Sample buffer 2X
Reagents Amount
Stacking buffer (see Table 4) 2.0 ml
ddHaO 4.0 ml
Glycerol 1.6 ml
SDS (10%) 3.2 ml
Mercaptoethanol 0.8 ml
Bromophenol Blue a few grains
Total volume 11.6 ml
Table 6. Separating gel mixtures-10% acrylamide for gradient gel
Reagents Amount
Acrylamide (30%) 10.0 ml
Resolving buffer (see Table 2) 3.75 ml
SDS (10% w/v) 0.3 ml
dd Water 10.0 ml
APS (1.5% w/v) 0.7 ml
TEMED* 0.008 ml
* TEMED was added to each just before pouring the gel.
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Table 7. Separating gel mixtnres-20% acrylamide for gradient gel
Reagents Amount
Acrylamide (30%) 20.0 ml
Resolving buffer (see Table 2) 3.75 ml
SDS (10% w/v) 0.3 ml
dd Water 2.75 ml
Sucrose (equivalent to 2.5 ml volume) 4.5 g
APS (1.5% w/v) 0.7 ml
TEMED* 0.008 ml
* TEMED was added to each just before pouring the gel.
Table 8. Lysis Solution used for method 1 *
Reagent Final Concentration Amount
Urea (Pharmacia) 8M 9.6 g
Chaps (Pharmacia) 4% 0.8 g
Tris base (Sigma) 40 mM 0.097 g
ddHiO 100 ml 20 ml
* 100 ml was aliquoted and stored at -20"C.
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Table 9. Lysate solution used for method 2
Reagent Final Concentration Amount
Chaps 0.4% 0.2 g
DTT 200 mM 0.152 g
Tris base 40 mM 0.024 g
ddHzO 5 ml 5 ml
100 pi was aliquoted and stored at -20*^C.
Table 10. Rehydration stock solution without IPG Buffer*
Reagent Final Concentration Amount
Urea 8M 12 g
Chaps 2% (w/v) 0.5 g
Bromophenol blue trace a few grains
ddHzO To 25 ml to 25 ml
* 2.5 ml was aliquoted and stored at -20°C.
Table 11. Rehydration stock solution with IPG Buffer*
Reagent Final
Concentration
Amount
Urea 8M 12 g
Chaps 2% (w/v) 0.5 g
IPG Buffer
(same pH range as the IPG strip)
0.5% or 2% (v/v) 125 or 500 pi
Bromophenol blue trace a few grains
ddHzO to 25 ml to 25 ml
* 2.5 ml was aliquoted and stored at -20"C.
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Table 12. SDS equilibration Buffer^
Reagent Final Concentration Amount
4 X Resolving buffer ** 50 mM 3.35 ml
Urea 6M 36.04 g
Glycerol (87% v/v) 30% (v/v) 34.5 ml
SDS 2% (w/v) 2 g
Bromophenol blue trace a few grains
dd H20 100 ml 100 ml
* Aliquoted 10 ml and stored at -20“C.
* * See Table 2.15
For each gel 2 aliquots were used as follows:
Equilibration I: 100 mg DTT was added to 10 ml equilibration buffer. 
Equilibration II: 250 mg iodoacetamide was added to 10 ml equilibration buffer.
Table 13. 4X Resolving gel buffer
Reagent Final Concentration Amount
Tris base 1.5 M 181.5 g
dd HiO 750 ml 750 ml
HCl (5 M) pH was adjusted to 8.8 pH was adjusted to 8.8
ddHzO to 1000 ml to 1000 ml
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Table 14. SDS-PAGE with 10% acrylamide.
Reagent 11 gels 12 gels
Acrylamide 40% 176.8 g 192.8 g
N-N-methyl bis acrylamid 
2%
94.4 g 102.9 g
4 X Resolving buffer* 174.4 ml 190.2 ml
ddH 20 243.8 ml 265.9 ml
10% SDS 7.1 ml 7.7 ml
10% APS 7.1 ml 7.7 ml
10% TEMED 1.2 ml 1.3 ml
See Table 2
Table 15. Displaying solution
Reagent Final Concentration Amount
4X Resolving buffer* 0.37 M 50 ml
Glycerol (87%) 50% (v/v) 100 ml
Bromophenol blue a few grains a few grains
ddHzO to 100 ml to 200 ml
* See Table 2
Table 16. Storage solution
Reagent Final Concentration Amount
4X Resolving buffer* 0.37 M 50 ml
10% SDS 0.1% (v/v) 2 ml
ddHzO to 200 ml to 200 ml
* See Table 2
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Table 17. SDS electrophoresis buffer
Reagent Final Concentration Amount
Tris base 25 mM 60.5 g
Glycine 192 mM 288.2 g
SDS 0.1% 20 g
ddHsO 20 liter 20 liter
Table 18. Agarose sealing solution
Reagent Final Concentration Amount
SDS electrophoresis buffer (see Table 2.14) 100 ml
Agarose 0.5% 0.5 g
Bromophenol blue trace A few grains
All reagents were added into a 500 ml Erlenmeyer flask and heated in a microwave 
oven on low until the agarose was completely dissolved.
Phosphate buffered saline (pH 7.2)
60.0 g Na2HP0 4 .1 2 H2 0
13.6 g Na2HP04.2H20
8.5 g NaCl
Made up to 1 litre with de-ionised and distilled water.
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DMEM
15.44 g DEME powdered medium (Gibco)
0.85 g NazCO]
Made up to 1 litre with de-ionised and distilled water, filter sterilised 
(Millipore/Gelman filter 0.22 pm size) and pH adjusted to pH 7.2.
10.0 ml Penicillin / Streptomicine.
Giemsa's Buffer
3.0 g Na2HP04
0.6 g KH2PO4
The pH was adjusted to pH 7.4 and made up to 1 litre with de-ionised distilled water.
Giemsa' stain
Giemsa' stain (Gurr BDH Ltd) was diluted 1:10 in Giemsa's buffer.
Coomassie Blue Stain
250.0 ml Methanol
100.0 ml Acetic acid
10.0 ml Glycerol
1.0 g Coomasie Blue
Made up to 1 litre with de-ionised and distilled water.
Coomassie Blue Destain
250.0 ml Methanol
100.0 ml Acetic acid
10.0 ml Glycerol
Made up to 1 litre with de-ionised and distilled water.
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Brilliant Crystal Blue
5.0 g Brilliant Crystal Blue powder
100.0 ml Methanol
Store for a few days before using.
Trypan Blue (for viability test)
0.1 g Trypan Blue powder
5 ml PBS
Then filter.
Evans Blue (for Fluorescent Staining) (Stock)
0.1 g Evance Blue powdered
10 ml PBS (pH 7.2)
Take 1 ml in 100 ml PBS
Coating Buffer
1.59 g NazCOs
2.93 g NaHCOs
0.2 NaN]
The pH was adjusted to pH 9.6 with NaOH and made up to 1 litre with de-ionised 
distilled water.
Tris Buffered Saline (TBS)
9 g NaCl
1.6 g Tris HCl
The pH was adjusted to pH 7.6 with HCL and made up to 1 litre with de-ionised 
distilled water.
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Transfer Buffer
14.42 g Glycine
3.03 g Tris
1.0 g SDS
200 ml Methanol
Made up to 1 litre with de-ionised and distilled water
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